
<html lang="en"     class="pb-page"  data-request-id="6ae87b38-705c-4bef-95e9-14f4941fd2cf"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/jm200469u;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2011.54.issue-17"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure–Activity Relationship and Pharmacokinetic Studies of Sotrastaurin (AEB071), a Promising Novel Medicine for Prevention of Graft Rejection and Treatment of Psoriasis" /></meta><meta name="dc.Creator" content="Jürgen  Wagner" /></meta><meta name="dc.Creator" content="Peter  von Matt" /></meta><meta name="dc.Creator" content="Bernard  Faller" /></meta><meta name="dc.Creator" content="Nigel G.  Cooke" /></meta><meta name="dc.Creator" content="Rainer  Albert" /></meta><meta name="dc.Creator" content="Richard  Sedrani" /></meta><meta name="dc.Creator" content="Hansjörg  Wiegand" /></meta><meta name="dc.Creator" content="Christian  Jean" /></meta><meta name="dc.Creator" content="Christian  Beerli" /></meta><meta name="dc.Creator" content="Gisbert  Weckbecker" /></meta><meta name="dc.Creator" content="Jean-Pierre  Evenou" /></meta><meta name="dc.Creator" content="Gerhard  Zenke" /></meta><meta name="dc.Creator" content="Sylvain  Cottens" /></meta><meta name="dc.Description" content="Protein kinase C (PKC) isotypes have emerged as key targets for the blockade of early T-cell activation. Herein, we report on the structure–activity relationship and the detailed physicochemical an..." /></meta><meta name="Description" content="Protein kinase C (PKC) isotypes have emerged as key targets for the blockade of early T-cell activation. Herein, we report on the structure–activity relationship and the detailed physicochemical an..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 8, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm200469u" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm200469u" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm200469u" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm200469u" /></link>
        
    
    

<title>Structure–Activity Relationship and Pharmacokinetic Studies of Sotrastaurin (AEB071), a Promising Novel Medicine for Prevention of Graft Rejection and Treatment of Psoriasis | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm200469u" /></meta><meta property="og:title" content="Structure–Activity Relationship and Pharmacokinetic Studies of Sotrastaurin (AEB071), a Promising Novel Medicine for Prevention of Graft Rejection and Treatment of Psoriasis" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0012.jpeg" /></meta><meta property="og:description" content="Protein kinase C (PKC) isotypes have emerged as key targets for the blockade of early T-cell activation. Herein, we report on the structure–activity relationship and the detailed physicochemical and in vivo pharmacokinetic properties of sotrastaurin (AEB071, 1), a novel maleimide-based PKC inhibitor currently in phase II clinical trials. Most notably, the preferred uptake of sotrastaurin into lymphoid tissues is an important feature, which is likely to contribute to its in vivo efficacy." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm200469u"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm200469u">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm200469u&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm200469u&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm200469u&amp;href=/doi/10.1021/jm200469u" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 6028-6039</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm200454y" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm200516a" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure–Activity Relationship and Pharmacokinetic Studies of Sotrastaurin (AEB071), a Promising Novel Medicine for Prevention of Graft Rejection and Treatment of Psoriasis</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J%C3%BCrgen++Wagner">Jürgen Wagner</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++von+Matt">Peter von Matt</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bernard++Faller">Bernard Faller</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nigel+G.++Cooke">Nigel G. Cooke</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rainer++Albert">Rainer Albert</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Sedrani">Richard Sedrani</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hansj%C3%B6rg++Wiegand">Hansjörg Wiegand</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christian++Jean">Christian Jean</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christian++Beerli">Christian Beerli</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gisbert++Weckbecker">Gisbert Weckbecker</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Pierre++Evenou">Jean-Pierre Evenou</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gerhard++Zenke">Gerhard Zenke</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sylvain++Cottens">Sylvain Cottens</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Novartis Institutes for BioMedical Research, Basel CH-4002, Switzerland</span></div><div class="corresp-info">For J.W.: phone, +41.61.696.23.85; fax, +41.61.696.24.55; e-mail, <a href="/cdn-cgi/l/email-protection#cfa5baaabda8aaa1e1b8aea8a1aabd8fa1a0b9aebdbba6bce1aca0a2"><span class="__cf_email__" data-cfemail="abc1deced9cccec585dccaccc5ced9ebc5c4ddcad9dfc2d885c8c4c6">[email protected]</span></a>. For P.v.M.: phone, +41.61.324.97.13; fax, +41.61.324.61.21; e-mail, <a href="/cdn-cgi/l/email-protection#1161746574633f677e7f4e7c706565517f7e6770636578623f727e7c"><span class="__cf_email__" data-cfemail="94e4f1e0f1e6bae2fbfacbf9f5e0e0d4fafbe2f5e6e0fde7baf7fbf9">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm200469u&amp;href=/doi/10.1021%2Fjm200469u" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 6028–6039</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 28, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 April 2011</li><li><span class="item_label"><b>Published</b> online</span>8 August 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 September 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm200469u" title="DOI URL">https://doi.org/10.1021/jm200469u</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6028%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJ%25C3%25BCrgen%2BWagner%252C%2BPeter%2Bvon%2BMatt%252C%2BBernard%2BFaller%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D17%26contentID%3Djm200469u%26title%3DStructure%25E2%2580%2593Activity%2BRelationship%2Band%2BPharmacokinetic%2BStudies%2Bof%2BSotrastaurin%2B%2528AEB071%2529%252C%2Ba%2BPromising%2BNovel%2BMedicine%2Bfor%2BPrevention%2Bof%2BGraft%2BRejection%2Band%2BTreatment%2Bof%2BPsoriasis%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6039%26publicationDate%3DSeptember%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm200469u"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2585</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">30</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm200469u" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure–Activity Relationship and Pharmacokinetic Studies of Sotrastaurin (AEB071), a Promising Novel Medicine for Prevention of Graft Rejection and Treatment of Psoriasis&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jürgen&quot;,&quot;last_name&quot;:&quot;Wagner&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;von Matt&quot;},{&quot;first_name&quot;:&quot;Bernard&quot;,&quot;last_name&quot;:&quot;Faller&quot;},{&quot;first_name&quot;:&quot;Nigel&quot;,&quot;last_name&quot;:&quot;G. Cooke&quot;},{&quot;first_name&quot;:&quot;Rainer&quot;,&quot;last_name&quot;:&quot;Albert&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Sedrani&quot;},{&quot;first_name&quot;:&quot;Hansjörg&quot;,&quot;last_name&quot;:&quot;Wiegand&quot;},{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;Jean&quot;},{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;Beerli&quot;},{&quot;first_name&quot;:&quot;Gisbert&quot;,&quot;last_name&quot;:&quot;Weckbecker&quot;},{&quot;first_name&quot;:&quot;Jean-Pierre&quot;,&quot;last_name&quot;:&quot;Evenou&quot;},{&quot;first_name&quot;:&quot;Gerhard&quot;,&quot;last_name&quot;:&quot;Zenke&quot;},{&quot;first_name&quot;:&quot;Sylvain&quot;,&quot;last_name&quot;:&quot;Cottens&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;6028-6039&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm200469u&quot;},&quot;abstract&quot;:&quot;Protein kinase C (PKC) isotypes have emerged as key targets for the blockade of early T-cell activation. Herein, we report on the structure–activity relationship and the detailed physicochemical and in vivo pharmacokinetic properties of sotrastaurin (AEB071, 1), a novel maleimide-based PKC inhibitor currently in phase II clinical trials. Most notably, the preferred uptake of sotrastaurin into lymphoid tissues is an important feature, which is likely to contribute to its in vivo efficacy.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200469u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200469u" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200469u&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200469u" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200469u&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200469u" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm200469u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200469u&amp;href=/doi/10.1021/jm200469u" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm200469u" /></input><a href="/doi/pdf/10.1021/jm200469u" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm200469u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm200469u%26sid%3Dliteratum%253Aachs%26pmid%3D21797275%26genre%3Darticle%26aulast%3DWagner%26date%3D2011%26atitle%3DStructure%25E2%2580%2593Activity%2BRelationship%2Band%2BPharmacokinetic%2BStudies%2Bof%2BSotrastaurin%2B%2528AEB071%2529%252C%2Ba%2BPromising%2BNovel%2BMedicine%2Bfor%2BPrevention%2Bof%2BGraft%2BRejection%2Band%2BTreatment%2Bof%2BPsoriasis%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D17%26spage%3D6028%26epage%3D6039%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292349" title="Alkyls">Alkyls</a>,</li><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jmcmar.2011.54.issue-17/production/jmcmar.2011.54.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/medium/jm-2011-00469u_0012.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200469u&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Protein kinase C (PKC) isotypes have emerged as key targets for the blockade of early T-cell activation. Herein, we report on the structure–activity relationship and the detailed physicochemical and in vivo pharmacokinetic properties of sotrastaurin (AEB071, <b>1</b>), a novel maleimide-based PKC inhibitor currently in phase II clinical trials. Most notably, the preferred uptake of sotrastaurin into lymphoid tissues is an important feature, which is likely to contribute to its in vivo efficacy.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34255" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34255" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Solid organ allotransplantation is currently the treatment of choice for patients with end stage renal, cardiac, hepatic, pancreatic, and pulmonary failure.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> Despite the considerable impact on extending and improving the quality of life of patients, safer and better tolerated immunosuppressants are still an unmet medical need. In particular, the blockade of T-cell activation, which is a central event in the complex process of graft rejection, is currently only achieved in the clinical setting with calcineurin inhibitors like cyclosporine A (CsA) and tacrolimus. The therapeutic value of these agents, although widely used in transplant patients, is limited by mechanism-based side effects. Thus, novel and specific inhibitors of early T-cell activation acting though an alternative mechanism of action are of high interest. Recently, we reported preliminary results on the discovery of sotrastaurin (STN, AEB071, <b>1</b>), an immunosuppressant that inhibits classical and novel protein kinase C (PKC) isotypes.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> The clinical data generated with <b>1</b> suggest that the pharmacologic inhibition of PKCs might offer an alternative mechanism-based therapeutic strategy for preventing early T-cell activation, thus providing unique treatment options for transplanted patients and patients suffering from T-cell dependent autoimmune pathologies like psoriasis.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a></div><div class="NLM_p">The PKC family of serine/threonine kinases plays a central role in signaling cascades of the immune system. The PKC isotypes are divided into three classes based on their cofactor requirements. Whereas the classical cPKCs α, β, and γ are regulated by diacylglycerol (DAG), phosphatidylserine (PS), and calcium, the novel nPKCs δ, ε, η, and θ require DAG and PS but are calcium insensitive. The atypical aPKCs ι/λ and ζ require neither DAG nor calcium.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In resting cells, the PKCs are predominantly localized in the cytosol and are catalytically inactive because of autoinhibition by their pseudosubstrate domain. Upon cell activation, PKC isotype-specific signals trigger translocation from the cytosol to the membrane and induce conformational changes, which displace the pseudosubstrate moiety from the catalytic domain and enable PKC isotypes to phosphorylate specific protein substrates. Interestingly, the unique function of each individual PKC isotype was only recently understood through the study of individual knockout mice.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> On the basis of the analysis of such phenotypes, three PKC isotypes, namely, α, β, and θ, emerged as key regulators of T and B cell signaling pathways.</div><div class="NLM_p last">Herein, we report on the structure–activity relationship (SAR) around the quinazolinyl-indolyl-maleimide scaffold and describe in depth the in vitro and in vivo pharmacokinetic properties of <b>1</b>. In particular, the importance of tissue distribution into lymphatic organs is highlighted. Indeed, the striking difference in exposure between <b>1</b> and the structurally closely related analogue <b>32</b>, which is in contrast to <b>1</b> inefficacious in preclinical rat models, emphasizes the need to reach high drug levels in the main target organs.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Synthesis</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60555" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60555" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All quinazolinylindolyl derivatives were obtained from commercially available building blocks according to the synthesis described for <b>1</b> in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The sodium salt of ethyl acetoacetate regioselectively replaced the 4-chloro atom of 2,4-dichloroquinazoline.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Upon exposure of the initially obtained adduct to aqueous ammonia, a retro-Claisen reaction and a primary amide formation ensued to afford <b>2</b>. Introduction of <i>N</i>-methylpiperazine resulted in intermediate <b>3</b> which was cyclized with (1<i>H</i>-indol-3-yl)oxoacetic acid methyl ester<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> under basic conditions to complete the synthesis of <b>1</b> in good yields.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/medium/jm-2011-00469u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Generic Synthesis of the Quinazolinyl Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200469u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: yields are given for <b>1</b> (R<sub>1</sub>, R<sub>2</sub> = H); (a) POCl<sub>3</sub>, dimethylphenylamine, 110 °C, 81%; (b) (i) 3-oxobutyric acid ethyl ester, NaH, THF, 0 °C, then toluene, 110 °C; (ii) NH<sub>4</sub>OH, room temperature; (iii) ethyl acetate, 76 °C, 54%; (c) <i>N</i>-methylpiperazine, 1-methyl-2-pyrrolidinone, 50 °C, 69%; (d) (1<i>H</i>-indol-3-yl)oxoacetic acid methyl ester, KO<i><sup>t</sup></i>Bu, THF, 0 °C to room temperature, 47%.</p></p></figure><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> describes the synthesis of the naphthyl-based maleimide <b>7</b>. 4-Bromonaphthalen-2-ol was protected as the benzyl ether and submitted to a palladium-catalyzed coupling with preformed tributylstannanylacetic acid ethyl ester to form the intermediate ester <b>4</b>.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> After hydrogenolytic removal of the benzyl group, the phenol was converted to the trifluoromethylsulfonate derivative <b>5</b>, which was used in the palladium-catalyzed coupling reaction with <i>N</i>-methylpiperazine.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Formamide in methanolic sodium methoxide served to directly convert the ester to the primary amide <b>6</b>,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> which was used in the cyclocondensation reaction.</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/medium/jm-2011-00469u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the Naphthyl Derivative <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200469u&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, BnBr, Bu<sub>4</sub>NI (cat.), DMF, room temperature, 93%; (b) tributylstannanylacetic acid ethyl ester, ZnBr<sub>2</sub>, PdCl<sub>2</sub>[P(<i>o</i>-tolyl)<sub>3</sub>]<sub>2</sub> (0.2 equiv), DMF, 80 °C, 42%; (c) Pd/C 10%, H<sub>2</sub>, MeOH, room temperature, 95%; (d) (CF<sub>3</sub>SO<sub>2</sub>)<sub>2</sub>O, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, room temperature, 89%; (e) Pd<sub>2</sub>(dba)<sub>3</sub> (0.05 equiv), 2-(di-<i>tert</i>-butylphosphino)biphenyl (0.05 equiv), <i>N</i>-methylpiperazine, K<sub>3</sub>PO<sub>4</sub>, THF, 80 °C, 84%; (f) formamide, NaOMe, DMF, 105 °C, 92%; (g) (1<i>H</i>-indol-3-yl)oxoacetic acid methyl ester, KO<i><sup>t</sup></i>Bu, THF, room temperature, 66%.</p></p></figure><div class="NLM_p">The synthesis of the quinolinyl derivative <b>10</b> is described in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. The previously reported methyl ester<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> was converted into the 2-chloroquinolinyl intermediate, which was then stirred in aqueous ammonia to form the primary amide <b>8</b>. Room temperature coupling with <i>N</i>-methylpiperazine yielded <b>9</b>, which was used in the base-mediated cyclocondensation to afford maleimide <b>10</b>.</div><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/medium/jm-2011-00469u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the Quinolinyl Derivative <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200469u&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) POCl<sub>3</sub> (1.6 equiv), 2 h, 80 °C, 95%; (b) NH<sub>4</sub>OH (28% aqueous), 16 h, room temperature, 62%; (c) <i>N</i>-methylpiperazine (5 equiv), NMP, 60 h, room temperature, 80%; (d) (1<i>H</i>-indol-3-yl)oxoacetic acid methyl ester (1 equiv), KO<i><sup>t</sup></i>Bu (5 equiv), DMF, 19 h, 80 °C, 62%.</p></p></figure><div class="NLM_p">Finally, the synthesis of the isoquinolinyl-based maleimide <b>13</b> started from commercially available 1,3-dichloroisoquinoline (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). The regioselective chlorine substitution with the sodium salt of malonic acid diethyl ester followed by in situ decarboxylation upon heating in xylene yielded the intermediate ester, which was converted to the primary amide <b>11</b> in methanolic ammonia. Cyclocondensation led to the intermediate maleimide <b>12</b>, which was transformed into the end product <b>13</b> through thermal substitution of chlorine with <i>N</i>-methylpiperazine.</div><figure id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/medium/jm-2011-00469u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the Isoquinolinyl Derivative <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200469u&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) malonic acid diethyl ester (3 equiv), NaH (2.8 equiv), xylene, 3 h, 140 °C, 62%; (b) NH<sub>3</sub> (4 M in MeOH), 16 h, 130 °C, 76%; (c) (1<i>H</i>-indol-3-yl)oxoacetic acid methyl ester (2.5 equiv), KO<sup><i>t</i></sup>Bu (1 M in THF, 5 equiv), 1 h, 80 °C, 54%; (d) <i>N</i>-methylpiperazine, 18 h, 130 °C, 29%.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47743" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47743" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">During the early stages of the chemical derivation program, our efforts focused on identifying the most promising bicyclic heteroaromatic moiety through modifications in positions X and Y (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The inhibitory potency on classical and novel PKC isotypes was determined by scintillation proximity assay (SPA) technology.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Results from these assays indicated that the replacement of the quinazolinyl by a naphthyl moiety in <b>7</b> reduced the potency by 5-fold on the novel PKC isotypes. In contrast, <b>7</b> retained full activity on the classical PKC isotypes α and β. Interestingly, the PKC activity of the quinolinyl derivative <b>10</b> was further reduced and single digit nanomolar potency was retained only on the classical isotypes. A very similar profile was measured for the partially hydrogenated 5,6,7,8-tetrahydronaphthyl derivative (data not shown), suggesting that the binding sites of PKC α and β are more flexible and can tolerate nonplanar fragments as well as polarity in position X of the quinazoline ring. These scaffolds may represent suitable leads for an approach aiming at specific inhibition of classical PKCs. Finally, the isoquinolinyl derivative <b>13</b> was equipotent to <b>1</b> on all isotypes, suggesting that the nitrogen atom in position X is not essential. Gratifyingly, the biochemical activity translated into prevention of T-cell activation measured by inhibition of IL-2 production after stimulation through the T cell receptor (TCR) and the coreceptor CD28.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Furthermore, the compounds also showed in vitro immunosuppressive activity as assessed in the mixed lymphocyte reaction (MLR) assay, which is a standard readout for alloantigen-induced T-cell proliferation.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The least potent derivative <b>10</b> was significantly less active in the mouse MLR, and as a general trend, the maleimides show superior inhibition of MLR responses using human rather than mouse cells. These derivatives are not general inhibitors of cell proliferation, as they affected the proliferation of mouse bone marrow cells only in the micromolar range (IC<sub>50s</sub> > 2.5 μM).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Further derivation efforts focused on the quinazolinyl scaffold because of the strong potency on PKC isotypes and the broad synthetic accessibility of the series.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Influence of Nitrogen Insertion on Isotype Selectivity</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/medium/jm-2011-00469u_0008.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">PKC isotypes<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="2" align="center">MLR<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="rowsep1 colsep0" align="center">TCR/CD28<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X, Y</th><th class="colsep0 rowsep0" align="center">α</th><th class="colsep0 rowsep0" align="center">β<sub>1</sub></th><th class="colsep0 rowsep0" align="center">δ</th><th class="colsep0 rowsep0" align="center">ε</th><th class="colsep0 rowsep0" align="center">η</th><th class="colsep0 rowsep0" align="center">θ</th><th class="colsep0 rowsep0" align="center">mouse</th><th class="colsep0 rowsep0" align="center">human</th><th class="colsep0 rowsep0" align="center">Jurkat cells</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">N, N</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">6.2</td><td class="colsep0 rowsep0" align="left">6.1</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">150</td><td class="colsep0 rowsep0" align="left">37</td><td class="colsep0 rowsep0" align="left">54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">C, C</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">7.3</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">4.8</td><td class="colsep0 rowsep0" align="left">123</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">N, C</td><td class="colsep0 rowsep0" align="left">3.6</td><td class="colsep0 rowsep0" align="left">5.2</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">72</td><td class="colsep0 rowsep0" align="left">118</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">575</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">C, N</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">6.2</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">73</td><td class="colsep0 rowsep0" align="left">37</td><td class="colsep0 rowsep0" align="left">23</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are reported in nM as the average of at least two independent experiments.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">MLR = mixed lymphocyte reaction assay. nd = not determined.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Inhibition of IL-2 secretion after TCR/CD28-mediated activation of Jurkat cells.</p></div></div></div><div class="NLM_p">In a second derivation round, the impact of substituents in positions 5–8 of the quinazolinyl fragment on potency and selectivity was explored (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Modifications in position 5 had little effect on activity as represented by the 5-methyl derivative <b>14</b>. In contrast, derivation of position 6 was more attractive, as it allowed modulation of the PKC isotype specificity. The 6-fluoro analogue <b>15</b> is the most potent derivative of the series and marginally superior over <b>1</b>. By increasing the bulk of the substituent, the activity on PKC β is gradually lost. This is well demonstrated by the chloro and methyl analogues <b>16</b> and <b>17</b>. The hydrophobic cavity was further explored with the isopropyl analogue <b>18</b>, which is inactive on all assayed isotypes except PKC δ and θ. These two PKC isotypes are phylogenetically most closely related and the comparable inhibitory activity is thus not unexpected.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Finally, all PKC activity is lost with the <i>tert</i>-butyl analogue <b>19</b>. Our attempts to substitute positions 7 and 8 were unsuccessful, as the activity on the target was rapidly lost with derivatives <b>20</b>–<b>22</b>. Even the 7-fluoro analogue <b>20</b>, with the sterically least demanding group, showed reduced potency. These results are confirmed by the X-ray crystal structure of <b>1</b> bound to the ATP-binding site of PKC α.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Indeed, the structure suggests that substituents in this part of the quinazolinyl moiety would clash with several residues of the protein in spatial proximity including Val<sub>353</sub>, Lys<sub>368</sub>, Met<sub>417</sub>, and Phe<sub>350</sub>. Overall, these results show that modifying position 6 of the quinazolinyl fragment has a strong impact on the PKC selectivity profile. Consequently, further derivation thereof may well lead to the identification of tool compounds with unique specificities and therefore of high value to test the role of individual isotypes in cellular signaling pathways.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Influence of Substituents around the Quinazolinyl Moiety on Isotype Selectivity</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/medium/jm-2011-00469u_0009.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">PKC isotypes<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">α</th><th class="colsep0 rowsep0" align="center">β<sub>1</sub></th><th class="colsep0 rowsep0" align="center">δ</th><th class="colsep0 rowsep0" align="center">ε</th><th class="colsep0 rowsep0" align="center">η</th><th class="colsep0 rowsep0" align="center">θ</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">5-Me</td><td class="colsep0 rowsep0" align="left">3.6</td><td class="colsep0 rowsep0" align="left">3.8</td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">6.2</td><td class="colsep0 rowsep0" align="left">9.2</td><td class="colsep0 rowsep0" align="left">2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">6-F</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">6-Cl</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">5.4</td><td class="colsep0 rowsep0" align="left">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">6-Me</td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="left">140</td><td class="colsep0 rowsep0" align="left">4.1</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">5.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">6-<i><sup>i</sup></i>Pr</td><td class="colsep0 rowsep0" align="left">>316</td><td class="colsep0 rowsep0" align="left">>316</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">>316</td><td class="colsep0 rowsep0" align="left">283</td><td class="colsep0 rowsep0" align="left">71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">6-<i><sup>t</sup></i>Bu</td><td class="colsep0 rowsep0" align="left">>316</td><td class="colsep0 rowsep0" align="left">>316</td><td class="colsep0 rowsep0" align="left">>316</td><td class="colsep0 rowsep0" align="left">>316</td><td class="colsep0 rowsep0" align="left">>316</td><td class="colsep0 rowsep0" align="left">>316</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">7-F</td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">5.0</td><td class="colsep0 rowsep0" align="left">6.3</td><td class="colsep0 rowsep0" align="left">15.3</td><td class="colsep0 rowsep0" align="left">9.0</td><td class="colsep0 rowsep0" align="left">7.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">7-Cl</td><td class="colsep0 rowsep0" align="left">280</td><td class="colsep0 rowsep0" align="left">304</td><td class="colsep0 rowsep0" align="left">224</td><td class="colsep0 rowsep0" align="left">>316</td><td class="colsep0 rowsep0" align="left">192</td><td class="colsep0 rowsep0" align="left">316</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">8-Me</td><td class="colsep0 rowsep0" align="left">235</td><td class="colsep0 rowsep0" align="left">>316</td><td class="colsep0 rowsep0" align="left">52</td><td class="colsep0 rowsep0" align="left">334</td><td class="colsep0 rowsep0" align="left">197</td><td class="colsep0 rowsep0" align="left">67</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are reported in nM as the average of at least two independent experiments.</p></div></div></div><div class="NLM_p">As reported previously, attempts to identify replacements for the unsubstituted indolyl fragment attached to the maleimide were unsuccessful.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> However, the introduction of a series of modifications on the periphery of the indolyl fragment was more rewarding (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). An initial fluorine scan in positions 4–7 of the indolyl had negligible effects on potency (data not shown). A similar screen with a bulky hydrophobic group like chlorine revealed a very similar PKC profile for the 5-, 6-, and 7-chlorine derivatives <b>24</b>–<b>26</b> with moderate activity retained on all isotypes. In contrast, the 4-chlorine analogue <b>23</b> was mostly inactive. Further derivation of position 7 resulted in the methyl analogue <b>27</b>, which shows subnanomolar potency on all classical and novel PKC isotypes and is one of the most potent PKC inhibitor reported so far. Finally, the modest effect on enzymatic activity of the <i>N</i>-methyl and <i>N</i>-isopropyl analogues <b>28</b> and <b>29</b> suggests that large hydrophobic side chains attached to the indole nitrogen are tolerated. On the other hand, the 2-methyl derivative <b>30</b> lost 10- to 30-fold in activity. Reduced rotational freedom of <b>30</b> may account for or contribute to the loss of activity. In conclusion, the derivation efforts around the indolyl group suggested that substituents are tolerated in several positions around the indolyl moiety but did not result in superior derivatives except for <b>27</b>. Unfortunately, <b>27</b> could not be further considered for development because the stronger activity in mouse and human MLR, 77 and 15 nM, respectively, was offset by the low bioavailability and higher clearance in single dose rat pharmacokinetic studies (data not shown).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Influence of Substituents around the Indolyl Moiety on Isotype Selectivity</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/medium/jm-2011-00469u_0010.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">PKC isotypes<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">α</th><th class="colsep0 rowsep0" align="center">β<sub>1</sub></th><th class="colsep0 rowsep0" align="center">δ</th><th class="colsep0 rowsep0" align="center">ε</th><th class="colsep0 rowsep0" align="center">η</th><th class="colsep0 rowsep0" align="center">θ</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">202</td><td class="colsep0 rowsep0" align="left">48</td><td class="colsep0 rowsep0" align="left">93</td><td class="colsep0 rowsep0" align="left">>316</td><td class="colsep0 rowsep0" align="left">202</td><td class="colsep0 rowsep0" align="left">221</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">5-Cl</td><td class="colsep0 rowsep0" align="left">8.3</td><td class="colsep0 rowsep0" align="left">6.5</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">9.8</td><td class="colsep0 rowsep0" align="left">9.1</td><td class="colsep0 rowsep0" align="left">8.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">6-Cl</td><td class="colsep0 rowsep0" align="left">8.5</td><td class="colsep0 rowsep0" align="left">7.7</td><td class="colsep0 rowsep0" align="left">8.2</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">9.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">7-Cl</td><td class="colsep0 rowsep0" align="left">9.1</td><td class="colsep0 rowsep0" align="left">6.0</td><td class="colsep0 rowsep0" align="left">6.2</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">7.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">7-Me</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left"><i>N</i>-Me</td><td class="colsep0 rowsep0" align="left">6.4</td><td class="colsep0 rowsep0" align="left">5.1</td><td class="colsep0 rowsep0" align="left">5.7</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">5.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left"><i>N</i>-<i><sup>i</sup></i>Pr</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">7.8</td><td class="colsep0 rowsep0" align="left">2.7</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">3.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">2-Me</td><td class="colsep0 rowsep0" align="left">63</td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">73</td><td class="colsep0 rowsep0" align="left">65</td><td class="colsep0 rowsep0" align="left">26</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are reported in nM as the average of at least two independent experiments.</p></div></div></div><div class="NLM_p">The excellent enzymatic and cellular profile prompted us to consider <b>1</b> for further development. Its in vitro physicochemical characteristics are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. <b>1</b> is a maleimide derivative with a weakly basic piperazine moiety (p<i>K</i><sub>a</sub> = 7.4) resulting in a fraction ionized of 0.8 under physiological pH. Its moderate intrinsic solubility at pH 6.8 is clearly below what is anticipated from its log <i>P</i>, suggesting that factors other than lipophilicity hinder solubility. In both fasted state simulated intestinal fluid (FaSSIF) and fed state simulated intestinal fluid (FeSSIF), the solubility was good. <b>1</b> showed moderate membrane permeability as measured in the parallel artificial membrane permeation assay (PAMPA) and confirmed using the human colon carcinoma epithelial cell line Caco-2 (P<sub>app</sub> = 4.5 × 10<sup>–6</sup> cm/s). The strong difference in efflux ratio measured with Caco-2 or Madin–Darby canine kidney (MDCK) cells, stably transfected with the gene for human p-glycoprotein, strongly suggested that <b>1</b> is a substrate for Pgp. Consequently, it is not surprising that <b>1</b> does not cross the blood–brain barrier. In vivo pharmacokinetic studies in mice, rats, and cynomolgus monkeys (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) revealed that <b>1</b> had in all species a medium clearance, which was clearly below the rates expected from the in vitro data using liver microsomes. The difference may be explained by the modest transcellular permeability of this molecule, preventing a quick uptake by hepatocytes. The high plasma protein binding might be another factor influencing the in vivo clearance. Exposure of <b>1</b> in monkeys is prolonged in comparison to rodents because of a later <i>T</i><sub>max</sub> and longer elimination half-life. <b>1</b> undergoes extensive metabolism through CYP3A4, and the metabolites are primarily excreted through the feces. The desmethylpiperazine derivative <b>31</b> is a major metabolite (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>), and the amounts formed after oral dosing are highly species dependent. In rats, the exposure of the metabolite is comparable or higher (2-fold) than of the parent, while in cynomolgus monkeys the metabolite represents only 8%, and in humans the percentage drops to 1.2% after a single dose.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a><b>31</b> is an active metabolite that retains subnanomolar activity on all PKC isotypes assayed (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Unexpectedly and in contrast to <b>1</b>, its immunosuppressive activity in the mouse but not human MLR is weak. Finally, <b>1</b> is also an inhibitor of CYP3A4-catalyzed midazolam 1′-hydroxylation in human liver microsomes with a <i>K</i><sub>i</sub> of 2.9 μM. To test the risk in exposure variation in the presence of a co-medication, a drug–drug interaction study was conducted in the clinic with ketoconazole as a strong CYP3A4 inhibitor.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Ketoconazole caused a 2.5-fold increase in maximum concentration and a 4.6-fold increase in the area under the curve of <b>1</b>, which is comparable to what is observed for other immunosuppressants like CsA.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Physicochemical Characteristics of <b>1</b> in Comparison to <b>32</b><a class="ref internalNav" href="#t4fn7" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center"><b>1</b></th><th class="colsep0 rowsep0" align="center"><b>32</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MW</td><td class="colsep0 rowsep0" align="left">438.49</td><td class="colsep0 rowsep0" align="left">438.49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PSA</td><td class="colsep0 rowsep0" align="left">94</td><td class="colsep0 rowsep0" align="left">94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p<i>K</i><sub>a</sub></td><td class="colsep0 rowsep0" align="left">9.3/7.5/2.4</td><td class="colsep0 rowsep0" align="left">9.5/8.4/2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">log <i>P</i></td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">log <i>D</i><sub>pH6.8</sub></td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="left">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Sol<sub>pH6.8</sub> (g/L)</td><td class="colsep0 rowsep0" align="left">0.019</td><td class="colsep0 rowsep0" align="left">0.195</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SGF<sub>pH2.0</sub> (g/L)<a class="ref internalNav" href="#t4fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.78</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FaSSIF<sub>pH6.5</sub> (g/L)<a class="ref internalNav" href="#t4fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.41</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FeSSIF<sub>pH5.8</sub> (g/L)<a class="ref internalNav" href="#t4fn3" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">0.53</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">logPAMPA (cm/s)<a class="ref internalNav" href="#t4fn4" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">–5.3</td><td class="colsep0 rowsep0" align="left">–5.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco-2 (B–A<sub>pp</sub>)<a class="ref internalNav" href="#t4fn5" aria-label="f">f</a>/(A–B<sub>pp</sub>)<a class="ref internalNav" href="#t4fn6" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">1.37</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MDCK1 (B-A<sub>pp</sub>)<a class="ref internalNav" href="#t4fn5" aria-label="f">f</a>/(A–B<sub>pp</sub>)<a class="ref internalNav" href="#t4fn6" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">43</td><td class="colsep0 rowsep0" align="left">64.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn7"><div class="footnote" id="t4fn7"><sup>a</sup><p class="last">nd = not determined.</p></div><div class="footnote" id="t4fn1"><sup>b</sup><p class="last">SGF: solubility in simulated gastric fluid.</p></div><div class="footnote" id="t4fn2"><sup>c</sup><p class="last">FaSSIF: solubility in simulated intestinal fluid (fasted state).</p></div><div class="footnote" id="t4fn3"><sup>d</sup><p class="last">FeSSIF: solubility in simulated intestinal fluid (fed state).</p></div><div class="footnote" id="t4fn4"><sup>e</sup><p class="last">logPAMPA: permeability measured in a PAMPA assay.</p></div><div class="footnote" id="t4fn5"><sup>f</sup><p class="last">B–A<sub>pp</sub>: basal to apical permeability.</p></div><div class="footnote" id="t4fn6"><sup>g</sup><p class="last">A–B<sub>pp</sub>: apical to basolateral permeability. </p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Properties of <b>1</b> and <b>32</b> in Mouse, Rat, and Cynomolgus Monkeys</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center"><b>1</b></th><th class="rowsep1 colsep0" align="center"><b>32</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">mouse</th><th class="colsep0 rowsep0" align="center">rat</th><th class="colsep0 rowsep0" align="center">cynomolgus monkey</th><th class="colsep0 rowsep0" align="center">rat</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv dose (mg/kg)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–∞</sub> (ng·h/mL)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">371</td><td class="colsep0 rowsep0" align="left">326</td><td class="colsep0 rowsep0" align="left">720</td><td class="colsep0 rowsep0" align="left">671</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cl ((mL/min)/kg)<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">45</td><td class="colsep0 rowsep0" align="left">51</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">6.5</td><td class="colsep0 rowsep0" align="left">5.9</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)<a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">4.8</td><td class="colsep0 rowsep0" align="left">4.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po dose (mg/kg)<a class="ref internalNav" href="#t5fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–∞</sub> (ng·h/mL)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">72</td><td class="colsep0 rowsep0" align="left">110</td><td class="colsep0 rowsep0" align="left">128</td><td class="colsep0 rowsep0" align="left">161</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)<a class="ref internalNav" href="#t5fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">34</td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in vitro Cl<sub>int</sub> ((μL/min)/mg)</td><td class="colsep0 rowsep0" align="left">248</td><td class="colsep0 rowsep0" align="left">505</td><td class="colsep0 rowsep0" align="left">433</td><td class="colsep0 rowsep0" align="left">112</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PPB (% unbound)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">1.1– 3.1</td><td class="colsep0 rowsep0" align="left">2.4– 4.7</td><td class="colsep0 rowsep0" align="left">nd</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">iv formulations are as follows. Balb/c mouse: PEG200/glucose. OFA rat: 80% saline (0.9%)/20% PEG400. Monkey: PEG400/0.1 M HCl/glucose.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Area under the curve extrapolated to infinity, dose normalized.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Total plasma clearance.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">Volume of distribution.</p></div><div class="footnote" id="t5fn5"><sup>e</sup><p class="last">Elimination half-life.</p></div><div class="footnote" id="t5fn6"><sup>f</sup><p class="last">po formulations are as follows. Balb/c mouse: PEG200/glucose. OFA rat: 80% water/20% PEG400. Monkey: PEG400/0.1 M HCl/water.</p></div><div class="footnote" id="t5fn7"><sup>g</sup><p class="last">Oral bioavailability. For <b>32</b>, 20% PEG400/glucose/0.1 M HCl was used for iv and po administration. Data reported as average of three animals.</p></div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Potency on PKC Isotypes of the Active Metabolite and Close Analogues of <b>1</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/medium/jm-2011-00469u_0011.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">PKC isotypes<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="2" align="center">MLR<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub>, R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">α</th><th class="colsep0 rowsep0" align="center">β<sub>1</sub></th><th class="colsep0 rowsep0" align="center">δ</th><th class="colsep0 rowsep0" align="center">ε</th><th class="colsep0 rowsep0" align="center">η</th><th class="colsep0 rowsep0" align="center">θ</th><th class="colsep0 rowsep0" align="center">mouse</th><th class="colsep0 rowsep0" align="center">human</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">H, H</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">854</td><td class="colsep0 rowsep0" align="left">51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">H, Me</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">3.8</td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">378</td><td class="colsep0 rowsep0" align="left">99</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are reported in nM as the average of at least two independent experiments.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">MLR = mixed lymphocyte reaction assay.</p></div></div></div><div class="NLM_p">The lymphoid tissues, including lymph nodes, spleen, and thymus, are relevant target organs for drugs acting on the immune system. Therefore, we conducted a study in rats to compare the exposure of <b>1</b> in blood versus lymphoid tissues after oral administration. The structurally close analogue <b>32</b> was included into the study with the aim to understand striking differences in in vivo efficacies. Indeed, <b>32</b> was inefficacious in the rat heart allograft survival model at an oral dose of 30 mg/kg b.i.d. which was fully efficacious for <b>1</b><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> despite very similar activity in the biochemical assays as well as in terms of physicochemical and pharmacokinetic properties (see Tables <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>–<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). The exposures measured in Wistar rats after a single oral dose of 30 mg/kg <b>1</b> or <b>32</b> are summarized in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. As expected from the initial PK studies, the areas under the curve in circulation for both compounds are very comparable (AUC<sub>0–24h</sub> of 1952 and 1729 [ng/(g·h)] for <b>1</b> and <b>32</b>, respectively). However, important differences were observed in exposures in the lymphoid tissues. <b>1</b> reached up to 16-fold higher levels in the target organs, while the exposure of <b>32</b> was comparable in both blood and lymphoid tissues. This large difference cannot be accounted for by volume of distribution only. The study also confirmed that the active metabolite <b>31</b> was formed in high amounts in rats after oral dosing of <b>1</b>. On the other hand, only negligible levels of <b>31</b> were measured after administration of <b>32</b>. These results suggest that two factors may contribute to the superior in vivo efficacy of <b>1</b>. The high drug levels in the disease-specific target organs are critical to achieve the strong pharmacodynamic effect, which may be further enhanced by the contribution of the active metabolite <b>31</b>. Unfortunately, the underlying reasons explaining the different tissue distribution of the two molecules are poorly understood, and only a hypothesis can be offered herein. Derivatives <b>1</b> and <b>32</b> differ only marginally in terms of physicochemical properties: the log <i>D</i><sub>pH6.8</sub> of <b>1</b> is higher because of the shift in the piperazine p<i>K</i><sub>a</sub> upon methylation, and the surface activity pH profiles<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> of <b>1</b> and <b>32</b> are fairly different (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The amphiphilic nature of <b>1</b> was not anticipated from its 2D chemical structure and is uncovered upon deprotonation of the piperazine moiety, suggesting a 3D rearrangement of the molecule. The tendency of the molecule to form micelles suggests that <b>1</b> could form mixed micelles with bile salts and be absorbed to some extent via the lymphatic system, mimicking the absorption of dietary fats.<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22-24)</a> Contribution of the intestinal lymphatics to the overall absorption has been postulated for compounds including halofantrine, CsA, probucol, mepitiostane.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><figure id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/medium/jm-2011-00469u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Area under concentration time curve in blood, mesenteric lymph node, spleen, thymus after peroral administration of 30 mg/kg <b>1</b> or <b>32</b> to male Wistar rats. In situ formation of metabolite <b>31</b> was measured in parallel after administration of either <b>1</b> or <b>32</b>. Formulation was PEG400/1 M HCl/5% glucose.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200469u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/medium/jm-2011-00469u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Surface activity pH profiles of <b>1</b> and <b>32</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200469u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74312" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74312" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, sotrastaurin (<b>1</b>) is a potent and selective inhibitor of classical and novel PKC isotypes efficacious in rodent transplant models.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The detailed structure–activity relationship studies around the quinazolinyl and indolyl moieties confirmed the tight fit of the maleimide derivative into the ATP binding site of protein kinase C isotypes. Furthermore, isotype specific derivatives were identified through modifications in position 6 of the quinazolinyl fragment. The special pharmacokinetic properties of <b>1</b>, like the selective uptake into lymphoid tissues, are likely to contribute to its strong pharmacodynamic effects in rodent preclinical models. On this basis, <b>1</b> is currently tested as monotherapy in patients with psoriasis and as part of a regimen in combination with other immunosuppressants for prevention of kidney transplant rejection. These phase II clinical trials are underway to explore the clinical potential of sotrastaurin (<b>1</b>) for patients suffering from T-cell dependent autoimmune diseases.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28076" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28076" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General</h3><div class="NLM_p last">All nonaqueous reactions were carried out under an inert gas atmosphere (nitrogen or argon) at room temperature, unless otherwise noted. Commercial reagents and anhydrous solvents were used without further purification. Analytical thin layer chromatography (TLC) and flash chromatography were performed on Merck silica gel 60 (230–400 mesh). Proton nuclear magnetic spectroscopy spectra were obtained on Bruker DPX400 and DRX500 instrumentation. Chemical shifts are reported in parts per million relative to Me<sub>4</sub>Si as internal standard. Conventional abbreviations used for signal shape are as follows: s, singlet; d, doublet; dd, doublet of doublets; t, triplet; m, multiplet; br, broad. Mass spectrometry (MS) analyses were performed on a Micromass platform electrospray mass spectrometer, using positive and negative ionization. New final SAR compounds were determined to be consistent with proposed structures by <sup>1</sup>H and <sup>13</sup>C NMR, MS or HRMS, and IR and were greater than 95% pure as determined by reversed phase UPLC (Waters Acquity Ultra Performance LC; column, Acquity UPLC HSS T3 1.8 μm, 2.1 mm × 50 mm; UV detection, Waters Acquity Ultra Performance LC PDA detector; flow rate, 0.5 mL/min; solvent A, water with 0.1% trifluoroacetic acid; solvent B, acetonitrile with 0.1% trifluoroacetic acid; gradient, solvent B from 20% to 100%).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 2-(2-Chloroquinazolin-4-yl)acetamide (<b>2</b>)</h3><div class="NLM_p last">To a suspension of 1<i>H</i>,3<i>H</i>-quinazoline-2,4-dione (10.0 g, 61.7 mmol) in POCl<sub>3</sub> (37 mL) was added dropwise <i>N</i>,<i>N</i>-dimethylaniline (7.8 mL, 1.0 equiv). The mixture was heated to 110 °C and kept at reflux for 3 h. The solution was cooled to room temperature and poured onto an ice–water mixture. The precipitate was filtered off and washed with H<sub>2</sub>O. The solid was dissolved in ethyl acetate and washed with H<sub>2</sub>O and brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated to afford crude 2,4-dichloroquinazoline (10.0 g, 81%), which can be crystallized from toluene/pentane. EI-MS: 198 [M – H]<sup>−</sup>, 163 [M – Cl]<sup>−</sup>. Ethyl acetoacetate (5.1 mL, 2.0 equiv) dissolved in THF (25 mL) was added dropwise to a suspension of NaH (60%, 1.0 g, 1.3 equiv) in THF (25 mL) at 0 °C. The solution was stirred for 30 min at 0 °C, and the solvent was evaporated. The residue was dissolved in toluene (125 mL), and 2,4-dichloroquinazoline (4.0 g, 20.0 mmol) was added. The mixture was stirred for 30 min at reflux, cooled to room temperature, and concentrated. The oily residue was dissolved in aqueous NH<sub>4</sub>OH, 25% (80 mL), and stirred overnight at room temperature. All volatile materials were evaporated, and the residue was taken up in ethyl acetate (80 mL). The suspension was heated at reflux for 15 min, cooled to 0 °C, and filtered to afford <b>2</b> (2.37 g, 54%) as a white solid. EI-MS: 220 [M – H]<sup>−</sup>, 178. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 4.21 (s, 2H), 7.24 (br s, 1H), 7.75–7.84 (m, 2H), 7.97 (d, <i>J</i> = 8.4 Hz, 1H), 8.08 (dd, <i>J</i> = 8.4, 7.5 Hz, 1H), 8.34 (d, <i>J</i> = 8.4 Hz, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100.6 MHz): δ 42.2, 123.3, 127.0, 127.6, 128.7, 135.9, 151.6, 156.0, 169.7, 171.1. IR (KBr) ν<sub>max</sub> 3299, 3135, 1681, 1546, 1388, 1286, 1196, 948, 770 cm<sup>–1</sup>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 3-(1<i>H</i>-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (<b>1</b>)</h3><div class="NLM_p last"><b>2</b> (220 mg, 1.0 mmol) was dissolved in 1-methyl-2-pyrrolidinone (2.0 mL), and <i>N</i>-methylpiperazine (555 μL, 5.0 equiv) was added. The mixture was heated for 45 min at 50 °C. Ethyl acetate was added, and the suspension was filtered to afford 2-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]acetamide (197 mg, 69%) as a white solid. ESI-MS: 308 [M + Na]<sup>+</sup>, 286 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 2.24 (s, 3H), 2.40 (m, 4H), 3.86 (m, 4H), 3.98 (s, 2H), 7.12 (br s, 1H), 7.24 (dd, <i>J</i> = 8.2, 7.5 Hz, 1H), 7.49 (d, <i>J</i> = 8.4 Hz, 1H), 7.63–7.72 (m, 2H), 7.95 (d, <i>J</i> = 8.2 Hz, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100.6 MHz): δ 42.6, 43.7, 46.1, 54.8, 119.0, 122.6, 125.9, 126.3, 134.2, 152.1, 158.2, 167.4, 170.4. IR (KBr) ν<sub>max</sub> 3344, 3130, 2786, 1671, 1618, 1587, 1557, 1299, 1006, 751 cm<sup>–1</sup>. 2-[2-(4-Methylpiperazin-1-yl)quinazolin-4-yl]acetamide (213 mg, 0.75 mmol) and 3-indoleglyoxylic acid methyl ester (167 mg, 1.1 equiv) were suspended in THF (15 mL). To the suspension was added dropwise at 0 °C KO<i><sup>t</sup></i>Bu (1.0 M in THF, 2.25 mL, 3.0 equiv). The mixture was stirred at room temperature overnight. A second portion of glyoxalate (30 mg, 0.2 equiv) and KO<i><sup>t</sup></i>Bu (0.5 mL) were added, and the mixture was stirred at room temperature for 24 h. Ethyl acetate was added, and the organic phase was washed with 1.0 M aqueous NaHCO<sub>3</sub> and brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated. The residue was purified by flash chromatography (Et<sub>2</sub>O/MeOH/aqueous NH<sub>4</sub>OH 90:10:1) to afford <b>1</b> (155 mg, 47%) as an orange-red powder. ESI-MS: 437 [M – H]<sup>−</sup>. HRMS: calcd for C<sub>25</sub>H<sub>22</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> 439.1882, found 439.1886. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 2.13 (s, 3H), 2.16 (m, 4H), 3.69 (m, 4H), 6.35 (d, <i>J</i> = 8.0 Hz, 1H), 6.64 (dd, <i>J</i> = 7.8, 7.4 Hz, 1H), 7.02 (dd, <i>J</i> = 7.6, 7.4 Hz, 1H), 7.10 (dd, <i>J</i> = 7.8, 7.2 Hz, 1H), 7.38 (d, <i>J</i> = 8.2 Hz, 1H), 7.53 (d, <i>J</i> = 8.4 Hz, 1H), 7.63–7.73 (m, 2H), 8.13 (s, 1H), 11.29 (br s, 1H), 12.01 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100.6 MHz): δ 43.9, 46.1, 54.5, 105.3, 112.8, 118.7, 120.4, 120.8, 122.8, 124.7, 125.1, 125.9, 127.3, 127.4, 133.1, 134.9, 136.9, 138.3, 152.7, 158.3, 162.5, 171.8, 172.1. IR (KBr) ν<sub>max</sub> 3320, 2930, 1709, 1548, 1339, 1004, 745 cm<sup>–1</sup>.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (3-Benzyloxynaphthalen-1-yl)acetic Acid Ethyl Ester (<b>4</b>)</h3><div class="NLM_p last">4-Bromonaphthalen-2-ol (5.0 g, 22.4 mmol) was dissolved in dry DMF (50 mL) under an atmosphere of argon. Sodium hydride (986 mg of a 60% suspension in mineral oil, 592 mg, 24.7 mmol) was added, and the mixture was stirred at 50 °C for 1 h. After the mixture was cooled to room temperature, benzyl bromide (3.5 mL, 5.0 g, 29.1 mmol) and tetrabutylammonium iodide (828 mg, 2.24 mmol) were added. After 16 h at room temperature, the reaction mixture was diluted with ethyl acetate. The solution was washed twice with semiconcentrated brine. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated, and the residue was purified by flash chromatography (hexane/ethyl acetate, 100:0 to 95:5 to 90:10) to yield 3-benzyloxy-1-bromonaphthalene (6.50 g, 93%). ES-MS: 312 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 5.22 (s, 2H), 7.25 (d, <i>J</i> = 1.5 Hz, 1H), 7.45 (m, 7H), 7.64 (d, <i>J</i> = 2.4 Hz, 1H), 7.75 (d, <i>J</i> = 7.8 Hz, 1H), 8.17 (d, <i>J</i> = 7.8 Hz, 1H). 3-Benzyloxy-1-bromonaphthalene (5.64 g, 18.0 mmol) was dissolved under an atmosphere of argon in dry DMF (100 mL). Tributylstannanylacetic acid ethyl ester (7.5 g, 19.8 mmol) was added, as well as [bis(tri-<i>o</i>-tolylphosphine)]palladium(II) dichloride (2.83 g, 3.6 mmol) and zinc(II) bromide (5.27 g, 23.4 mmol). The reaction mixture was heated to 80 °C for 3 h, cooled to room temperature, diluted with ethyl acetate, and washed twice with diluted brine. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed, and the residue was purified by flash chromatography (hexane/ethyl acetate 100:0 to 97.5:2.5 to 95:5 to 90:10). The resulting oil, still containing tin residues, was stirred in a 1:1 mixture of ethyl acetate/1 M NaOH (200 mL) for 1 h. The mixture was extracted twice with ethyl acetate. The combined organic layers were washed twice with H<sub>2</sub>O, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was purified by flash chromatography (hexane/ethyl acetate, 100:0 to 97:3 to 95:5 to 93:7 to 92:8 to 90:10) to yield <b>4</b> (2.43 g, 42%). ES-MS: 320 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.18 (t, <i>J</i> = 7.2 Hz, 3H), 4.10 (q, <i>J</i> = 7.2 Hz, 2H), 4.11 (s, 2H), 5.25 (s, 2H), 7.21 (d, <i>J</i> = 3.0 Hz, 1H), 7.41 (m, 8H), 7.53 (d, <i>J</i> = 6.6 Hz, 1H), 7.84 (dd, <i>J</i> = 7.2 Hz, 1H).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (3-Trifluoromethanesulfonyloxynaphthalen-1-yl)acetic Acid Ethyl Ester (<b>5</b>)</h3><div class="NLM_p last"><b>4</b> (2.43 g, 7.6 mmol) was dissolved in MeOH (50 mL). Then 10% palladium on charcoal (807 mg) was added, and the reaction mixture was stirred at room temperature under an atmosphere of hydrogen (1 atm) for 14 h. The reaction mixture was filtered. Concentration yielded (3-hydroxynaphthalen-1-yl)acetic acid ethyl ester (1.67 g, 95%) of adequate purity for the next reaction step. ES-MS: 230 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.18 (t, <i>J</i> = 7.2 Hz, 3H), 4.05 (s, 2H), 4.10 (q, <i>J</i> = 7.2 Hz, 2H), 7.04 (d, <i>J</i> = 1.8 Hz, 1H), 7.06 (d, <i>J</i> = 1.8 Hz, 1H), 7.30 (t, <i>J</i> = 7.8 Hz, 1H), 7.40 (t, <i>J</i> = 7.8 Hz, 1H), 7.70 (d, <i>J</i> = 7.8 Hz, 1H), 7.80 (d, <i>J</i> = 7.8 Hz, 1H). (3-Hydroxynaphthalen-1-yl)acetic acid ethyl ester (1.67 g, 7.25 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) under an atmosphere of argon. Pyridine (1.17 mL, 1.15 g, 14.5 mmol) was added, and the reaction mixture was cooled to 0 °C, whereupon trifluoromethanesulfonic anhydride (1.79 mL, 3.07 g, 10.9 mmol) was added dropwise. The reaction mixture was warmed to room temperature, and after 1 h at room temperature, TLC analysis indicated complete consumption of starting material. The reaction mixture was diluted with ethyl acetate and washed twice with H<sub>2</sub>O. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, the solvent was removed, and the residue was purified by flash chromatography (hexanes/ethyl acetate, 100:0 to 97:3 to 95:5 to 93:7 to 90:10) to yield <b>5</b> (2.33 g, 89%). ES-MS: 362 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.19 (t, <i>J</i> = 7.2 Hz, 3H), 4.11 (q, <i>J</i> = 7.2 Hz, 2H), 4.38 (s, 2H), 7.60 (d, <i>J</i> = 3.0 Hz, 1H), 7.70 (m, 2H), 8.03 (m, 1H), 8.12 (m, 2H).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2-[3-(4-Methylpiperazin-1-yl)naphthalen-1-yl]acetamide (<b>6</b>)</h3><div class="NLM_p last"><b>5</b> (500 mg, 1.4 mmol) and <i>N</i>-methylpiperazine (166 mg, 1.66 mmol) were dissolved in THF (10 mL). Potassium phosphate (410 mg, 1.93 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (62 mg, 0.069 mmol), and biphenyl-2-yldi-<i>tert</i>-butylphosphane (21 mg, 0.064 mmol) were added. The reaction mixture was heated to 80 °C for 4 h. After the mixture was cooled to room temperature, filtered, and concentrated, the crude product was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 98:2 to 80:20) to afford the piperazine intermediate (360 mg, 84%) as an oil. ES-MS: 313 [M + H]<sup>+</sup>, 335 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 1.18 (t, <i>J</i> = 7.4 Hz, 3H), 2.25 (s, 3H), 2.48–2.54 (m, 4H), 3.23–3.28 (m, 4H), 4.06 (s, 2H), 4.09 (q, <i>J</i> = 7.4 Hz, 2H), 7.10 (d, <i>J</i> = 2.1 Hz, 1H), 7.28 (t, <i>J</i> = 8.4 Hz, 1H), 7.35 (d, <i>J</i> = 2.1 Hz, 1H), 7.39 (t, <i>J</i> = 8.4 Hz, 1H), 7.72–7.78 (m, 2H). The piperazine intermediate from the above reaction (355 mg, 1.14 mmol) and formamide (171 mg, 3.8 mmol) was dissolved in DMF (5 mL). The solution was heated to 105 °C, and a solution of sodium methoxide (5.4 M in MeOH, 148 μL) was slowly added over 15 min. After 1 h at 105 °C, an additional portion of sodium methoxide (63 μL) was added, and heating was continued for another hour. The reaction mixture was cooled to room temperature, diluted with water, and extracted sequentially with ethyl acetate and with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Purification by flash chromatography (ethyl acetate/AcOH/H<sub>2</sub>O, 700:110:90 to 650:130:120) afforded <b>6</b> (monoacetate, 358 mg, 92%) as a solid. ES-MS: 284 [M + H]<sup>+</sup>, 306 [M + Na]<sup>+</sup>. HRMS: calcd for C<sub>17</sub>H<sub>22</sub>N<sub>3</sub>O [M + H]<sup>+</sup> 284.175 74, found 284.175 84. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz, trifluoroacetate salt): δ 2.88 (s, 3H), 3.01–3.12 (m, 2H), 3.16–3.27 (br, 2H), 3.53–3.63 (br, 2H), 3.81 (s, 2H), 3.91–4.01 (br, 2H), 6.97 (s, 1H), 7.19 (s, 1H), 7.33 (dd, <i>J</i> = 8.4, 7.4 Hz, 1H), 7.34 (s, 1H), 7.42 (dd, <i>J</i> = 8.2, 7.4 Hz, 1H), 7.54 (s, 1H), 7.75 (d, <i>J</i> = 8.2 Hz, 1H), 7.93 (d, <i>J</i> = 8.4 Hz, 1H), 10.08–10.20 (br, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125.8 MHz, trifluoroacetate salt): δ 39.01, 42.12, 45.88 (2×), 52.28 (2×), 109.40, 121.14, 123.52, 124.00, 126.04, 127.28, 127.40, 134.01, 134.54, 146.72, 171.99. IR (FTIR microscope, transmission, trifluoroacetate salt) ν<sub>max</sub> 3371, 3198, 3032, 2841, 2733, 2621, 2489, 1673, 1624, 1602, 1509, 1458, 1407, 1272, 1235, 1060 cm<sup>–1</sup>.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 3-(1<i>H</i>-Indol-3-yl)-4-[3-(4-methylpiperazin-1-yl)naphthalen-1-yl]pyrrole-2,5-dione (<b>7</b>)</h3><div class="NLM_p last">The monoacetic acid salt of <b>6</b> (100 mg, 0.29 mmol) and (1<i>H</i>-indol-3-yl)oxoacetic acid methyl ester (89 mg, 0.44 mmol) and 1 cm<sup>3</sup> of dry 3 Å molecular sieves were suspended in THF (2.5 mL). A solution of potassium <i>tert</i>-butoxide (1 M in THF, 1.16 mL) was slowly added during 30 min. After an additional 30 min, the reaction mixture was diluted with concentrated aqueous NH<sub>4</sub>Cl solution and extracted with ethyl acetate. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Purification by flash chromatography (MeO<i><sup>t</sup></i>Bu/MeOH/aqueous NH<sub>3</sub>, 99:1:0.5 to 80:20:0.5, afforded <b>7</b> as an orange solid. This material was dissolved in a mixture of MeOH and AcOH. After concentration and azeotropic removal of excess AcOH with MeOH, the monoacetate salt of <b>7</b> (95 mg, 66%) was obtained. ES-MS: 437 [M + H]<sup>+</sup>. HRMS: calcd for C<sub>27</sub>H<sub>25</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 437.197 20, found 437.197 30. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz, trifluoroacetate salt): δ 2.83 (s, 3H), 2.90–3.10 (m, 4H), 3.45–3.55 (br, 2H), 3.80–3.95 (m, 2H), 6.28 (d, <i>J</i> = 8.3 Hz, 1H), 6.46 (dd, <i>J</i> = 8.3, 7.7 Hz, 1H), 6.92 (dd, <i>J</i> = 8.1, 7.7 Hz, 1H), 7.15 (dd, <i>J</i> = 8.4, 7.7 Hz, 1H), 7.32 (d, <i>J</i> = 8.1 Hz, 1H), 7.34–7.42 (m, 3H), 7.58 (d, <i>J</i> = 8.4 Hz, 1H), 7.80 (d, <i>J</i> = 8.3 Hz, 1H), 7.97 (d, <i>J</i> = 3.0 Hz, 1H), 10.05–10.20 (br s, 1H), 11.16 (s, 1H), 11.90 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125.8 MHz, trifluoroacetate salt): δ 42.09, 45.97 (2×), 52.08 (2×), 105.06, 111.61, 112.01, 119.84, 120.64, 121.59, 121.96, 123.91, 124.71, 125.34, 126.46, 126.66, 127.25, 128.31, 130.20, 131.42, 134.26, 135.68, 136.30, 146.56, 172.25, 172.54. IR (FTIR microscope, transmission, trifluoroacetate salt) ν<sub>max</sub> 3469, 3218, 3054, 2838, 2732, 2631, 2490, 1751, 1707, 1621, 1601, 1510, 1494, 1455, 1432, 1345, 1237, 750 cm<sup>–1</sup>.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 2-(2-Chloroquinolin-4-yl)acetamide (<b>8</b>)</h3><div class="NLM_p last">Under an atmosphere of argon, (2-oxo-1,2-dihydroquinolin-4-yl)acetic acid methyl ester (9.35 g, 43.0 mmol) was suspended in POCl<sub>3</sub> (6.4 mL). The thick suspension was heated to 80 °C for 2 h. After the mixture was cooled to room temperature, the orange suspension was carefully poured onto an ice–water mixture. The mixture was rendered basic by the addition of NaOH (8 M aqueous solution) and extracted with ethyl acetate. The organic layers were washed with H<sub>2</sub>O (3×) and brine (2×), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford crude (2-chloroquinolin-4-yl)acetic acid methyl ester (9.63 g, 95%) pure enough to be used in the next step directly. ES-MS: 236 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz): δ 3.71 (s, 3H), 4.05 (s, 3H), 7.61 (dd, <i>J</i> = 9.2, 8.2 Hz, 1H), 7.75 (dd, <i>J</i> = 9.2, 8.2 Hz, 1H), 7.95 (d, <i>J</i> = 9.2 Hz, 1H), 8.05 (d, <i>J</i> = 9.2 Hz, 1H). (2-Chloroquinolin-4-yl)acetic acid methyl ester (5.45 g, 23.13 mmol) was suspended in aqueous NH<sub>4</sub>OH (28%, 110 mL). The mixture was stirred at room temperature for 16 h. After concentration, the solid residue was taken up in hot ethyl acetate. Upon slow cooling to 0 °C, <b>8</b> (3.18 g, 62%) separated as a slightly yellow solid. ES-MS: 221 [M + H]<sup>+</sup>. HRMS: calcd for C<sub>11</sub>H<sub>9</sub>ClN<sub>2</sub>O [M + H]<sup>+</sup> 221.0482, found 221.0480. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz): δ 3.88 (s, 2H), 7.16 (br s, 1H), 7.30 (s, 1H), 7.65 (dd, <i>J</i> = 8.4, 7.5 Hz, 1H), 7.70 (br s, 1H), 7.80 (dd, <i>J</i> = 8.4, 7.5 Hz, 1H), 7.93 (d, <i>J</i> = 8.4 Hz, 1H), 8.12 (d, <i>J</i> = 8.4 Hz, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100.7 MHz): δ 38.9, 123.7, 125.0, 126.8, 127.5, 128.8, 131.0, 147.3, 147.7, 149.8, 170.7. IR (KBr) ν<sub>max</sub> 3305, 3144, 1697, 1401, 1107, 918, 761 cm<sup>–1</sup>.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 2-[2-(4-Methylpiperazin-1-yl)quinolin-4-yl]acetamide (<b>9</b>)</h3><div class="NLM_p last"><b>8</b> (500 mg, 2.27 mmol) was dissolved in 1-methyl-2-pyrrolidinone (3.0 mL). <i>N</i>-Methylpiperazine (1.3 mL, 11.33 mmol) was added, and the mixture was stirred at room temperature for 60 h. After dilution with ethyl acetate, the resulting suspension was filtered. The solution was concentrated, and the resulting solid was stirred with hexanes. The remaining solid was combined with the filtered-off solid, and purification by flash chromatography (ethyl acetate/MeOH/aqueous NH<sub>4</sub>OH, 80:18:1) afforded <b>9</b> (518 mg, 80%) as a slightly tan-colored solid. ES-MS: 285 [M + H]<sup>+</sup>, HRMS: calcd for C<sub>16</sub>H<sub>20</sub>N<sub>4</sub>O [M + H]<sup>+</sup> 285.1715, found 285.1712. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 2.25 (s, 3H), 2.47 (m, 4H), 3.67 (m, 4H), 3.77 (s, 2H), 7.00 (br s, 1H), 7.16 (s, 1H), 7.22 (dd, <i>J</i> = 8.4, 7.5 Hz, 1H), 7.50 (dd, <i>J</i> = 8.4, 7.5 Hz, 1H), 7.56 (m, 2H), 7.85 (d, <i>J</i> = 8.4 Hz, 1H). IR (KBr) ν<sub>max</sub> 3337, 1668, 1614, 1403, 1221, 994, 766 cm<sup>–1</sup>.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 3-(1<i>H</i>-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinolin-4-yl]pyrrole-2,5-dione (<b>10</b>)</h3><div class="NLM_p last"><b>9</b> (200 mg, 0.7 mmol) and 3-indoleglyoxylic acid methyl ester (143 mg, 0.7 mmol) were dissolved in <i>N</i>,<i>N</i>-dimethylformamide (7 mL). Potassium <i>tert</i>-butoxide (1.0 M in THF, 3.52 mL, 5 equiv) was added dropwise at 0 °C. The mixture was stirred at 80 °C for 19 h. After dilution with methylene chloride, the organic layer was washed with H<sub>2</sub>O (2×) and brine (1×), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by flash chromatography (ethyl acetate/H<sub>2</sub>O/AcOH, 50:1:10). The product-containing fractions were concentrated. The residue was dissolved in ethyl acetate, and the solution was washed with aqueous NaHCO<sub>3</sub> solution (2×) and brine (2×). After the aqueous layers were back-extracted with ethyl acetate (2×), the combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford the free base of <b>10</b> (190 mg, 62%) as an orange solid. ESI-MS: 438 [M + H]<sup>+</sup>. HRMS: calcd for C<sub>26</sub>H<sub>23</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup> 438.1930, found 438.1925. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 2.20 (s, 3H), 2.28–2.42 (m, 4H), 3.56–3.72 (m, 4H), 6.56–6.63 (m, 2H), 6.98–7.07 (m, 2H), 7.21 (s, 1H), 7.36 (d, <i>J</i> = 8.0 Hz, 1H), 7.46–7.52 (m, 2H), 7.61 (d, <i>J</i> = 8.3 Hz, 1H), 7.96 (d, <i>J</i> = 2.7 Hz, 1H), 11.23 (s, 1H), 11.90 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100.6 MHz): δ 45.0, 46.0, 54.6, 105.2, 112.1, 112.5, 120.4, 121.0, 121.4, 122.5, 122.6, 125.0, 125.7, 126.7, 126.9, 129.9, 132.1, 136.9, 137.7, 139.6, 147.8, 156.8, 172.2, 172.4. IR (KBr) ν<sub>max</sub> 3330, 1706, 1595, 1432, 1338, 1234, 1000, 751 cm<sup>–1</sup>.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-(3-Chloroisoquinolin-1-yl)acetamide (<b>11</b>)</h3><div class="NLM_p last">Sodium hydride (60% in mineral oil, 2.0 g, 50 mmol) was suspended in xylene (100 mL). A solution of malonic acid diethyl ester (8.65 g, 54.0 mmol) in xylene (20 mL) was added dropwise at room temperature. The mixture was heated to 80 °C for 30 min. 1,3-Dichloroisoquinoline (3.6 g, 18.2 mmol) dissolved in xylene (50 mL) was added dropwise at 80 °C. The solution was heated to 140 °C for 3 h. After the mixture was cooled to room temperature, the solvent was removed and the residue was taken up in ethyl acetate. After the mixture was washed with aqueous NaHCO<sub>3</sub> solution, the organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Purification by flash chromatography (toluene/ethyl acetate, 95:5) afforded (3-chloroisoquinolin-1-yl)acetic acid ethyl ester (2.81 g, 62%) as a viscous oil. ES-MS: 250 [M + H]<sup>+</sup>. HRMS: calcd for C<sub>13</sub>H<sub>13</sub>NO<sub>2</sub>Cl [M + H]<sup>+</sup> 250.062 93, found 250.063 03. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz): δ 1.18 (t, <i>J</i> = 7.3 Hz, 3H), 4.12 (q, <i>J</i> = 7.3 Hz, 2H), 4.39 (s, 2H), 7.70–7.73 (m, 1H), 7.82–7.85 (m, 1H), 7.97–8.00 (m, 2H), 8.21 (d, <i>J</i> = 8.8 Hz, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150.9 MHz): δ 14.0, 40.7, 60.6, 119.2, 125.8, 125.9, 126.6, 128.0, 131.4, 138.0, 143.0, 156.3, 169.7. IR (FTIR) ν<sub>max</sub> 3068, 2981, 2936, 1726, 1579, 1557, 1367, 1335, 1214, 1196, 1021, 754 cm<sup>–1</sup>. A solution of (3-chloroisoquinolin-1-yl)acetic acid ethyl ester (1.0 g, 4.1 mmol) in NH<sub>3</sub> (approximately 4 M in MeOH, 50 mL) was heated to 130 °C in a stainless steel pressure reactor for 16 h. After the mixture was cooled and carefully concentrated, the residue was crystallized from EtOH to afford <b>11</b> (684 mg, 76%). ES-MS: 221 [M + H]<sup>+</sup>. HRMS: calcd for C<sub>11</sub>H<sub>10</sub>NO<sub>2</sub>Cl [M + H]<sup>+</sup> 221.047 62, found 221.047 60. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz): δ 4.14 (s, 2H), 7.13 (br s, 1H), 7.68–7.71 (m, 2H), 7.79–7.82 (m, 2H), 7.93 (s, 1H), 7.96 (d, <i>J</i> = 8.0 Hz, 1H), 8.25 (d, <i>J</i> = 8.4 Hz, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150.9 MHz): δ 42.1, 118.7, 126.3 (2×), 126.5, 127.7, 131.2, 137.9, 143.1, 158.2, 170.5. IR (FTIR) ν<sub>max</sub> 3353, 3175, 2942, 1675, 1620, 1583, 1557, 916, 749, 665 cm<sup>–1</sup>.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 3-(3-Chloroisoquinolin-1-yl)-4-(1<i>H</i>-indol-3-yl)pyrrole-2,5-dione (<b>12</b>)</h3><div class="NLM_p last"><b>11</b> (440 mg, 2.0 mmol) and (1<i>H</i>-indol-3-yl)oxoacetic acid methyl ester (1.0 g, 4.9 mmol) were dissolved in THF (15 mL). After the mixture was heated to 80 °C, potassium <i>tert</i>-butoxide (1 M in THF, 10 mL) was added dropwise, and heating to reflux was continued for 1 h. The reaction mixture was concentrated, taken up in ethyl acetate, and washed with aqueous NaHCO<sub>3</sub> solution. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. <b>12</b> (400 mg, 54%) was obtained as a red solid by crystallization from diethyl ether. ES-MS: 374 [M + H]<sup>+</sup>. HRMS: calcd for C<sub>21</sub>H<sub>13</sub>ClN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 374.069 08, found 374.069 15. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz): δ 5.98 (d, <i>J</i> = 8.1 Hz, 1H), 6.50 (dd, <i>J</i> = 8.1, 6.6 Hz, 1H), 6.95 (dd, <i>J</i> = 8.1, 6.6 Hz, 1H), 7.35 (d, <i>J</i> = 8.1 Hz, 1H), 7.49–7.52 (m, 1H), 7.73–7.76 (m, 1H), 7.97–8.00 (m, 2H), 8.15 (br s, 2H), 11.32 (s, 1H), 12.04 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150.9 MHz): δ 104.9, 112.5, 119.5, 120.4, 122.4, 124.7, 126.5, 126.7, 126.8, 128.3, 131.9, 132.6, 136.5, 137.5, 138.0, 143.7, 153.1, 171.8, 171.9. IR (FTIR, transmission) ν<sub>max</sub> 3170, 3061, 2934, 1764, 1710, 1623, 1578, 1551, 1513, 1340, 1330, 749 cm<sup>–1</sup>.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 3-(1<i>H</i>-Indol-3-yl)-4-[3-(4-methylpiperazin-1-yl)isoquinolin-1-yl]pyrrole-2,5-dione (<b>13</b>)</h3><div class="NLM_p last"><b>12</b> (90 mg, 0.24 mmol) was dissolved in <i>N</i>-methylpiperazine (1.5 mL). The solution was heated to 130 °C for 18 h. After concentration, the residue was dissolved in ethyl acetate and washed with aqueous NaHCO<sub>3</sub> and then extracted into aqueous HCl (0.2 M). The aqueous phase was carefully rendered basic by the addition of solid NaHCO<sub>3</sub> and then extracted with methylene chloride. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/aqueous NH<sub>3</sub>, 91:1:1 to 82:2:2) afforded the free base of <b>13</b> (30 mg, 29%) as a dark red solid. ES-MS: 438 [M + H]<sup>+</sup>. HRMS: calcd for C<sub>26</sub>H<sub>24</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup> 438.192 45, found 438.192 43. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz): δ 2.75 (s, 3H), 2.90–3.15 (br, 4H), 3.35–3.50 (br, 2H), 4.25–4.35 (br, 2H), 6.03 (d, <i>J</i> = 8.1 Hz, 1H), 6.51 (dd, <i>J</i> = 8.1, 6.9 Hz, 1H), 6.96 (dd, <i>J</i> = 8.0, 6.9 Hz, 1H), 7.17–7.19 (m, 1H), 7.29 (s, 1H), 7.35 (d, <i>J</i> = 8.0 Hz, 1H), 7.52–7.55 (m, 1H), 7.74–7.76 (m, 2H), 8.10 (d, <i>J</i> = 2.9 Hz, 1H), 10.10–10.20 (br, 1H), 11.22 (s, 1H), 12.04 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150.9 MHz): δ 42.2, 42.9, 51.8, 100.9, 105.1, 112.3, 120.0, 120.2, 122.2, 122.9, 124.2, 124.9, 125.9, 126.6, 130.7, 132.2, 136.5, 136.8, 138.9, 150.8, 153.9, 172.1, 172.3. IR (FTIR, transmission) ν<sub>max</sub> 2854, 2733, 2491, 1758, 1712, 1625, 1583, 1447, 1343, 750 cm<sup>–1</sup>.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 3-(1<i>H</i>-Indol-3-yl)-4-[5-methyl-2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (<b>14</b>)</h3><div class="NLM_p last"><b>14</b> was synthesized as described for <b>1</b> but starting from commercially available 5-methyl-1<i>H</i>-quinazoline-2,4-dione. ES-MS: 453 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 2.13 (s, 3H), 2.18–2.26 (m, 4H), 2.49 (s, 3H), 3.59–3.78 (m, 4H), 6.66–6.73 (m, 2H), 7.04–7.09 (m, 2H), 7.41–7.47 (m, 2H), 7.58–7.62 (m, 1H), 8.05 (s, 1H), 11.25–11.50 (br, 1H), 11.90–12.10 (br, 1H).</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 3-[6-Fluoro-2-(4-methylpiperazin-1-yl)quinazolin-4-yl]-4-(1<i>H</i>-indol-3-yl)pyrrole-2,5-dione (<b>15</b>)</h3><div class="NLM_p last"><b>15</b> was synthesized as described for <b>1</b> but starting from commercially available 6-fluoro-1<i>H</i>-quinazoline-2,4-dione. EI-MS: 456 [M + H]<sup>+</sup>. HRMS: calcd for C<sub>25</sub>H<sub>21</sub>FN<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> 457.1788, found 457.1785. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 2.11–2.20 (br, 4H), 2.14 (s, 3H), 3.62–3.71 (br, 4H), 6.29 (d, <i>J</i> = 8.0 Hz, 1H), 6.66 (dd, <i>J</i> = 8.0, 7.0 Hz, 1H), 7.04 (dd, <i>J</i> = 8.0, 7.0 Hz, 1H), 7.40 (d, <i>J</i> = 8.0 Hz, 1H), 7.54–7.61 (m, 3H), 8.16 (s, 1H), 11.26 (br s, 1H), 12.05 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100.6 MHz): δ 44.0, 46.1, 54.5, 105.3, 110.8 (d, <i>J</i> = 22.8 Hz), 112.8, 118.4 (d, <i>J</i> = 9.3 Hz), 120.3, 120.8, 122.8, 124.2, 124.8, 125.0, 128.5 (d, <i>J</i> = 8.3 Hz), 133.2, 136.9, 138.6, 150.1, 155.8, 158.3 (d, <i>J</i> = 10.5 Hz), 162.1 (d, <i>J</i> = 4.9 Hz), 171.7, 172.1. IR (KBr) ν<sub>max</sub> 3350, 1710, 1549, 1338, 1002, 745 cm<sup>–1</sup>.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 3-[6-Chloro-2-(4-methylpiperazin-1-yl)quinazolin-4-yl]-4-(1<i>H</i>-indol-3-yl)pyrrole-2,5-dione (<b>16</b>)</h3><div class="NLM_p last"><b>16</b> was synthesized as described for <b>1</b> but starting from commercially available 6-chloro-1<i>H</i>-quinazoline-2,4-dione. ES-MS: 471 [M – H]<sup>−</sup>. HRMS: calcd for C<sub>25</sub>H<sub>21</sub>ClN<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> 473.1493, found 473.1489. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 2.04–2.22 (br s, 7H), 3.56–3.72 (br, 4H), 6.27 (d, <i>J</i> = 8.0 Hz, 1H), 6.67 (dd, <i>J</i> = 8.0, 7.1 Hz, 1H), 7.05 (dd, <i>J</i> = 8.0, 7.1 Hz, 1H), 7.41 (d, <i>J</i> = 8.0 Hz, 1H), 7.54 (d, <i>J</i> = 9.2 Hz, 1H), 7.66 (d, <i>J</i> = 9.2, 2.1 Hz, 1H), 7.85 (d, <i>J</i> = 2.1 Hz, 1H), 8.17 (s, 1H), 11.2–11.3 (br, 1H), 12.0–12.1 (br, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100.7 MHz): δ 43.9, 46.0, 54.4, 105.4, 112.9, 119.1, 120.4, 120.8, 122.8, 123.9, 125.0, 126.3, 126.4, 128.0, 133.4, 135.3, 137.0, 138.9, 151.5, 158.4, 161.9, 171.8, 172.0. IR (KBr) ν<sub>max</sub> 3350, 1709, 1545, 1339, 1001, 746 cm<sup>–1</sup>.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 3-(1<i>H</i>-Indol-3-yl)-4-[6-methyl-2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (<b>17</b>)</h3><div class="NLM_p last"><b>17</b> was synthesized as described for <b>1</b> but starting from commercially available 6-methyl-1<i>H</i>-quinazoline-2,4-dione. ES-MS: 451 [M – H]<sup>−</sup>. HRMS: calcd for C<sub>26</sub>H<sub>24</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> 453.2039, found 453.2042. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 2.12–2.22 (br, 4H), 2.13 (s, 3H), 2.28 (s, 3H), 3.62–3.72 (br, 4H), 6.38 (d, <i>J</i> = 8.2 Hz, 1H), 6.65 (dd, <i>J</i> = 8.2, 7.1 Hz, 1H), 7.04 (dd, <i>J</i> = 8.2, 7.1 Hz, 1H), 7.40 (d, <i>J</i> = 8.2 Hz, 1H), 7.47 (d, <i>J</i> = 8.4 Hz, 1H), 7.52 (d, <i>J</i> = 1.8 Hz, 1H), 7.53 (dd, <i>J</i> = 8.4, 1.8 Hz, 1H), 8.13 (s, 1H), 11.26 (br s, 1H), 12.01 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100.6 MHz): δ 21.6, 44.5, 46.6, 55.0, 105.9, 113.3, 119.3, 121.0, 121.3, 123.3, 125.6, 125.7, 126.3, 126.4, 132.6, 133.5, 137.4, 137.5, 138.7, 151.8, 158.7, 162.3, 172.4, 172.8. IR (KBr) ν<sub>max</sub> 2919, 2850, 1708, 1548, 1442, 1338, 1002, 744 cm<sup>–1</sup>.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 3-(1<i>H</i>-Indol-3-yl)-4-[6-isopropyl-2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (<b>18</b>)</h3><div class="NLM_p last"><b>18</b> was synthesized as described for <b>1</b>. The starting 6-isopropyl-1<i>H</i>-quinazoline-2,4-dione was prepared from commercially available 2-amino-5-isopropylbenzoic acid as described.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> ES-MS: 479 [M – H]<sup>−</sup>. HRMS: calcd for C<sub>28</sub>H<sub>28</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> 481.2352, found 481.2357. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 0.97 (d, <i>J</i> = 6.9 Hz, 6H), 2.17 (s, 3H), 2.18–2.28 (br, 4H), 2.74 (hept, <i>J</i> = 6.9 Hz, 1H), 3.67–3.77 (br, 4H), 6.29 (d, <i>J</i> = 8.2 Hz, 1H), 6.61 (dd, <i>J</i> = 8.2, 7.1 Hz, 1H), 7.00 (dd, <i>J</i> = 8.2, 7.1 Hz, 1H), 7.36 (d, <i>J</i> = 8.2 Hz, 1H), 7.38 (d, <i>J</i> = 2.0 Hz, 1H), 7.45 (d, <i>J</i> = 8.8 Hz, 1H), 7.53 (dd, <i>J</i> = 8.8, 2.0 Hz, 1H), 8.10 (s, 1H), 11.26 (br s, 1H), 12.00 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100.6 MHz): δ 23.7, 33.1, 44.0, 46.2, 54.6, 105.5, 112.6, 118.3, 120.3, 120.6, 122.7, 123.0, 124.8, 125.1, 125.9, 132.7, 134.4, 136.9, 138.3, 142.5, 151.5, 158.2, 161.5, 171.7, 172.2. IR (KBr) ν<sub>max</sub> 3331, 2957, 1711, 1549, 1446, 1340, 1237, 1139, 1003, 744 cm<sup>–1</sup>.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 3-[6-<i>tert</i>-Butyl-2-(4-methylpiperazin-1-yl)quinazolin-4-yl]-4-(1<i>H</i>-indol-3-yl)pyrrole-2,5-dione (<b>19</b>)</h3><div class="NLM_p last"><b>19</b> was synthesized as described for <b>1</b>. The starting 6-<i>tert</i>-butyl-1<i>H</i>-quinazoline-2,4-dione was prepared from commercially available 2-amino-5-<i>tert</i>-butylbenzoic acid using known procedures.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> ES-MS: 493 [M – H]<sup>−</sup>. HRMS: calcd for C<sub>29</sub>H<sub>30</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> 495.2508, found 495.2510. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 1.02 (s, 9H), 2.19 (s, 3H), 2.22–2.35 (br, 1H), 3.70–3.80 (br, 1H), 6.21 (d, <i>J</i> = 8.0 Hz, 1H), 6.21 (d, <i>J</i> = 8.0 Hz, 1H), 6.60 (dd, <i>J</i> = 8.0, 7.0 Hz, 1H), 6.98 (dd, <i>J</i> = 8.1, 7.0 Hz, 1H), 7.36 (d, <i>J</i> = 8.1 Hz, 1H), 7.37 (s, 1H), 7.44 (d, <i>J</i> = 9.0 Hz, 1H), 7.67 (dd, <i>J</i> = 9.0, 1.6 Hz, 1H), 8.12 (s, 1H), 11.2–11.4 (br, 1H), 11.9–12.2 (br, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100.7 MHz): δ 30.8, 34.4, 44.0, 46.2, 54.6, 105.6, 112.5, 117.9, 120.2, 120.6, 121.7, 122.7, 124.5, 125.1, 125.7, 132.8, 133.2, 136.8, 138.2, 144.6, 151.1, 158.3, 161.5, 171.6, 172.1. IR (KBr) ν<sub>max</sub> 3328, 2953, 1711, 1548, 1445, 1341, 1247, 1142, 1003, 744 cm<sup>–1</sup>.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 3-[7-Fluoro-2-(4-methylpiperazin-1-yl)quinazolin-4-yl]-4-(1<i>H</i>-indol-3-yl)pyrrole-2,5-dione (<b>20</b>)</h3><div class="NLM_p last"><b>20</b> was synthesized as described for <b>1</b> but starting from commercially available 7-fluoro-1<i>H</i>-quinazoline-2,4-dione. ES-MS: 457 [M + H]<sup>+</sup>. HRMS: calcd for C<sub>25</sub>H<sub>21</sub>FN<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> 457.1788, found 457.1786. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 2.06–2.20 (br, 4H), 2.13 (s, 3H), 3.60–3.76 (br, 4H), 6.32 (d, <i>J</i> = 8.0 Hz, 1H), 6.67 (dd, <i>J</i> = 8.0, 7.0 Hz, 1H), 6.95–7.01 (m, 1H), 7.05 (dd, <i>J</i> = 8.0, 7.0 Hz, 1H), 7.23–7.26 (dd, <i>J</i> = 10.8, 2.3 Hz, 1H), 7.41 (d, <i>J</i> = 8.0 Hz, 1H), 7.81–7.85 (m, 1H), 8.16 (s, 1H), 11.28 (br s, 1H), 12.05 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100.6 MHz): δ 44.8, 47.0, 55.4, 106.2, 110.3 (<i>J</i> = 20.6 Hz), 113.5 (<i>J</i> = 25.1 Hz), 117.0, 121.3, 121.8, 123.8, 125.1, 126.0, 131.7 (<i>J</i> = 11.5 Hz), 134.2, 137.9, 139.5, 155.6 (<i>J</i> = 14.7 Hz), 159.6, 163.2, 167.1 (<i>J</i> = 252.3 Hz), 172.6, 173.0. IR (KBr) ν<sub>max</sub> 2940, 1710, 1626, 1555, 1491, 1332, 1004, 745 cm<sup>–1</sup>.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 3-[7-Chloro-2-(4-methylpiperazin-1-yl)quinazolin-4-yl]-4-(1<i>H</i>-indol-3-yl)pyrrole-2,5-dione (<b>21</b>)</h3><div class="NLM_p last"><b>21</b> was synthesized as described for <b>1</b> but starting from commercially available 7-chloro-1<i>H</i>-quinazoline-2,4-dione. ES-MS: 471 [M – H]<sup>−</sup>. HRMS: calcd for C<sub>25</sub>H<sub>21</sub>ClN<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> 473.1493, found 473.1491. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 2.08–2.22 (br, 4H), 2.13 (s, 3H), 3.61–3.78 (br, 4H), 6.29 (d, <i>J</i> = 8.0 Hz, 1H), 6.69 (dd, <i>J</i> = 8.0, 7.0 Hz, 1H), 7.06 (dd, <i>J</i> = 8.2, 7.0 Hz, 1H), 7.11 (dd, <i>J</i> = 8.8, 1.6 Hz, 1H), 7.42 (d, <i>J</i> = 8.2 Hz, 1H), 7.58 (d, <i>J</i> = 1.6 Hz, 1H), 7.77 (d, <i>J</i> = 8.8 Hz, 1H), 8.18 (s, 1H), 11.31 (br s, 1H), 12.08 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100.6 MHz): δ 43.9, 46.0, 54.5, 105.9, 112.9, 117.2, 120.3, 120.9, 122.9, 123.1, 123.9, 124.5, 125.0, 129.6, 133.4, 137.0, 138.7, 139.6, 153.6, 158.7, 162.6, 171.7, 172.0. IR (KBr) ν<sub>max</sub> 3200, 1761, 1692, 1606, 1544, 752 cm<sup>–1</sup>.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 3-(1<i>H</i>-Indol-3-yl)-4-[8-methyl-2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (<b>22</b>)</h3><div class="NLM_p last"><b>22</b> was synthesized as described for <b>1</b> but starting from commercially available 8-methyl-1<i>H</i>-quinazoline-2,4-dione. ES-MS: 451 [M – H]<sup>−</sup>. HRMS: calcd for C<sub>26</sub>H<sub>24</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> 453.2039, found 453.2041. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 2.15 (s, 3H), 2.16–2.26 (br, 4H), 2.53 (s, 3H), 3.67–3.78 (br, 4H), 6.47 (d, <i>J</i> = 8.2 Hz, 1H), 6.66 (dd, <i>J</i> = 8.2, 6.9 Hz, 1H), 6.97–7.05 (m, 2H), 7.38 (d, <i>J</i> = 8.0 Hz, 1H), 7.52–7.54 (m, 2H), 8.08 (s, 1H), 11.25 (br s, 1H), 11.99 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100.6 MHz): δ 17.2, 44.0, 46.1, 54.5, 105.3, 112.7, 118.3, 120.5, 120.8, 122.3, 122.8, 124.9, 125.2, 125.3, 132.8, 133.5, 134.3, 136.9, 138.1, 151.6, 157.9, 162.8, 171.8, 172.1. IR (KBr) ν<sub>max</sub> 3142, 1688, 1617, 1553, 1428, 760 cm<sup>–1</sup>.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 3-(4-Chloro-1<i>H</i>-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (<b>23</b>)</h3><div class="NLM_p last"><b>23</b> was synthesized as described for <b>1</b>, but the final cyclocondensation was conducted with commercially available (4-chloro-1<i>H</i>-indol-3-yl)oxoacetic acid methyl ester. ES-MS: 473 [M + H]<sup>+</sup>. HRMS: calcd for C<sub>25</sub>H<sub>22</sub>ClN<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> 473.148 73, found 473.148 99. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz): δ 2.82 (s, 3H), 2.90–3.10 (br, 2H), 3.25–3.35 (br, 2H), 3.45–3.55 (br, 2H), 4.70–4.85 (br, 2H), 7.06 (d, <i>J</i> = 7.7 Hz, 1H), 7.12 (dd, <i>J</i> = 8.1, 7.7 Hz, 1H), 7.19–7.22 (m, 1H), 7.39 (d, <i>J</i> = 8.1 Hz, 1H), 7.52 (br s, 1H), 7.56 (d, <i>J</i> = 8.4 Hz, 1H), 7.70–7.73 (m, 2H), 10.30–10.45 (br, 1H), 11.53 (s, 1H), 12.03 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150.9 MHz): δ 40.9, 42.3, 52.0, 102.4, 111.4, 118.1, 120.8, 123.2, 123.5, 123.7, 124.7, 125.8, 126.6, 129.9, 133.3, 135.0, 137.7, 141.0, 151.9, 157.2, 160.9, 170.7, 171.6. IR (FTIR, transmission) ν<sub>max</sub> 3202, 3041, 2730, 2486, 1766, 1720, 1618, 1571, 1553, 1485, 1455, 756 cm<sup>–1</sup>.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 3-(5-Chloro-1<i>H</i>-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (<b>24</b>)</h3><div class="NLM_p last"><b>24</b> was synthesized as described for <b>1</b>, but the final cyclocondensation was conducted with commercially available (5-chloro-1<i>H</i>-indol-3-yl)oxoacetic acid methyl ester. ES-MS: 473 [M + H]<sup>+</sup>. HRMS: calcd for C<sub>25</sub>H<sub>22</sub>ClN<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> 473.148 73, found 473.148 92. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz): δ 2.70–3.00 (br, 2H), 2.79 (s, 3H), 3.15–3.35 (br, 2H), 3.40–3.55 (br, 2H), 4.70–4.80 (br, 2H), 6.31 (br s, 1H), 7.06 (dd, <i>J</i> = 8.4, 1.8 Hz, 1H), 7.19 (dd, <i>J</i> = 8.1, 7.0 Hz, 1H), 7.41 (d, <i>J</i> = 8.4 Hz, 1H), 7.64 (d, <i>J</i> = 8.4 Hz, 1H), 7.74 (dd, <i>J</i> = 8.4, 7.0 Hz, 1H), 7.78 (d, <i>J</i> = 8.1 Hz, 1H), 8.16 (d, <i>J</i> = 2.9 Hz, 1H), 10.30–10.45 (br, 1H), 11.41 (s, 1H), 12.34 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150.9 MHz): δ 41.0, 42.4, 52.2, 104.4, 114.1, 118.9, 119.7, 122.4, 123.7, 124.8, 125.0, 125.9, 127.0, 134.1, 135.0, 135.2, 137.7, 152.1, 157.5, 162.7, 171.3, 171.6. IR (FTIR, transmission) ν<sub>max</sub> 3166, 3037, 2730, 1760, 1716, 1620, 1570, 1551, 1484, 1456, 1429, 757 cm<sup>–1</sup>.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 3-(6-Chloro-1<i>H</i>-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (<b>25</b>)</h3><div class="NLM_p last"><b>25</b> was synthesized as described for <b>1</b>, but the final cyclocondensation was conducted with commercially available (6-chloro-1<i>H</i>-indol-3-yl)oxoacetic acid methyl ester. ES-MS: 473 [M + H]<sup>+</sup>. HRMS: calcd for C<sub>25</sub>H<sub>22</sub>ClN<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> 473.148 73, found 473.148 83. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz): δ 2.05–2.25 (br, 4H), 2.12 (s, 3H), 3.60–3.80 (br, 4H), 6.35 (d, <i>J</i> = 8.1 Hz, 1H), 6.68 (d, <i>J</i> = 8.1 Hz, 1H), 7.10 (dd, <i>J</i> = 8.1, 6.9 Hz, 1H), 7.45 (s, 1H), 7.54 (d, <i>J</i> = 8.5 Hz, 1H), 7.67 (dd, <i>J</i> = 8.5, 6.9 Hz, 1H), 7.72 (d, <i>J</i> = 8.1 Hz, 1H), 8.11 (s, 1H), 11.25–11.50 (br, 1H), 11.95–12.20 (br, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150.9 MHz): δ 43.6, 45.8, 54.2, 105.0, 112.2, 118.1, 120.6, 121.4, 122.5, 123.5, 125.5, 125.7, 127.1, 133.5, 134.7, 137.1, 137.7, 152.5, 157.9, 161.8, 171.4, 171.6. IR (FTIR, transmission) ν<sub>max</sub> 3190, 2946, 2805, 1769, 1757, 1696, 1619, 1568, 1550, 1505, 1485, 1342, 759 cm<sup>–1</sup>.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 3-(7-Chloro-1<i>H</i>-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (<b>26</b>)</h3><div class="NLM_p last"><b>26</b> was synthesized as described for <b>1</b>, but the final cyclocondensation was conducted with commercially available (7-chloro-1<i>H</i>-indol-3-yl)oxoacetic acid methyl ester. ES-MS: 473 [M + H]<sup>+</sup>. HRMS: calcd for C<sub>25</sub>H<sub>22</sub>ClN<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> 473.148 73, found 473.148 95. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz): δ 2.79 (s, 3H), 3.10–3.35 (br, 2H), 3.35–3.65 (br, 4H), 4.65–4.80 (br, 2H), 6.36 (d, <i>J</i> = 8.4 Hz, 1H), 6.70 (dd, <i>J</i> = 8.4, 7.8 Hz, 1H), 7.13 (d, <i>J</i> = 7.8 Hz, 1H), 7.17 (dd, <i>J</i> = 8.4, 6.6 Hz, 1H), 7.61 (d, <i>J</i> = 8.4 Hz, 1H), 7.72–7.74 (m, 1H), 7.79 (d, <i>J</i> = 8.4 Hz, 1H), 8.08 (d, <i>J</i> = 3.3 Hz, 1H), 10.30–10.45 (br, 1H), 11.46 (s, 1H), 12.51 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150.9 MHz): δ 41.0, 42.4, 52.2, 105.9, 116.9, 118.8, 119.1, 121.6, 122.2, 123.7, 125.9, 126.0, 126.8, 127.2, 133.3, 133.5, 135.3, 137.8, 152.2, 157.6, 162.4, 171.3, 171.6. IR (FTIR, transmission) ν<sub>max</sub> 3062, 2871, 2730, 2489, 1761, 1716, 1621, 1551, 1485, 1433, 1343, 784 cm<sup>–1</sup>.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 3-(7-Methyl-1<i>H</i>-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (<b>27</b>)</h3><div class="NLM_p last"><b>27</b> was synthesized as described for <b>1</b>, but the final cyclocondensation was conducted with commercially available (7-methyl-1<i>H</i>-indol-3-yl)oxoacetic acid methyl ester. ES-MS: 453 [M + H]<sup>+</sup>. HRMS: calcd for C<sub>26</sub>H<sub>25</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> 453.203 35, found 453.203 43. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz): δ 2.42 (s, 3H), 2.60–2.90 (br, 2H), 2.75 (s, 3H), 3.10–3.25 (br, 2H), 3.25–3.50 (br, 2H), 4.60–4.80 (br, 2H), 6.04 (d, <i>J</i> = 8.1 Hz, 1H), 6.54 (dd, <i>J</i> = 8.1, 7.0 Hz, 1H), 6.83 (d, <i>J</i> = 7.0 Hz, 1H), 7.20 (dd, <i>J</i> = 8.0, 7.4 Hz, 1H), 7.62 (d, <i>J</i> = 8.4 Hz, 1H), 7.74 (dd, <i>J</i> = 7.4 Hz, 1H), 7.81 (d, <i>J</i> = 8.0 Hz, 1H), 8.14 (d, <i>J</i> = 3.0 Hz, 1H), 10.18–10.28 (br, 1H), 11.36 (br s, 1H), 12.21 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150.9 MHz): δ 16.6, 40.9, 42.3, 52.0, 105.4, 117.5, 118.9, 120.7, 122.0, 123.2, 123.5, 123.8, 124.5, 125.8, 127.3, 132.8, 135.0, 136.1, 138.2, 152.1, 157.4, 162.7, 171.4, 171.8. IR (FTIR, transmission) ν<sub>max</sub> 2956, 2730, 2485, 1760, 1714, 1619, 1551, 1485, 1345, 784, 757 cm<sup>–1</sup>.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 3-(1-Methyl-1<i>H</i>-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (<b>28</b>)</h3><div class="NLM_p last"><b>28</b> was synthesized as described for <b>1</b>, but the final cyclocondensation was conducted with commercially available (1-methyl-1<i>H</i>-indol-3-yl)oxoacetic acid methyl ester. ESI-MS: 453 [M + H]<sup>+</sup>. HRMS: calcd for C<sub>26</sub>H<sub>24</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> 453.2039, found 453.2045. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 2.14 (s, 3H), 2.14–2.22 (br, 4H), 3.64–3.76 (br, 4H), 3.88 (s, 3H), 6.28 (d, <i>J</i> = 8.0 Hz, 1H), 6.68 (dd, <i>J</i> = 8.0, 7.0 Hz, 1H), 7.08–7.12 (m, 2H), 7.45 (d, <i>J</i> = 8.4 Hz, 1H), 7.53 (d, <i>J</i> = 8.4 Hz, 1H), 7.65–7.71 (m, 2H), 8.24 (s, 1H), 11.29 (br, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125.8 MHz): δ 33.2, 43.6, 45.8, 54.2, 104.0, 110.9, 118.4, 120.1, 120.8, 122.5, 122.6, 123.9, 125.2, 125.6, 127.0, 134.8, 136.4, 137.2, 137.4, 152.4, 158.0, 162.2, 171.5, 171.8. IR (KBr) ν<sub>max</sub> 2960, 1707, 1548, 1333, 1005, 749 cm<sup>–1</sup>.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 3-(1-Isopropyl-1<i>H</i>-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (<b>29</b>)</h3><div class="NLM_p last"><b>29</b> was synthesized as described for <b>1</b>, but the final cyclocondensation was conducted with (1-isopropyl-1<i>H</i>-indol-3-yl)oxoacetic acid methyl ester, which was synthesized from 1-isopropyl-1<i>H</i>-indole<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> as described.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> ES-MS: 481 [M + H]<sup>+</sup>. HRMS: calcd for C<sub>28</sub>H<sub>28</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> 481.2352, found 481.2358. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 1.48 (d, <i>J</i> = 6.6 Hz, 6H), 2.05–2.15 (br, 4H), 2.13 (s, 3H), 3.60–3.70 (br, 4H), 4.83 (h, <i>J</i> = 6.6 Hz, 1H), 6.40 (d, <i>J</i> = 8.2 Hz, 1H), 6.68–6.72 (m, 1H), 7.08–7.16 (m, 2H), 7.54–7.58 (m, 2H), 7.68–7.72 (m, 1H), 7.74 (d, <i>J</i> = 8.3, 1H), 8.20 (s, 1H), 11.28–11.34 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100.7 MHz): δ 22.4, 43.9, 46.1, 47.8, 54.5, 105.0, 111.4, 118.6, 120.7, 121.1, 122.7, 122.8, 124.9, 125.7, 125.9, 127.4, 131.7, 134.9, 136.3, 138.2, 152.9, 158.3, 162.3, 171.7, 172.1. IR (KBr) ν<sub>max</sub> 1717, 1547, 1300, 1234, 1214, 1002, 738 cm<sup>–1</sup>.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 3-(2-Methyl-1<i>H</i>-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (<b>30</b>)</h3><div class="NLM_p last"><b>30</b> was synthesized as described for <b>1</b>, but the final cyclocondensation was conducted with commercially available (2-methyl-1<i>H</i>-indol-3-yl)oxoacetic acid methyl ester. ES-MS: 453 [M + H]<sup>+</sup>. HRMS: calcd for C<sub>26</sub>H<sub>24</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> 453.2039, found 453.2044. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 2.20 (s, 3H), 2.21 (s, 3H), 2.27–2.33 (br, 4H), 3.75–3.82 (br, 4H), 6.76–6.80 (m, 1H), 6.95–6.99 (m, 1H), 7.00–7.03 (m, 1H), 7.11 (d, <i>J</i> = 7.9 Hz, 1H), 7.20 (d, <i>J</i> = 8.1 Hz, 1H), 7.45 (d, <i>J</i> = 8.5 Hz, 1H), 7.56–7.64 (m, 2H), 11.33 (br, 1H), 11.56 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100.6 MHz): δ 14.2, 44.6, 46.7, 55.3, 102.7, 111.8, 118.2, 120.0, 120.6, 122.2, 123.3, 126.5, 127.3, 127.7, 131.3, 135.3 (2x), 136.5, 140.0, 141.2, 159.0, 162.6, 171.8, 172.1. IR (KBr) ν<sub>max</sub> 2938, 1715, 1549, 1339, 1003, 754 cm<sup>–1</sup>.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 3-(1<i>H</i>-Indol-3-yl)-4-(2-piperazin-1-yl-quinazolin-4-yl)pyrrole-2,5-dione (<b>31</b>)</h3><div class="NLM_p last"><b>31</b> was synthesized as described for <b>1</b> but using piperazine instead of <i>N</i>-methylpiperazine in the reaction with 2-(2-chloroquinazolin-4-yl)acetamide. ES-MS: 423 [M – H]<sup>−</sup>. HRMS: calcd for C<sub>24</sub>H<sub>20</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> 425.1726, found 425.1720. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 2.56–2.66 (br, 4H), 3.55–3.75 (br, 4H), 6.41 (d, <i>J</i> = 8.0 Hz, 1H), 6.66 (dd, <i>J</i> = 8.0, 7.2 Hz, 1H), 7.01–7.05 (m, 1H), 7.07 (dd, <i>J</i> = 8.0, 7.2 Hz, 1H), 7.39 (d, <i>J</i> = 8.0 Hz, 1H), 7.52 (d, <i>J</i> = 8.6 Hz, 1H), 7.63–7.69 (m, 2H), 8.13 (br s, 1H), 11.8–12.2 (br, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100.7 MHz): δ 45.2, 45.7, 105.3, 112.8, 118.6, 120.5, 120.7, 122.6, 122.7, 124.8, 125.1, 125.9, 127.3, 133.0, 134.8, 136.9, 138.2, 152.7, 158.4, 162.5, 171.8, 172.2. IR (KBr) ν<sub>max</sub> 3310, 1709, 1548, 1337, 750 cm<sup>–1</sup>.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 3-(1-Methyl-1<i>H</i>-indol-3-yl)-4-(2-piperazin-1-yl-quinazolin-4-yl)pyrrole-2,5-dione (<b>32</b>)</h3><div class="NLM_p last"><b>32</b> was synthesized as described for <b>1</b> but using 2-(2-piperazin-1-yl-quinazolin-4-yl)acetamide and (1-methyl-1<i>H</i>-indol-3-yl)oxoacetic acid methyl ester in the final cyclocondensation. ES-MS: 439 [M + H]<sup>+</sup>. HRMS: calcd for C<sub>25</sub>H<sub>22</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> 439.1882, found 439.1879. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 2.58–2.66 (br, 4H), 3.62–3.70 (br, 4H), 3.89 (s, 3H), 6.34 (d, <i>J</i> = 8.2 Hz, 1H), 6.69 (dd, <i>J</i> = 8.2, 7.1 Hz, 1H), 7.06–7.12 (m, 2H), 7.46 (d, <i>J</i> = 8.2 Hz, 1H), 7.52 (d, <i>J</i> = 8.4 Hz, 1H), 7.63–7.69 (m, 2H), 8.24 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100.6 MHz): δ 32.6, 42.0, 43.1, 103.1, 110.1, 117.7, 119.2, 119.8, 121.7, 121.9, 124.3, 124.8, 126.1, 133.8, 135.6, 136.3, 136.5, 151.4, 156.9, 161.5, 170.6, 170.9. IR (KBr) ν<sub>max</sub> 2941, 1703, 1544, 1331, 1226, 1121, 748 cm<sup>–1</sup>.</div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52224" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52224" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jürgen Wagner</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, Basel CH-4002, Switzerland</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e18b94849386848fcf9680868f8493a18f8e978093958892cf828e8cc19184958493cf978e8fbe8c809595a18f8e978093958892cf828e8c"><span class="__cf_email__" data-cfemail="5b312e3e293c3e35752c3a3c353e291b35342d3a292f322875383436">[email protected]</span> <span class="__cf_email__" data-cfemail="d2a2b7a6b7a0fca4bdbc8dbfb3a6a692bcbda4b3a0a6bba1fcb1bdbf">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter von Matt</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, Basel CH-4002, Switzerland</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f69c839384919398d8819791989384b69899809784829f85d895999bd68693829384d8809998a99b978282b69899809784829f85d895999b"><span class="__cf_email__" data-cfemail="68021d0d1a0f0d06461f090f060d1a2806071e091a1c011b460b0705">[email protected]</span> <span class="__cf_email__" data-cfemail="3c4c5948594e124a535263515d48487c52534a5d4e48554f125f5351">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bernard Faller</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, Basel CH-4002, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nigel G. Cooke</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, Basel CH-4002, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rainer Albert</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, Basel CH-4002, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Sedrani</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, Basel CH-4002, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hansjörg Wiegand</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, Basel CH-4002, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian Jean</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, Basel CH-4002, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian Beerli</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, Basel CH-4002, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gisbert Weckbecker</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, Basel CH-4002, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-Pierre Evenou</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, Basel CH-4002, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gerhard Zenke</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, Basel CH-4002, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sylvain Cottens</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, Basel CH-4002, Switzerland</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm200469u" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i49">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34825" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34825" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Volker Brinkmann for the MLR studies and Karen Beltz for the solubility studies in simulated gastric fluids.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i50" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i50"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i51" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i51"> Abbreviations Used</h2><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">PKC</td><td class="NLM_def"><p class="first last">protein kinase C</p></td></tr><tr><td class="NLM_term">CsA</td><td class="NLM_def"><p class="first last">cyclosporine A</p></td></tr><tr><td class="NLM_term">DAG</td><td class="NLM_def"><p class="first last">diacylglycerol</p></td></tr><tr><td class="NLM_term">PS</td><td class="NLM_def"><p class="first last">phosphatidylserine</p></td></tr><tr><td class="NLM_term">TCR</td><td class="NLM_def"><p class="first last">T cell receptor</p></td></tr><tr><td class="NLM_term">MLR</td><td class="NLM_def"><p class="first last">mixed lymphocyte reaction</p></td></tr><tr><td class="NLM_term">log <i>P</i></td><td class="NLM_def"><p class="first last">octanol/water partition coefficient</p></td></tr><tr><td class="NLM_term">Pgp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">FaSSIF</td><td class="NLM_def"><p class="first last">fasted state simulated intestinal fluid</p></td></tr><tr><td class="NLM_term">FeSSIF</td><td class="NLM_def"><p class="first last">fed state simulated intestinal fluid</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney cell line</p></td></tr><tr><td class="NLM_term">Caco-2</td><td class="NLM_def"><p class="first last">human colon carcinoma epithelial cell line</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i52">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28778" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28778" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 27 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Dumont, F. J.</span><span> </span><span class="NLM_article-title">Immunosuppressive strategies for prevention of transplant rejection</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm200469u&amp;key=10.1517%2F13543776.11.3.377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslSisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=377-404&author=F.+J.+Dumont&title=Immunosuppressive+strategies+for+prevention+of+transplant+rejection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Immunosuppressive strategies for prevention of transplant rejection</span></div><div class="casAuthors">Dumont, Francis J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">377-404</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with 560 refs. is given.  Organ transplantation is the treatment of choice for end stage organ failure.  This procedure has greatly benefited from the introduction of potent immunosuppressive drugs that suppress anti-allograft immune response, esp. cyclosporin A (CsA) and FK506 which both inhibit calcineurin, a crit. mol. switch of T-cell activation.  However, use of these agents is limited by severe mechanism-based adverse effects, principally nephrotoxicity and neurotoxicity.  Although newer immunosuppressants, including monoclonal antibodies (mAbs) to CD3 and IL-2 receptor (IL-2R), mycophenolate mofetil and more recently rapamycin, have contributed to mitigate the toxicity of calcineurin inhibitors and decrease the rate of acute graft rejection, the long-term graft survival is still a major problem due to poorly controlled chronic rejection.  Late loss of transplant is all the more frustrating given the current penury in donated organs.  There is therefore considerable incentive to discover more effective and safer immunosuppressive agents or methodologies affecting immunoregulatory pathways in a manner distinct from existing drugs.  The patent literature of the last three years (1998-2000), reviewed here, reflects intense academic and industrial research towards this goal.  Capitalising on recent advances in the understanding of T-cell activation and immune regulation, efforts have been focused on strategies that (a) inhibit signalling mechanisms and/or proliferation of T-cells, (b) interfere with cell surface mols. involved in immune cell interactions or (c) alter the trafficking/intragraft recruitment of lymphocytes responsible for graft rejection.  Many of these patents claim for agents and modalities that may help achieve allograft tolerance, the ultimate goal of transplantation medicine.  Special efforts were also devoted to xenotransplantation with hopes that this exptl. technol. will graduate to the clinic in a not too distant future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4iUc5l-eeRrVg90H21EOLACvtfcHk0ljbsg_aFPBHJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslSisrY%253D&md5=5ba6973f9e63ceec460c69f363180b26</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1517%2F13543776.11.3.377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.11.3.377%26sid%3Dliteratum%253Aachs%26aulast%3DDumont%26aufirst%3DF.%2BJ.%26atitle%3DImmunosuppressive%2520strategies%2520for%2520prevention%2520of%2520transplant%2520rejection%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2001%26volume%3D11%26spage%3D377%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Halloran, P. F.</span><span> </span><span class="NLM_article-title">Immunosuppressive drugs for kidney transplantation</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x">, </span> <span class="NLM_fpage">2715</span><span class="NLM_x">–</span> <span class="NLM_lpage">2729</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm200469u&amp;key=10.1056%2FNEJMra033540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm200469u&amp;key=15616206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFWitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2004&pages=2715-2729&author=P.+F.+Halloran&title=Immunosuppressive+drugs+for+kidney+transplantation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Immunosuppressive drugs for kidney transplantation</span></div><div class="casAuthors">Halloran, Philip F.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2715-2729</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review on immunosuppressive agents that are either approved or in phase 2 or phase 3 trials in kidney transplantation.  Immunosuppression can be achieved by depleting lymphocytes, diverting lymphocyte traffic, or blocking lymphocyte response pathways.  Immunosuppressive drugs have three effects: the therapeutic effect (suppressing rejection), undesired consequences of immunodeficiency (infection or cancer), and nonimmune toxicity to other tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfWUKDaIyFxLVg90H21EOLACvtfcHk0ljbsg_aFPBHJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFWitw%253D%253D&md5=322c7383267f227e2ef128bac1183fa1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMra033540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra033540%26sid%3Dliteratum%253Aachs%26aulast%3DHalloran%26aufirst%3DP.%2BF.%26atitle%3DImmunosuppressive%2520drugs%2520for%2520kidney%2520transplantation%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D351%26spage%3D2715%26epage%3D2729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Liu, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harlan, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span> </span><span class="NLM_article-title">T cell-directed therapies: lessons learned and future prospects</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm200469u&amp;key=10.1038%2Fni1429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm200469u&amp;key=17179969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlaqsL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=25-30&author=E.+H.+Liuauthor=R.+M.+Siegelauthor=D.+M.+Harlanauthor=J.+J.+O%E2%80%99Shea&title=T+cell-directed+therapies%3A+lessons+learned+and+future+prospects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">T cell-directed therapies: lessons learned and future prospects</span></div><div class="casAuthors">Liu, Eric H.; Siegel, Richard M.; Harlan, David M.; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-30</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Agents interfering with T cell function are therapeutic mainstays for various autoimmune diseases and for transplant approaches to organ failure.  The understanding of T cell biol. has blossomed since the development of most agents now in use.  Here we discuss T cell-specific agents now in use, others recently added to the therapeutic armamentarium and promising agents being investigated in clin. and preclin. studies.  In addn., we reflect on the risks and benefits involved in the testing of such agents clin., with examples of agents that have successfully been used in the clinic and agents that failed to reach therapeutic use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBHcvwZuFJhrVg90H21EOLACvtfcHk0ljbsg_aFPBHJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlaqsL7L&md5=eeaddb16c63810e784f5d53c0a12d268</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fni1429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1429%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DE.%2BH.%26aulast%3DSiegel%26aufirst%3DR.%2BM.%26aulast%3DHarlan%26aufirst%3DD.%2BM.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DT%2520cell-directed%2520therapies%253A%2520lessons%2520learned%2520and%2520future%2520prospects%26jtitle%3DNat.%2520Immunol.%26date%3D2007%26volume%3D8%26spage%3D25%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Wagner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Matt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedrani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrhardt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rummel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strauss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan-Jacob, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beerli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weckbecker, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evenou, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zenke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottens, S.</span><span> </span><span class="NLM_article-title">Discovery of 3-(1<i>H</i>-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]-pyrrole-2,5-dione (AEB071), a potent and selective inhibitor of protein kinase C isotypes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6193</span><span class="NLM_x">–</span> <span class="NLM_lpage">6196</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901108b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6193-6196&author=J.+Wagnerauthor=P.+von+Mattauthor=R.+Sedraniauthor=R.+Albertauthor=N.+Cookeauthor=C.+Ehrhardtauthor=M.+Geiserauthor=G.+Rummelauthor=W.+Starkauthor=A.+Straussauthor=S.+W.+Cowan-Jacobauthor=C.+Beerliauthor=G.+Weckbeckerauthor=J.-P.+Evenouauthor=G.+Zenkeauthor=S.+Cottens&title=Discovery+of+3-%281H-indol-3-yl%29-4-%5B2-%284-methylpiperazin-1-yl%29quinazolin-4-yl%5D-pyrrole-2%2C5-dione+%28AEB071%29%2C+a+potent+and+selective+inhibitor+of+protein+kinase+C+isotypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm901108b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901108b%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3Dvon%2BMatt%26aufirst%3DP.%26aulast%3DSedrani%26aufirst%3DR.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DCooke%26aufirst%3DN.%26aulast%3DEhrhardt%26aufirst%3DC.%26aulast%3DGeiser%26aufirst%3DM.%26aulast%3DRummel%26aufirst%3DG.%26aulast%3DStark%26aufirst%3DW.%26aulast%3DStrauss%26aufirst%3DA.%26aulast%3DCowan-Jacob%26aufirst%3DS.%2BW.%26aulast%3DBeerli%26aufirst%3DC.%26aulast%3DWeckbecker%26aufirst%3DG.%26aulast%3DEvenou%26aufirst%3DJ.-P.%26aulast%3DZenke%26aufirst%3DG.%26aulast%3DCottens%26aufirst%3DS.%26atitle%3DDiscovery%2520of%25203-%25281H-indol-3-yl%2529-4-%255B2-%25284-methylpiperazin-1-yl%2529quinazolin-4-yl%255D-pyrrole-2%252C5-dione%2520%2528AEB071%2529%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520protein%2520kinase%2520C%2520isotypes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6193%26epage%3D6196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Evenou, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zenke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovarik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welzenbach, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weitz-Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guntermann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Towbin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaminski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letschka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutz-Nicoladoni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann-Kleiter, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thuille, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baier, G.</span><span> </span><span class="NLM_article-title">The potent protein kinase C selective inhibitor AEB071 (sotrastaurin) represents a new class of immunosuppressive agents affecting early T cell activation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">792</span><span class="NLM_x">–</span> <span class="NLM_lpage">801</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm200469u&amp;key=10.1124%2Fjpet.109.153205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm200469u&amp;key=19491325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVyitLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2009&pages=792-801&author=J.-P.+Evenouauthor=J.+Wagnerauthor=G.+Zenkeauthor=V.+Brinkmannauthor=K.+Wagnerauthor=J.+Kovarikauthor=K.+A.+Welzenbachauthor=G.+Weitz-Schmidtauthor=C.+Guntermannauthor=H.+Towbinauthor=S.+Cottensauthor=S.+Kaminskiauthor=T.+Letschkaauthor=C.+Lutz-Nicoladoniauthor=T.+Gruberauthor=N.+Hermann-Kleiterauthor=N.+Thuilleauthor=G.+Baier&title=The+potent+protein+kinase+C+selective+inhibitor+AEB071+%28sotrastaurin%29+represents+a+new+class+of+immunosuppressive+agents+affecting+early+T+cell+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The potent protein kinase C-selective inhibitor AEB071 (sotrastaurin) represents a new class of immunosuppressive agents affecting early T-cell activation</span></div><div class="casAuthors">Evenou, Jean-Pierre; Wagner, Jurgen; Zenke, Gerhard; Brinkmann, Volker; Wagner, Kathrin; Kovarik, Jiri; Welzenbach, Karl A.; Weitz-Schmidt, Gabriele; Guntermann, Christine; Towbin, Harry; Cottens, Sylvain; Kaminski, Sandra; Letschka, Thomas; Lutz-Nicoladoni, Christina; Gruber, Thomas; Hermann-Kleiter, Natascha; Thuille, Nikolaus; Baier, Gottfried</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">792-801</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">There is a pressing need for immunosuppressants with an improved safety profile.  The search for novel approaches to blocking T-cell activation led to the development of the selective protein kinase C (PKC) inhibitor AEB071 (sotrastaurin).  In cell-free kinase assays AEB071 inhibited PKC, with Ki values in the subnanomolar to low nanomolar range.  Upon T-cell stimulation, AEB071 markedly inhibited in situ PKCθ catalytic activity and selectively affected both the canonical nuclear factor-κB and nuclear factor of activated T cells (but not activator protein-1) transactivation pathways.  In primary human and mouse T cells, AEB071 treatment effectively abrogated at low nanomolar concn. markers of early T-cell activation, such as interleukin-2 secretion and CD25 expression.  Accordingly, the CD3/CD28 antibody- and alloantigen-induced T-cell proliferation responses were potently inhibited by AEB071 in the absence of nonspecific antiproliferative effects.  Unlike former PKC inhibitors, AEB071 did not enhance apoptosis of murine T-cell blasts in a model of activation-induced cell death.  Furthermore, AEB071 markedly inhibited lymphocyte function-assocd. antigen-1-mediated T-cell adhesion at nanomolar concns.  The mode of action of AEB071 is different from that of calcineurin inhibitors, and AEB071 and cyclosporine A seem to have complementary effects on T-cell signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLsBh_sy4icrVg90H21EOLACvtfcHk0lg32d7KfNk_Zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVyitLzN&md5=de769c096a575c867056def9491244b9</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.153205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.153205%26sid%3Dliteratum%253Aachs%26aulast%3DEvenou%26aufirst%3DJ.-P.%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DZenke%26aufirst%3DG.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DWagner%26aufirst%3DK.%26aulast%3DKovarik%26aufirst%3DJ.%26aulast%3DWelzenbach%26aufirst%3DK.%2BA.%26aulast%3DWeitz-Schmidt%26aufirst%3DG.%26aulast%3DGuntermann%26aufirst%3DC.%26aulast%3DTowbin%26aufirst%3DH.%26aulast%3DCottens%26aufirst%3DS.%26aulast%3DKaminski%26aufirst%3DS.%26aulast%3DLetschka%26aufirst%3DT.%26aulast%3DLutz-Nicoladoni%26aufirst%3DC.%26aulast%3DGruber%26aufirst%3DT.%26aulast%3DHermann-Kleiter%26aufirst%3DN.%26aulast%3DThuille%26aufirst%3DN.%26aulast%3DBaier%26aufirst%3DG.%26atitle%3DThe%2520potent%2520protein%2520kinase%2520C%2520selective%2520inhibitor%2520AEB071%2520%2528sotrastaurin%2529%2520represents%2520a%2520new%2520class%2520of%2520immunosuppressive%2520agents%2520affecting%2520early%2520T%2520cell%2520activation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D330%26spage%3D792%26epage%3D801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Skvara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawid, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleyn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meingassner, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumortier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopp, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fallahi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stary, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkhart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grenet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hijazi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGeown, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rordorf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, C. E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stingl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, T.</span><span> </span><span class="NLM_article-title">The PKC inhibitor AEB071 may be a therapeutic option for psiorasis</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">3151</span><span class="NLM_x">–</span> <span class="NLM_lpage">3159</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=3151-3159&author=H.+Skvaraauthor=M.+Dawidauthor=E.+Kleynauthor=B.+Wolffauthor=J.+G.+Meingassnerauthor=H.+Knightauthor=T.+Dumortierauthor=T.+Koppauthor=N.+Fallahiauthor=G.+Staryauthor=C.+Burkhartauthor=O.+Grenetauthor=J.+Wagnerauthor=Y.+Hijaziauthor=R.+M.+Morrisauthor=C.+McGeownauthor=C.+Rordorfauthor=C.+E.+M.+Griffithsauthor=G.+Stinglauthor=T.+Jung&title=The+PKC+inhibitor+AEB071+may+be+a+therapeutic+option+for+psiorasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkvara%26aufirst%3DH.%26aulast%3DDawid%26aufirst%3DM.%26aulast%3DKleyn%26aufirst%3DE.%26aulast%3DWolff%26aufirst%3DB.%26aulast%3DMeingassner%26aufirst%3DJ.%2BG.%26aulast%3DKnight%26aufirst%3DH.%26aulast%3DDumortier%26aufirst%3DT.%26aulast%3DKopp%26aufirst%3DT.%26aulast%3DFallahi%26aufirst%3DN.%26aulast%3DStary%26aufirst%3DG.%26aulast%3DBurkhart%26aufirst%3DC.%26aulast%3DGrenet%26aufirst%3DO.%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DHijazi%26aufirst%3DY.%26aulast%3DMorris%26aufirst%3DR.%2BM.%26aulast%3DMcGeown%26aufirst%3DC.%26aulast%3DRordorf%26aufirst%3DC.%26aulast%3DGriffiths%26aufirst%3DC.%2BE.%2BM.%26aulast%3DStingl%26aufirst%3DG.%26aulast%3DJung%26aufirst%3DT.%26atitle%3DThe%2520PKC%2520inhibitor%2520AEB071%2520may%2520be%2520a%2520therapeutic%2520option%2520for%2520psiorasis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2008%26volume%3D118%26spage%3D3151%26epage%3D3159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Budde, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommerer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asderakis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietruck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grinyo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigotti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dantal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barten, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, M.</span><span> </span><span class="NLM_article-title">Sotrastaurin, a novel small molecule inhibiting protein kinase C: first clinical results in renal-transplant recipients</span> <span class="citation_source-journal">Am. J. Transpl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">581</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm200469u&amp;key=10.1111%2Fj.1600-6143.2009.02980.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm200469u&amp;key=20121745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1ahtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=571-581&author=K.+Buddeauthor=C.+Sommererauthor=T.+Beckerauthor=A.+Asderakisauthor=F.+Pietruckauthor=J.+M.+Grinyoauthor=P.+Rigottiauthor=J.+Dantalauthor=J.+Ngauthor=M.+J.+Bartenauthor=M.+Weber&title=Sotrastaurin%2C+a+novel+small+molecule+inhibiting+protein+kinase+C%3A+first+clinical+results+in+renal-transplant+recipients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Sotrastaurin, a novel small molecule inhibiting protein kinase C: first clinical results in renal-transplant recipients</span></div><div class="casAuthors">Budde, K.; Sommerer, C.; Becker, T.; Asderakis, A.; Pietruck, F.; Grinyo, J. M.; Rigottig, P.; Dantal, J.; Ng, J.; Barten, M. J.; Weber, M.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Transplantation</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">571-581</span>CODEN:
                <span class="NLM_cas:coden">AJTMBR</span>;
        ISSN:<span class="NLM_cas:issn">1600-6135</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Sotrastaurin, a novel protein-kinase-C inhibitor, blocks early T-cell activation.  In this 12-mo, Phase II study, de novo renal-transplant patients were randomized to sotrastaurin (200 mg b.i.d.) + std.-exposure tacrolimus (SET) or reduced-exposure tacrolimus (RET) (SET: n = 76; RET: n = 66), or control (SET + mycophenolic acid [MPA, 720 mg b.i.d.]; n = 74).  In both sotrastaurin groups, patients were converted from tacrolimus to MPA after Month 3, achieving calcineurin inhibitor-free immunosuppression.  The primary endpoint was composite efficacy failure (treated biopsyproven acute rejection, graft loss, death or loss to follow-up).  The key secondary endpoint was glomerular filtration rate (GFR).  Composite efficacy failure rates were: 4.1%, 5.4% and 1.5% at Month 3 (preconversion) and 7.8%, 44.8% and 34.1% at study end in the control, sotrastaurin + SET and sotrastaurin + RET groups, resp.; these results led to premature study discontinuation.  Median GFR at Month 6 was: 57.0, 53.0 and 60.0 mL/min/1.73 m2, resp.  Study-drug discontinuations due to adverse events occurred in 16.2%, 18.4% and 12.1%, resp.  Leukopenia and neutropenia occurred more frequently preconversion in control vs. sotrastaurin groups: 13.7%, 5.6%, and 4.6%; and 11.1%, 4.3% and 3.1%, resp.  The initial sotrastaurin + tacrolimus regimen was efficacious and well tolerated but the postconversion sotrastaurin + MPA regimen showed inadequate efficacy.  Longer-term evaluation of sotrastaurin + tacrolimus is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsD4GC4kdZtrVg90H21EOLACvtfcHk0liiLEqk7tVITg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1ahtLw%253D&md5=d4399839e8fb66b9f46ea2e2aed304d5</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-6143.2009.02980.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-6143.2009.02980.x%26sid%3Dliteratum%253Aachs%26aulast%3DBudde%26aufirst%3DK.%26aulast%3DSommerer%26aufirst%3DC.%26aulast%3DBecker%26aufirst%3DT.%26aulast%3DAsderakis%26aufirst%3DA.%26aulast%3DPietruck%26aufirst%3DF.%26aulast%3DGrinyo%26aufirst%3DJ.%2BM.%26aulast%3DRigotti%26aufirst%3DP.%26aulast%3DDantal%26aufirst%3DJ.%26aulast%3DNg%26aufirst%3DJ.%26aulast%3DBarten%26aufirst%3DM.%2BJ.%26aulast%3DWeber%26aufirst%3DM.%26atitle%3DSotrastaurin%252C%2520a%2520novel%2520small%2520molecule%2520inhibiting%2520protein%2520kinase%2520C%253A%2520first%2520clinical%2520results%2520in%2520renal-transplant%2520recipients%26jtitle%3DAm.%2520J.%2520Transpl.%26date%3D2010%26volume%3D10%26spage%3D571%26epage%3D581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Newton, A. C.</span><span> </span><span class="NLM_article-title">Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">371</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2003&pages=361-371&author=A.+C.+Newton&title=Regulation+of+the+ABC+kinases+by+phosphorylation%3A+protein+kinase+C+as+a+paradigm"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNewton%26aufirst%3DA.%2BC.%26atitle%3DRegulation%2520of%2520the%2520ABC%2520kinases%2520by%2520phosphorylation%253A%2520protein%2520kinase%2520C%2520as%2520a%2520paradigm%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D370%26spage%3D361%26epage%3D371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Tan, S.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, P. J.</span><span> </span><span class="NLM_article-title">Emerging and diverse roles of protein kinase C in immune cell signalling</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">552</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=2003&pages=545-552&author=S.-L.+Tanauthor=P.+J.+Parker&title=Emerging+and+diverse+roles+of+protein+kinase+C+in+immune+cell+signalling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DS.-L.%26aulast%3DParker%26aufirst%3DP.%2BJ.%26atitle%3DEmerging%2520and%2520diverse%2520roles%2520of%2520protein%2520kinase%2520C%2520in%2520immune%2520cell%2520signalling%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D376%26spage%3D545%26epage%3D552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Baier, G.</span><span> </span><span class="NLM_article-title">The PKC gene module: molecular biosystematics to resolve its T cell function</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">192</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm200469u&amp;key=10.1034%2Fj.1600-065X.2003.00018.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm200469u&amp;key=12670396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsVOnt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2003&pages=64-79&author=G.+Baier&title=The+PKC+gene+module%3A+molecular+biosystematics+to+resolve+its+T+cell+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The PKC gene module: molecular biosystematics to resolve its T cell functions</span></div><div class="casAuthors">Baier, Gottfried</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">64-79</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">A review.  The distinct protein kinase C (PKC) multigene family (PKC gene module) is known to be the 'classic' intracellular receptor for mitogenic phorbol esters, and it is widely accepted in the scientific community that the 'PKC effect' is essential in activation, differentiation, adhesion and motility, as well as in cellular survival, of T cells.  Nevertheless, the first concepts about PKC isotype heterogeneity of cellular localization and function emerged only recently, when the PKC-.vtheta. pathways were mapped to crit. signaling networks that control T cell receptor (TCR)/CD3-dependent interleukin (IL)-2 prodn. and proliferation in T lymphocytes.  This review summarizes the current knowledge about T cell expressed PKC gene products, their known and/or suspected regulation and cellular effector pathways, as well as physiol. functions in T lymphocytes (as detd. by mol. cell biol. and ongoing mouse genetic studies).  Given PKCs integral role in T cell function but today's very fragmentary mol. understanding of directly PKC-mediated effector functions in transmembrane signaling, a 'mol. biosystematics' approach is suggested to resolve the isotype-selective functions of this PKC gene family.  Such an approach has to be based not only on genomic/cytogenetic anal. to establish its genetic relationships but also on biochem./cell biol. and genetic studies to resolve its functional diversity and, ultimately, nonredundant roles in real T cell physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcRXXh24tHqrVg90H21EOLACvtfcHk0liiLEqk7tVITg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsVOnt70%253D&md5=981fe5f84b4da5cae591d65a234d8d00</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1034%2Fj.1600-065X.2003.00018.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1600-065X.2003.00018.x%26sid%3Dliteratum%253Aachs%26aulast%3DBaier%26aufirst%3DG.%26atitle%3DThe%2520PKC%2520gene%2520module%253A%2520molecular%2520biosystematics%2520to%2520resolve%2520its%2520T%2520cell%2520function%26jtitle%3DImmunol.%2520Rev.%26date%3D2003%26volume%3D192%26spage%3D64%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Guo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlings, D. J.</span><span> </span><span class="NLM_article-title">Protein kinase C family functions in B-cell activation</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm200469u&amp;key=10.1016%2Fj.coi.2004.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm200469u&amp;key=15134787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVamtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2004&pages=367-373&author=B.+Guoauthor=T.+T.+Suauthor=D.+J.+Rawlings&title=Protein+kinase+C+family+functions+in+B-cell+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase C family functions in B-cell activation</span></div><div class="casAuthors">Guo, Beichu; Su, Thomas T.; Rawlings, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">367-373</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Members of the protein kinase C (PKC) family play important but distinct roles in B-cell activation, as demonstrated by emerging genetic and biochem. studies.  PKCβ is indispensable for B-cell antigen receptor (BCR)-induced NF-κB activation and B-cell survival.  Recent evidence indicates that PKCβ might regulate inhibitor of κB kinase (IKK) and NF-κB activation through interaction with the CARMA1/Bcl10/MALT signaling complex in BCR microdomains.  By contrast, the novel PKC isoform PKCδ is specifically required to maintain the tolerance of self-reactive B cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMGBS557krDLVg90H21EOLACvtfcHk0liiLEqk7tVITg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVamtrk%253D&md5=6642a6eb30c04cb0ac2ea3ee9909c92b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.coi.2004.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coi.2004.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DB.%26aulast%3DSu%26aufirst%3DT.%2BT.%26aulast%3DRawlings%26aufirst%3DD.%2BJ.%26atitle%3DProtein%2520kinase%2520C%2520family%2520functions%2520in%2520B-cell%2520activation%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2004%26volume%3D16%26spage%3D367%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Ife, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blurton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keeling, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meeson, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theobald, C. J.</span><span> </span><span class="NLM_article-title">Reversible inhibitors of the gastric (H<sup>+</sup>/K<sup>+</sup>)-ATPase. 5. Substituted 2,4-diaminoquinazolines and thienopyrimidines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">2763</span><span class="NLM_x">–</span> <span class="NLM_lpage">2773</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00014a027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=2763-2773&author=R.+J.+Ifeauthor=T.+H.+Brownauthor=P.+Blurtonauthor=D.+J.+Keelingauthor=C.+A.+Leachauthor=M.+L.+Meesonauthor=M.+E.+Parsonsauthor=C.+J.+Theobald&title=Reversible+inhibitors+of+the+gastric+%28H%2B%2FK%2B%29-ATPase.+5.+Substituted+2%2C4-diaminoquinazolines+and+thienopyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm00014a027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00014a027%26sid%3Dliteratum%253Aachs%26aulast%3DIfe%26aufirst%3DR.%2BJ.%26aulast%3DBrown%26aufirst%3DT.%2BH.%26aulast%3DBlurton%26aufirst%3DP.%26aulast%3DKeeling%26aufirst%3DD.%2BJ.%26aulast%3DLeach%26aufirst%3DC.%2BA.%26aulast%3DMeeson%26aufirst%3DM.%2BL.%26aulast%3DParsons%26aufirst%3DM.%2BE.%26aulast%3DTheobald%26aufirst%3DC.%2BJ.%26atitle%3DReversible%2520inhibitors%2520of%2520the%2520gastric%2520%2528H%252B%252FK%252B%2529-ATPase.%25205.%2520Substituted%25202%252C4-diaminoquinazolines%2520and%2520thienopyrimidines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D2763%26epage%3D2773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Faul, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winneroski, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumrich, C. A.</span><span> </span><span class="NLM_article-title">A new, efficient method for the synthesis of bisindolylmaleimides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">6053</span><span class="NLM_x">–</span> <span class="NLM_lpage">6058</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo980513c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADyaK1cXkvFKmtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=6053-6058&author=M.+M.+Faulauthor=L.+L.+Winneroskiauthor=C.+A.+Krumrich&title=A+new%2C+efficient+method+for+the+synthesis+of+bisindolylmaleimides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A New, Efficient Method for the Synthesis of Bisindolylmaleimides</span></div><div class="casAuthors">Faul, Margaret M.; Winneroski, Leonard L.; Krumrich, Christine A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6053-6058</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Both sym. and unsym. bisindolylmaleimides were prepd. by reaction of indole-3-acetamides with Me indolyl-3-glyoxylates using a soln. of KOBu-t in THF.  The reaction is successful in the presence of a variety of functional groups (H, alkyl, Oh, NMe2, OTr).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6p6e4vJJuurVg90H21EOLACvtfcHk0liOmoIur6e7VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvFKmtL8%253D&md5=3d2975997fde454c6d7ed53c8b8ede22</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjo980513c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo980513c%26sid%3Dliteratum%253Aachs%26aulast%3DFaul%26aufirst%3DM.%2BM.%26aulast%3DWinneroski%26aufirst%3DL.%2BL.%26aulast%3DKrumrich%26aufirst%3DC.%2BA.%26atitle%3DA%2520new%252C%2520efficient%2520method%2520for%2520the%2520synthesis%2520of%2520bisindolylmaleimides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D6053%26epage%3D6058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Kosugi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kameyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migita, T.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed displacement of aryl halide by tin analogue of Reformatsky reagent</span> <span class="citation_source-journal">Bull. Chem. Soc. Jpn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3383</span><span class="NLM_x">–</span> <span class="NLM_lpage">3384</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1985&pages=3383-3384&author=M.+Kosugiauthor=Y.+Negishiauthor=M.+Kameyamaauthor=T.+Migita&title=Palladium-catalyzed+displacement+of+aryl+halide+by+tin+analogue+of+Reformatsky+reagent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKosugi%26aufirst%3DM.%26aulast%3DNegishi%26aufirst%3DY.%26aulast%3DKameyama%26aufirst%3DM.%26aulast%3DMigita%26aufirst%3DT.%26atitle%3DPalladium-catalyzed%2520displacement%2520of%2520aryl%2520halide%2520by%2520tin%2520analogue%2520of%2520Reformatsky%2520reagent%26jtitle%3DBull.%2520Chem.%2520Soc.%2520Jpn.%26date%3D1985%26volume%3D58%26spage%3D3383%26epage%3D3384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Wolfe, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed amination of aryl triflates</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1264</span><span class="NLM_x">–</span> <span class="NLM_lpage">1267</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo961915s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADyaK2sXhs1Cqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=1264-1267&author=J.+P.+Wolfeauthor=S.+L.+Buchwald&title=Palladium-catalyzed+amination+of+aryl+triflates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Amination of Aryl Triflates</span></div><div class="casAuthors">Wolfe, John P.; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1264-1267</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The conversion of aryl triflates to the corresponding aniline derivs. was accomplished in moderate to good yield using a catalyst consisting of the combination of palladium acetate (2 mol %) and either BINAP or Tol-BINAP.  In contrast to the corresponding palladium-catalyzed amination of aryl bromides and iodides, electronically neutral aryl triflates gave higher yields of arylamines than did electron deficient aryl triflates, presumably due to the increased rate of base-promoted triflate cleavage in electron deficient substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDMTN7WXJXArVg90H21EOLACvtfcHk0liOmoIur6e7VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhs1Cqs74%253D&md5=d5a541960bab033e95cc5e6b9816a1de</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjo961915s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo961915s%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DJ.%2BP.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DPalladium-catalyzed%2520amination%2520of%2520aryl%2520triflates%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D1264%26epage%3D1267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Jagdmann, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munson, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gero, T. W.</span><span> </span><span class="NLM_article-title">A mild efficient procedure for the conversion of carboxylic acid esters to primary amides using formamide/methanolic sodium methoxide</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1203</span><span class="NLM_x">–</span> <span class="NLM_lpage">1208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm200469u&amp;key=10.1080%2F00397919008052828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADyaK3cXmtFSqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1990&pages=1203-1208&author=G.+E.+Jagdmannauthor=H.+R.+Munsonauthor=T.+W.+Gero&title=A+mild+efficient+procedure+for+the+conversion+of+carboxylic+acid+esters+to+primary+amides+using+formamide%2Fmethanolic+sodium+methoxide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A mild efficient procedure for the conversion of carboxylic acid esters to primary amides using formamide/methanolic sodium methoxide</span></div><div class="casAuthors">Jagdmann, G. Erik, Jr.; Munson, H. Randall, Jr.; Gero, Thomas W.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1203-8</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">A variety of primary amides were prepd. from esters by using 3 mol equiv formamide and 0.33-0.69 mol equiv 25% methanolic NaOH in DMF or THF.  The reactions were carried out at 60-100° and were usually complete in less than one hour.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8PjBCLiG_ErVg90H21EOLACvtfcHk0liOmoIur6e7VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmtFSqtrY%253D&md5=3333a65c7a4bef6b5073bf4884698d5d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1080%2F00397919008052828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919008052828%26sid%3Dliteratum%253Aachs%26aulast%3DJagdmann%26aufirst%3DG.%2BE.%26aulast%3DMunson%26aufirst%3DH.%2BR.%26aulast%3DGero%26aufirst%3DT.%2BW.%26atitle%3DA%2520mild%2520efficient%2520procedure%2520for%2520the%2520conversion%2520of%2520carboxylic%2520acid%2520esters%2520to%2520primary%2520amides%2520using%2520formamide%252Fmethanolic%2520sodium%2520methoxide%26jtitle%3DSynth.%2520Commun.%26date%3D1990%26volume%3D20%26spage%3D1203%26epage%3D1208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">McCort, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoornaert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aletru, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denys, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duclos, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadilhac, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guilpain, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dellac, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galzin, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delahaye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guilbert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, S.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of 3- and 4-substituted quinolin-2-ones: discovery of mixed 5-HT<sub>1B</sub>/5-HT<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2129</span><span class="NLM_x">–</span> <span class="NLM_lpage">2137</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=2129-2137&author=G.+McCortauthor=C.+Hoornaertauthor=M.+Aletruauthor=C.+Denysauthor=O.+Duclosauthor=C.+Cadilhacauthor=E.+Guilpainauthor=G.+Dellacauthor=P.+Janiakauthor=A.-M.+Galzinauthor=M.+Delahayeauthor=F.+Guilbertauthor=S.+O%E2%80%99Connor&title=Synthesis+and+SAR+of+3-+and+4-substituted+quinolin-2-ones%3A+discovery+of+mixed+5-HT1B%2F5-HT2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCort%26aufirst%3DG.%26aulast%3DHoornaert%26aufirst%3DC.%26aulast%3DAletru%26aufirst%3DM.%26aulast%3DDenys%26aufirst%3DC.%26aulast%3DDuclos%26aufirst%3DO.%26aulast%3DCadilhac%26aufirst%3DC.%26aulast%3DGuilpain%26aufirst%3DE.%26aulast%3DDellac%26aufirst%3DG.%26aulast%3DJaniak%26aufirst%3DP.%26aulast%3DGalzin%26aufirst%3DA.-M.%26aulast%3DDelahaye%26aufirst%3DM.%26aulast%3DGuilbert%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520SAR%2520of%25203-%2520and%25204-substituted%2520quinolin-2-ones%253A%2520discovery%2520of%2520mixed%25205-HT1B%252F5-HT2A%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2001%26volume%3D9%26spage%3D2129%26epage%3D2137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Kovarik, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sfikas, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandler, P. A.</span><span> </span><span class="NLM_article-title">The effect on sotrastaurin pharmacokinetics of strong CYP3A inhibition by ketoconazole</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">385</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm200469u&amp;key=10.1111%2Fj.1365-2125.2009.03457.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm200469u&amp;key=19740395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ylsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2009&pages=381-385&author=J.+M.+Kovarikauthor=H.-L.+A.+Huangauthor=A.+Sladeauthor=N.+Sfikasauthor=P.+A.+Chandler&title=The+effect+on+sotrastaurin+pharmacokinetics+of+strong+CYP3A+inhibition+by+ketoconazole"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The effect on sotrastaurin pharmacokinetics of strong CYP3A inhibition by ketoconazole</span></div><div class="casAuthors">Kovarik, John M.; Huang, Hsun-Lun A.; Slade, Alan; Sfikas, Nikos; Chandler, Patricia A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">381-385</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims: Sotrastaurin is an immunosuppressant that reduces T-lymphocyte activation via protein kinase C inhibition.  The effect of CYP3A4 inhibition by ketoconazole on the pharmacokinetics of sotrastaurin, a CYP3A4 substrate, was investigated.  Methods: This was a two-period, single-sequence crossover study in 18 healthy subjects.  They received a single 50 mg oral dose of sotrastaurin in period 1 followed by a 14-day inter-treatment phase.  In period 2 they received ketoconazole 200 mg twice daily for 6 days and a single 50 mg dose of sotrastaurin on the fourth day of ketoconazole administration.  Results: Co-administration of single-dose sotrastaurin during steady-state ketoconazole increased sotrastaurin Cmax by 2.5-fold (90% confidence interval 2.2, 2.9) from 285 ± 128 to 678 ± 189 ng ml-1 and increased AUC by 4.6-fold (4.1, 5.2) from 1666 ± 808 to 7378 ± 3011 ng ml-1 h.  Sotrastaurin half-life was nearly doubled from 5.9 ± 1.7 to 10.6 ± 2.5 h.  The AUC of the active metabolite N-desmethyl-sotrastaurin was increased by 6.8-fold.  Sotrastaurin did not alter ketoconazole steady-state predose plasma concns.  Conclusions: The strong CYP3A4 inhibitor ketoconazole increased sotrastaurin AUC by 4.6-fold.  A compensatory redn. in the dose of sotrastaurin is warranted when strong CYP3A4 inhibitors are co-administered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0RW-0VPBjErVg90H21EOLACvtfcHk0lhx9T0pAntd1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ylsLzE&md5=2c193041610ebc6d3136016be7a295b8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2009.03457.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2009.03457.x%26sid%3Dliteratum%253Aachs%26aulast%3DKovarik%26aufirst%3DJ.%2BM.%26aulast%3DHuang%26aufirst%3DH.-L.%2BA.%26aulast%3DSlade%26aufirst%3DA.%26aulast%3DSfikas%26aufirst%3DN.%26aulast%3DChandler%26aufirst%3DP.%2BA.%26atitle%3DThe%2520effect%2520on%2520sotrastaurin%2520pharmacokinetics%2520of%2520strong%2520CYP3A%2520inhibition%2520by%2520ketoconazole%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2009%26volume%3D68%26spage%3D381%26epage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Choc, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhmle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charnick, S. B.</span><span> </span><span class="NLM_article-title">Relative bioavailability of Neoral versus Sandimmun in the presence of a P450IIIA and P-glycoprotein inhibitor</span> <span class="citation_source-journal">Transplant Proc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1664</span><span class="NLM_x">–</span> <span class="NLM_lpage">1665</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm200469u&amp;key=10.1016%2FS0041-1345%2898%2900383-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm200469u&amp;key=9723234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADyaK1cXlvV2jtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1998&pages=1664-1665&author=M.+G.+Chocauthor=E.+A.+Muellerauthor=W.+T.+Robinsonauthor=A.+Kuhmleauthor=H.+T.+Smithauthor=S.+B.+Charnick&title=Relative+bioavailability+of+Neoral+versus+Sandimmun+in+the+presence+of+a+P450IIIA+and+P-glycoprotein+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Relative bioavailability of Neoral versus Sandimmune in the presence of a P450IIIA and P-glycoprotein inhibitor</span></div><div class="casAuthors">Choc, M. G.; Mueller, E. A.; Robinson, W. T.; Kumle, A.; Smith, H. T.; Charnick, S. B.</div><div class="citationInfo"><span class="NLM_cas:title">Transplantation Proceedings</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1664-1665</span>CODEN:
                <span class="NLM_cas:coden">TRPPA8</span>;
        ISSN:<span class="NLM_cas:issn">0041-1345</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">In order to test the possibility that a formulation-specific inhibition of metab. or counter transport provide the mechanism for Neoral's increased bioavailability vs. Sandimmune, this study compared cyclosporine A bioavailability for both Neoral and Sandimmune in the presence and absence of a well-characterized inhibitor of P450IIIA/P-glycoprotein.  Cyclosporine AUC , Cmax, and bioavailability ratios in the presence and absence of the P450IIIA/P-gp inhibitor were not statistically different between the two cyclosporine formulations.  These results suggest that the enhanced bioavailability of Neoral compared to Sandimmune is simply explained by improved drug absorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTNX65pnWVg7Vg90H21EOLACvtfcHk0lhx9T0pAntd1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlvV2jtbk%253D&md5=94850a1f38a26999a33ce287db0f0fce</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0041-1345%2898%2900383-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0041-1345%252898%252900383-2%26sid%3Dliteratum%253Aachs%26aulast%3DChoc%26aufirst%3DM.%2BG.%26aulast%3DMueller%26aufirst%3DE.%2BA.%26aulast%3DRobinson%26aufirst%3DW.%2BT.%26aulast%3DKuhmle%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DH.%2BT.%26aulast%3DCharnick%26aufirst%3DS.%2BB.%26atitle%3DRelative%2520bioavailability%2520of%2520Neoral%2520versus%2520Sandimmun%2520in%2520the%2520presence%2520of%2520a%2520P450IIIA%2520and%2520P-glycoprotein%2520inhibitor%26jtitle%3DTransplant%2520Proc.%26date%3D1998%26volume%3D30%26spage%3D1664%26epage%3D1665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Weckbecker, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pally, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beerli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkhart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieczorek, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metzler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span> </span><span class="NLM_article-title">Effects of the novel protein kinase C inhibitor AEB071 (sotrastaurin) on rat cardiac allograft survival using single agent treatment or combination therapy with cyclosporine, everolimus or FTY720</span> <span class="citation_source-journal">Transpl. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">552</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm200469u&amp;key=10.1111%2Fj.1432-2277.2009.01015.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm200469u&amp;key=20003043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFCksr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=543-552&author=G.+Weckbeckerauthor=C.+Pallyauthor=C.+Beerliauthor=C.+Burkhartauthor=G.+Wieczorekauthor=B.+Metzlerauthor=R.+E.+Morrisauthor=J.+Wagnerauthor=C.+Bruns&title=Effects+of+the+novel+protein+kinase+C+inhibitor+AEB071+%28sotrastaurin%29+on+rat+cardiac+allograft+survival+using+single+agent+treatment+or+combination+therapy+with+cyclosporine%2C+everolimus+or+FTY720"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the novel protein kinase C inhibitor AEB071 (Sotrastaurin) on rat cardiac allograft survival using single agent treatment or combination therapy with cyclosporine, everolimus or FTY720</span></div><div class="casAuthors">Weckbecker, Gisbert; Pally, Charles; Beerli, Christian; Burkhart, Christoph; Wieczorek, Grazyna; Metsler, Barbara; Morris, Randall E.; Wagner, Juergen; Bruns, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Transplant International</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">543-552</span>CODEN:
                <span class="NLM_cas:coden">TRINE5</span>;
        ISSN:<span class="NLM_cas:issn">0934-0874</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">NVP-AEB071 (AEB, sotrastaurin), an oral inhibitor of protein kinase C (PKC), effectively blocks T-cell activation.  The immunosuppressive effects of oral AEB were demonstrated in a rat local graft vs. host (GvH) reaction and rat cardiac transplantation models.  T-cell activation was suppressed by 95% in blood from AEB-treated rats, with a pos. correlation between T-cell inhibition and AEB blood concn.  In GvH studies, AEB inhibited lymph node swelling dose-dependently (3-30 mg/kg).  BN and DA cardiac allografts were acutely rejected within 6-10 days post-transplantation in untreated LEW rats.  AEB at 10 and 30 mg/kg b.i.d. prolonged BN graft survival to a mean survival time of 15 and >28 days, and DA grafts to 6.5 and 17.5 days, resp.  In the DA to LEW model, combining a nonefficacious dose of AEB (10 mg/kg b.i.d.) with a nonefficacious dose of cyclosporine, everolimus or FTY720 led to prolonged median survival times (26 days, >68 days and >68 days, resp.).  Pharmacokinetic monitoring excluded drug-drug interactions, suggesting synergy.  In conclusion, these studies are the first to demonstrate that AEB prolongs rat heart allograft survival safely as monotherapy and in combination with nonefficacious doses of cyclosporine, everolimus or FTY720.  Thus, AEB may have the potential to offer an alternative to calcineurin inhibitor-based therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB6Ge3QcvIKbVg90H21EOLACvtfcHk0ligbjZEIf9FjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFCksr0%253D&md5=64942e83bfffc98d94bdfdc2c01d9d88</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-2277.2009.01015.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-2277.2009.01015.x%26sid%3Dliteratum%253Aachs%26aulast%3DWeckbecker%26aufirst%3DG.%26aulast%3DPally%26aufirst%3DC.%26aulast%3DBeerli%26aufirst%3DC.%26aulast%3DBurkhart%26aufirst%3DC.%26aulast%3DWieczorek%26aufirst%3DG.%26aulast%3DMetzler%26aufirst%3DB.%26aulast%3DMorris%26aufirst%3DR.%2BE.%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DBruns%26aufirst%3DC.%26atitle%3DEffects%2520of%2520the%2520novel%2520protein%2520kinase%2520C%2520inhibitor%2520AEB071%2520%2528sotrastaurin%2529%2520on%2520rat%2520cardiac%2520allograft%2520survival%2520using%2520single%2520agent%2520treatment%2520or%2520combination%2520therapy%2520with%2520cyclosporine%252C%2520everolimus%2520or%2520FTY720%26jtitle%3DTranspl.%2520Int.%26date%3D2010%26volume%3D23%26spage%3D543%26epage%3D552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><div class="note"><p class="first last">For experimental details, see the following: </p></div><span class="NLM_contrib-group">Suomalainen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johans, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soederlund, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinnunen, P. K. J.</span><span> </span><span class="NLM_article-title">Surface activity profiling of drugs applied to the prediction of blood–brain barrier permeability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1783</span><span class="NLM_x">–</span> <span class="NLM_lpage">1788</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0309001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1783-1788&author=P.+Suomalainenauthor=C.+Johansauthor=T.+Soederlundauthor=P.+K.+J.+Kinnunen&title=Surface+activity+profiling+of+drugs+applied+to+the+prediction+of+blood%E2%80%93brain+barrier+permeability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm0309001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0309001%26sid%3Dliteratum%253Aachs%26aulast%3DSuomalainen%26aufirst%3DP.%26aulast%3DJohans%26aufirst%3DC.%26aulast%3DSoederlund%26aufirst%3DT.%26aulast%3DKinnunen%26aufirst%3DP.%2BK.%2BJ.%26atitle%3DSurface%2520activity%2520profiling%2520of%2520drugs%2520applied%2520to%2520the%2520prediction%2520of%2520blood%25E2%2580%2593brain%2520barrier%2520permeability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1783%26epage%3D1788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Frenkel, Y. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewi, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, P. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1974</span><span class="NLM_x">–</span> <span class="NLM_lpage">1983</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049439i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhs1CqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1974-1983&author=Y.+V.+Frenkelauthor=A.+D.+Clarkauthor=K.+Dasauthor=Y.-H.+Wangauthor=P.+J.+Lewiauthor=P.+A.+J.+Janssenauthor=E.+Arnold&title=Concentration+and+pH+dependent+aggregation+of+hydrophobic+drug+molecules+and+relevance+to+oral+bioavailability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability</span></div><div class="casAuthors">Frenkel, Yulia Volovik; Clark, Arthur D., Jr.; Das, Kalyan; Wang, Yuh-Hwa; Lewi, Paul J.; Janssen, Paul A. J.; Arnold, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1974-1983</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have examd. selected physicochem. properties of compds. from the diaryltriazine/diarylpyrimidine (DATA/DAPY) classes of non-nucleoside reverse transcriptase inhibitors (NNRTIs) and explored possible correlations with their bioavailability.  In simple aq. solns. designed to mimic the gastrointestinal (GI) environment of a fasting individual, all NNRTIs demonstrated formation of aggregates as detected by dynamic light scattering and electron microscopy.  Under various conditions mimicking physiol. transitions in the GI environment, aggregate size distributions were shown to depend on compd. concn. and pH.  NNRTIs with good absorption were capable of forming aggregates with hydrodynamic radii of ≤100 nm at higher concns. and over wide ranges of pH, while poorly absorbed inhibitors form aggregates with radii of ≥250 nm at concns. above 0.01 mM, probably representing ppt.  We propose a model in which the uptake rate into systemic circulation depends on having hydrophobic drug aggregates of appropriate size available for absorption at different locations within the GI tract.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNGjTCVuba-7Vg90H21EOLACvtfcHk0ligbjZEIf9FjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhs1CqtLY%253D&md5=a80f14252dbef3b4152447d5b350b495</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm049439i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049439i%26sid%3Dliteratum%253Aachs%26aulast%3DFrenkel%26aufirst%3DY.%2BV.%26aulast%3DClark%26aufirst%3DA.%2BD.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.-H.%26aulast%3DLewi%26aufirst%3DP.%2BJ.%26aulast%3DJanssen%26aufirst%3DP.%2BA.%2BJ.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DConcentration%2520and%2520pH%2520dependent%2520aggregation%2520of%2520hydrophobic%2520drug%2520molecules%2520and%2520relevance%2520to%2520oral%2520bioavailability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1974%26epage%3D1983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Porter, C. J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">William, N.</span><span> </span><span class="NLM_article-title">Transport and absorption of drugs via the lymphatic system</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">2</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2001&pages=1-2&author=C.+J.+H.+Porterauthor=N.+William&title=Transport+and+absorption+of+drugs+via+the+lymphatic+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DC.%2BJ.%2BH.%26aulast%3DWilliam%26aufirst%3DN.%26atitle%3DTransport%2520and%2520absorption%2520of%2520drugs%2520via%2520the%2520lymphatic%2520system%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D50%26spage%3D1%26epage%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Wasan, K. M.</span><span> </span><span class="NLM_article-title">The role of lymphatic transport in enhancing oral protein and peptide drug delivery</span> <span class="citation_source-journal">Drug Dev. Ind. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1047</span><span class="NLM_x">–</span> <span class="NLM_lpage">1058</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2002&pages=1047-1058&author=K.+M.+Wasan&title=The+role+of+lymphatic+transport+in+enhancing+oral+protein+and+peptide+drug+delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWasan%26aufirst%3DK.%2BM.%26atitle%3DThe%2520role%2520of%2520lymphatic%2520transport%2520in%2520enhancing%2520oral%2520protein%2520and%2520peptide%2520drug%2520delivery%26jtitle%3DDrug%2520Dev.%2520Ind.%2520Pharm.%26date%3D2002%26volume%3D28%26spage%3D1047%26epage%3D1058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Smits, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuiderveld, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broeker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sansuk, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guaita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coruzzi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haaksma, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span> </span><span class="NLM_article-title">Discovery of quinazolines as histamine H<sub>4</sub> receptor inverse agonists using a scaffold hopping approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7855</span><span class="NLM_x">–</span> <span class="NLM_lpage">7865</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800876b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7855-7865&author=R.+A.+Smitsauthor=I.+J.+P.+de+Eschauthor=O.+P.+Zuiderveldauthor=J.+Broekerauthor=K.+Sansukauthor=E.+Guaitaauthor=G.+Coruzziauthor=M.+Adamiauthor=E.+Haaksmaauthor=R.+Leurs&title=Discovery+of+quinazolines+as+histamine+H4+receptor+inverse+agonists+using+a+scaffold+hopping+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm800876b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800876b%26sid%3Dliteratum%253Aachs%26aulast%3DSmits%26aufirst%3DR.%2BA.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DZuiderveld%26aufirst%3DO.%2BP.%26aulast%3DBroeker%26aufirst%3DJ.%26aulast%3DSansuk%26aufirst%3DK.%26aulast%3DGuaita%26aufirst%3DE.%26aulast%3DCoruzzi%26aufirst%3DG.%26aulast%3DAdami%26aufirst%3DM.%26aulast%3DHaaksma%26aufirst%3DE.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520quinazolines%2520as%2520histamine%2520H4%2520receptor%2520inverse%2520agonists%2520using%2520a%2520scaffold%2520hopping%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7855%26epage%3D7865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Dawson, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farhana, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiselyuk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correa, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itkin-Ansar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontana, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.-K.</span><span> </span><span class="NLM_article-title">Derivation of a retinoid X receptor scaffold from peroxisome proliferator-activated receptor γ ligand 1-di(1<i>H</i>-indol-3-yl)methyl-4-trifluoromethylbenzene</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1106</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1106-1119&author=M.+I.+Dawsonauthor=M.+Yeauthor=X.+Caoauthor=L.+Farhanaauthor=Q.-Y.+Huauthor=Y.+Zhaoauthor=L.+P.+Xuauthor=A.+Kiselyukauthor=R.+G.+Correaauthor=L.+Yangauthor=T.+Houauthor=J.+C.+Reedauthor=P.+Itkin-Ansarauthor=F.+Levineauthor=M.+F.+Sannerauthor=J.+A.+Fontanaauthor=X.-K.+Zhang&title=Derivation+of+a+retinoid+X+receptor+scaffold+from+peroxisome+proliferator-activated+receptor+%CE%B3+ligand+1-di%281H-indol-3-yl%29methyl-4-trifluoromethylbenzene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DM.%2BI.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DFarhana%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DQ.-Y.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DL.%2BP.%26aulast%3DKiselyuk%26aufirst%3DA.%26aulast%3DCorrea%26aufirst%3DR.%2BG.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DHou%26aufirst%3DT.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DItkin-Ansar%26aufirst%3DP.%26aulast%3DLevine%26aufirst%3DF.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DFontana%26aufirst%3DJ.%2BA.%26aulast%3DZhang%26aufirst%3DX.-K.%26atitle%3DDerivation%2520of%2520a%2520retinoid%2520X%2520receptor%2520scaffold%2520from%2520peroxisome%2520proliferator-activated%2520receptor%2520%25CE%25B3%2520ligand%25201-di%25281H-indol-3-yl%2529methyl-4-trifluoromethylbenzene%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1106%26epage%3D1119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Ilovich, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billauer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishani, E.</span><span> </span><span class="NLM_article-title">Labeled 3-aryl-4-indolylmaleimide derivatives and their potential as angiogenic PET biomarkers</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">612</span><span class="NLM_x">–</span> <span class="NLM_lpage">620</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=612-620&author=O.+Ilovichauthor=H.+Billauerauthor=S.+Dotanauthor=E.+Mishani&title=Labeled+3-aryl-4-indolylmaleimide+derivatives+and+their+potential+as+angiogenic+PET+biomarkers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIlovich%26aufirst%3DO.%26aulast%3DBillauer%26aufirst%3DH.%26aulast%3DDotan%26aufirst%3DS.%26aulast%3DMishani%26aufirst%3DE.%26atitle%3DLabeled%25203-aryl-4-indolylmaleimide%2520derivatives%2520and%2520their%2520potential%2520as%2520angiogenic%2520PET%2520biomarkers%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D612%26epage%3D620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 30 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Prakash Kumar Sahoo, Yu Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Shoubhik Das</span>. </span><span class="cited-content_cbyCitation_article-title">CO2-Promoted Reactions: An Emerging Concept for the Synthesis of Fine Chemicals and Pharmaceuticals. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2021,</strong> <em>11 </em>
                                    (6)
                                     , 3414-3442. <a href="https://doi.org/10.1021/acscatal.0c05681" title="DOI URL">https://doi.org/10.1021/acscatal.0c05681</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.0c05681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.0c05681%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DCO2-Promoted%252BReactions%25253A%252BAn%252BEmerging%252BConcept%252Bfor%252Bthe%252BSynthesis%252Bof%252BFine%252BChemicals%252Band%252BPharmaceuticals%26aulast%3DSahoo%26aufirst%3DPrakash%2BKumar%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D2021%26date%3D27122020%26date%3D14022021%26date%3D02032021%26volume%3D11%26issue%3D6%26spage%3D3414%26epage%3D3442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kalidas B.  Rasal</span> and <span class="hlFld-ContribAuthor ">Ganapati D.  Yadav</span>  . </span><span class="cited-content_cbyCitation_article-title">Carbon Dioxide Mediated Novel Synthesis of Quinazoline-2,4(1H,3H)-dione in Water. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2016,</strong> <em>20 </em>
                                    (12)
                                     , 2067-2073. <a href="https://doi.org/10.1021/acs.oprd.6b00244" title="DOI URL">https://doi.org/10.1021/acs.oprd.6b00244</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.6b00244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.6b00244%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DCarbon%252BDioxide%252BMediated%252BNovel%252BSynthesis%252Bof%252BQuinazoline-2%25252C4%2525281H%25252C3H%252529-dione%252Bin%252BWater%26aulast%3DRasal%26aufirst%3DKalidas%2BB.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D18072016%26date%3D08122016%26date%3D16122016%26date%3D21112016%26volume%3D20%26issue%3D12%26spage%3D2067%26epage%3D2073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dawn M.  George</span>, <span class="hlFld-ContribAuthor ">Eric C.  Breinlinger</span>, <span class="hlFld-ContribAuthor ">Michael  Friedman</span>, <span class="hlFld-ContribAuthor ">Yang  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianfei  Wang</span>, <span class="hlFld-ContribAuthor ">Maria  Argiriadi</span>, <span class="hlFld-ContribAuthor ">Pratima  Bansal-Pakala</span>, <span class="hlFld-ContribAuthor ">Martine  Barth</span>, <span class="hlFld-ContribAuthor ">David B.  Duignan</span>, <span class="hlFld-ContribAuthor ">Prisca  Honore</span>, <span class="hlFld-ContribAuthor ">QingYu  Lang</span>, <span class="hlFld-ContribAuthor ">Scott  Mittelstadt</span>, <span class="hlFld-ContribAuthor ">Dominique  Potin</span>, <span class="hlFld-ContribAuthor ">Lian  Rundell</span>, and <span class="hlFld-ContribAuthor ">Jeremy J.  Edmunds</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Selective and Orally Bioavailable Protein Kinase Cθ (PKCθ) Inhibitors from a Fragment Hit. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 222-236. <a href="https://doi.org/10.1021/jm500669m" title="DOI URL">https://doi.org/10.1021/jm500669m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500669m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500669m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BSelective%252Band%252BOrally%252BBioavailable%252BProtein%252BKinase%252BC%2525CE%2525B8%252B%252528PKC%2525CE%2525B8%252529%252BInhibitors%252Bfrom%252Ba%252BFragment%252BHit%26aulast%3DGeorge%26aufirst%3DDawn%2BM.%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D29042014%26date%3D07072014%26date%3D08012015%26date%3D24062014%26volume%3D58%26issue%3D1%26spage%3D222%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dawn M.  George</span>, <span class="hlFld-ContribAuthor ">Eric C.  Breinlinger</span>, <span class="hlFld-ContribAuthor ">Maria A.  Argiriadi</span>, <span class="hlFld-ContribAuthor ">Yang  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianfei  Wang</span>, <span class="hlFld-ContribAuthor ">Pratima  Bansal-Pakala</span>, <span class="hlFld-ContribAuthor ">David B.  Duignan</span>, <span class="hlFld-ContribAuthor ">Prisca  Honore</span>, <span class="hlFld-ContribAuthor ">QingYu  Lang</span>, <span class="hlFld-ContribAuthor ">Scott  Mittelstadt</span>, <span class="hlFld-ContribAuthor ">Lian  Rundell</span>, <span class="hlFld-ContribAuthor ">Annette  Schwartz</span>, <span class="hlFld-ContribAuthor ">Jiakang  Sun</span>, and <span class="hlFld-ContribAuthor ">Jeremy J.  Edmunds</span>  . </span><span class="cited-content_cbyCitation_article-title">Optimized Protein Kinase Cθ (PKCθ) Inhibitors Reveal Only Modest Anti-inflammatory Efficacy in a Rodent Model of Arthritis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 333-346. <a href="https://doi.org/10.1021/jm5013006" title="DOI URL">https://doi.org/10.1021/jm5013006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5013006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5013006%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimized%252BProtein%252BKinase%252BC%2525CE%2525B8%252B%252528PKC%2525CE%2525B8%252529%252BInhibitors%252BReveal%252BOnly%252BModest%252BAnti-inflammatory%252BEfficacy%252Bin%252Ba%252BRodent%252BModel%252Bof%252BArthritis%26aulast%3DGeorge%26aufirst%3DDawn%2BM.%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D26082014%26date%3D09102014%26date%3D08012015%26date%3D25092014%26volume%3D58%26issue%3D1%26spage%3D333%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fardokht A.  Abulwerdi</span>, <span class="hlFld-ContribAuthor ">Chenzhong  Liao</span>, <span class="hlFld-ContribAuthor ">Ahmed S.  Mady</span>, <span class="hlFld-ContribAuthor ">Jordan  Gavin</span>, <span class="hlFld-ContribAuthor ">Chenxi  Shen</span>, <span class="hlFld-ContribAuthor ">Tomasz  Cierpicki</span>, <span class="hlFld-ContribAuthor ">Jeanne A.  Stuckey</span>, <span class="hlFld-ContribAuthor ">H. D. Hollis  Showalter</span>, and <span class="hlFld-ContribAuthor ">Zaneta  Nikolovska-Coleska</span>  . </span><span class="cited-content_cbyCitation_article-title">3-Substituted-N-(4-Hydroxynaphthalen-1-yl)arylsulfonamides as a Novel Class of Selective Mcl-1 Inhibitors: Structure-Based Design, Synthesis, SAR, and Biological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (10)
                                     , 4111-4133. <a href="https://doi.org/10.1021/jm500010b" title="DOI URL">https://doi.org/10.1021/jm500010b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500010b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500010b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D3-Substituted-N-%2525284-Hydroxynaphthalen-1-yl%252529arylsulfonamides%252Bas%252Ba%252BNovel%252BClass%252Bof%252BSelective%252BMcl-1%252BInhibitors%25253A%252BStructure-Based%252BDesign%25252C%252BSynthesis%25252C%252BSAR%25252C%252Band%252BBiological%252BEvaluation%26aulast%3DAbulwerdi%26aufirst%3DFardokht%2BA.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D03012014%26date%3D07052014%26date%3D22052014%26date%3D21042014%26volume%3D57%26issue%3D10%26spage%3D4111%26epage%3D4133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin H.  Bolli</span>, <span class="hlFld-ContribAuthor ">Jörg  Velker</span>, <span class="hlFld-ContribAuthor ">Claus  Müller</span>, <span class="hlFld-ContribAuthor ">Boris  Mathys</span>, <span class="hlFld-ContribAuthor ">Magdalena  Birker</span>, <span class="hlFld-ContribAuthor ">Roberto  Bravo</span>, <span class="hlFld-ContribAuthor ">Daniel  Bur</span>, <span class="hlFld-ContribAuthor ">Ruben  de Kanter</span>, <span class="hlFld-ContribAuthor ">Patrick  Hess</span>, <span class="hlFld-ContribAuthor ">Christopher  Kohl</span>, <span class="hlFld-ContribAuthor ">David  Lehmann</span>, <span class="hlFld-ContribAuthor ">Solange  Meyer</span>, <span class="hlFld-ContribAuthor ">Oliver  Nayler</span>, <span class="hlFld-ContribAuthor ">Markus  Rey</span>, <span class="hlFld-ContribAuthor ">Michael  Scherz</span>, and <span class="hlFld-ContribAuthor ">Beat  Steiner</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel S1P1 Receptor Agonists - Part 2: From Bicyclo[3.1.0]hexane-Fused Thiophenes to Isobutyl Substituted Thiophenes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (1)
                                     , 78-97. <a href="https://doi.org/10.1021/jm401456d" title="DOI URL">https://doi.org/10.1021/jm401456d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401456d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401456d%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BS1P1%252BReceptor%252BAgonists%252B-%252BPart%252B2%25253A%252BFrom%252BBicyclo%25255B3.1.0%25255Dhexane-Fused%252BThiophenes%252Bto%252BIsobutyl%252BSubstituted%252BThiophenes%26aulast%3DBolli%26aufirst%3DMartin%2BH.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D20092013%26date%3D17122013%26date%3D09012014%26volume%3D57%26issue%3D1%26spage%3D78%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan-Miguel  Jimenez</span>, <span class="hlFld-ContribAuthor ">Dean  Boyall</span>, <span class="hlFld-ContribAuthor ">Guy  Brenchley</span>, <span class="hlFld-ContribAuthor ">Philip N.  Collier</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Davis</span>, <span class="hlFld-ContribAuthor ">Damien  Fraysse</span>, <span class="hlFld-ContribAuthor ">Shazia B.  Keily</span>, <span class="hlFld-ContribAuthor ">Jaclyn  Henderson</span>, <span class="hlFld-ContribAuthor ">Andrew  Miller</span>, <span class="hlFld-ContribAuthor ">Francoise  Pierard</span>, <span class="hlFld-ContribAuthor ">Luca  Settimo</span>, <span class="hlFld-ContribAuthor ">Heather C.  Twin</span>, <span class="hlFld-ContribAuthor ">Claire M.  Bolton</span>, <span class="hlFld-ContribAuthor ">Adam P.  Curnock</span>, <span class="hlFld-ContribAuthor ">Peter  Chiu</span>, <span class="hlFld-ContribAuthor ">Adam J.  Tanner</span>, and <span class="hlFld-ContribAuthor ">Stephen  Young</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Optimization of Selective Protein Kinase C θ (PKCθ) Inhibitors for the Treatment of Autoimmune Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (5)
                                     , 1799-1810. <a href="https://doi.org/10.1021/jm301465a" title="DOI URL">https://doi.org/10.1021/jm301465a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301465a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301465a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BOptimization%252Bof%252BSelective%252BProtein%252BKinase%252BC%252B%2525CE%2525B8%252B%252528PKC%2525CE%2525B8%252529%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BAutoimmune%252BDiseases%26aulast%3DJimenez%26aufirst%3DJuan-Miguel%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D10102012%26date%3D11022013%26date%3D14032013%26volume%3D56%26issue%3D5%26spage%3D1799%26epage%3D1810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vasiliki  Daikopoulou</span>, <span class="hlFld-ContribAuthor ">Panagiotis  Apostolou</span>, <span class="hlFld-ContribAuthor ">Sofia  Mourati</span>, <span class="hlFld-ContribAuthor ">Ioanna  Vlachou</span>, <span class="hlFld-ContribAuthor ">Maria  Gougousi</span>, <span class="hlFld-ContribAuthor ">Ioannis  Papasotiriou</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting SARS-CoV-2 Polymerase with New Nucleoside Analogues. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (11)
                                     , 3461. <a href="https://doi.org/10.3390/molecules26113461" title="DOI URL">https://doi.org/10.3390/molecules26113461</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26113461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26113461%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DTargeting%252BSARS-CoV-2%252BPolymerase%252Bwith%252BNew%252BNucleoside%252BAnalogues%26aulast%3DDaikopoulou%26aufirst%3DVasiliki%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D11%26spage%3D3461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haroon  Khan</span>, <span class="hlFld-ContribAuthor ">Hammad  Ullah</span>, <span class="hlFld-ContribAuthor ">Sumaira  Khattak</span>, <span class="hlFld-ContribAuthor ">Michael  Aschner</span>, <span class="hlFld-ContribAuthor ">Cristobal N.  Aguilar</span>, <span class="hlFld-ContribAuthor ">Syed M. A.  Halimi</span>, <span class="hlFld-ContribAuthor ">Omar  Cauli</span>, <span class="hlFld-ContribAuthor ">Syed M. M.  Shah</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic potential of alkaloids in autoimmune diseases: Promising candidates for clinical trials. </span><span class="cited-content_cbyCitation_journal-name">Phytotherapy Research</span><span> <strong>2021,</strong> <em>35 </em>
                                    (1)
                                     , 50-62. <a href="https://doi.org/10.1002/ptr.6763" title="DOI URL">https://doi.org/10.1002/ptr.6763</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ptr.6763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fptr.6763%26sid%3Dliteratum%253Aachs%26jtitle%3DPhytotherapy%2520Research%26atitle%3DTherapeutic%252Bpotential%252Bof%252Balkaloids%252Bin%252Bautoimmune%252Bdiseases%25253A%252BPromising%252Bcandidates%252Bfor%252Bclinical%252Btrials%26aulast%3DKhan%26aufirst%3DHaroon%26date%3D2021%26date%3D2020%26volume%3D35%26issue%3D1%26spage%3D50%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arun  Rawat</span>, <span class="hlFld-ContribAuthor ">Darawan  Rinchai</span>, <span class="hlFld-ContribAuthor ">Mohammed  Toufiq</span>, <span class="hlFld-ContribAuthor ">Alexandra K.  Marr</span>, <span class="hlFld-ContribAuthor ">Tomoshige  Kino</span>, <span class="hlFld-ContribAuthor ">Mathieu  Garand</span>, <span class="hlFld-ContribAuthor ">Zohreh  Tatari-Calderone</span>, <span class="hlFld-ContribAuthor ">Basirudeen Syed Ahamed  Kabeer</span>, <span class="hlFld-ContribAuthor ">Navaneethakrishnan  Krishnamoorthy</span>, <span class="hlFld-ContribAuthor ">Davide  Bedognetti</span>, <span class="hlFld-ContribAuthor ">Mohammed Yousuf  Karim</span>, <span class="hlFld-ContribAuthor ">Konduru S.  Sastry</span>, <span class="hlFld-ContribAuthor ">Damien  Chaussabel</span>. </span><span class="cited-content_cbyCitation_article-title">A Neutrophil-Driven Inflammatory Signature Characterizes the Blood Transcriptome Fingerprint of Psoriasis. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fimmu.2020.587946" title="DOI URL">https://doi.org/10.3389/fimmu.2020.587946</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2020.587946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2020.587946%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DA%252BNeutrophil-Driven%252BInflammatory%252BSignature%252BCharacterizes%252Bthe%252BBlood%252BTranscriptome%252BFingerprint%252Bof%252BPsoriasis%26aulast%3DRawat%26aufirst%3DArun%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Li</span>, <span class="hlFld-ContribAuthor ">Chenhao  Guo</span>, <span class="hlFld-ContribAuthor ">Nana  Shen</span>, <span class="hlFld-ContribAuthor ">Xinying  Zhang</span>, <span class="hlFld-ContribAuthor ">Xuesen  Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of maleimide fused benzocarbazoles and imidazo[1,2-
              a
              ]pyridines
              via
              rhodium(
              iii
              )-catalyzed [4 + 2] oxidative cycloaddition. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2020,</strong> <em>7 </em>
                                    (22)
                                     , 3698-3704. <a href="https://doi.org/10.1039/D0QO01109F" title="DOI URL">https://doi.org/10.1039/D0QO01109F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO01109F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO01109F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DSynthesis%252Bof%252Bmaleimide%252Bfused%252Bbenzocarbazoles%252Band%252Bimidazo%25255B1%25252C2-%252Ba%252B%25255Dpyridines%252Bvia%252Brhodium%252528%252Biii%252B%252529-catalyzed%252B%25255B4%252B%25252B%252B2%25255D%252Boxidative%252Bcycloaddition%26aulast%3DLi%26aufirst%3DBin%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D22%26spage%3D3698%26epage%3D3704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shigeki  Kunikawa</span>, <span class="hlFld-ContribAuthor ">Akira  Tanaka</span>, <span class="hlFld-ContribAuthor ">Yuji  Takasuna</span>, <span class="hlFld-ContribAuthor ">Mamoru  Tasaki</span>, <span class="hlFld-ContribAuthor ">Noboru  Chida</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2,4-diamino-5-cyanopyrimidine derivatives as protein kinase C theta inhibitors with mitigated time-dependent drug-drug interactions. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (5)
                                     , 790-799. <a href="https://doi.org/10.1016/j.bmc.2019.01.019" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.01.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.01.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.01.019%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B2%25252C4-diamino-5-cyanopyrimidine%252Bderivatives%252Bas%252Bprotein%252Bkinase%252BC%252Btheta%252Binhibitors%252Bwith%252Bmitigated%252Btime-dependent%252Bdrug-drug%252Binteractions%26aulast%3DKunikawa%26aufirst%3DShigeki%26date%3D2019%26volume%3D27%26issue%3D5%26spage%3D790%26epage%3D799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shigeki  Kunikawa</span>, <span class="hlFld-ContribAuthor ">Akira  Tanaka</span>, <span class="hlFld-ContribAuthor ">Yuji  Takasuna</span>, <span class="hlFld-ContribAuthor ">Mamoru  Tasaki</span>, <span class="hlFld-ContribAuthor ">Noboru  Chida</span>. </span><span class="cited-content_cbyCitation_article-title">A novel 2,4-diaminopyrimidine derivative as selective inhibitor of protein kinase C theta prevents allograft rejection in a rat heart transplant model. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (20)
                                     , 5499-5509. <a href="https://doi.org/10.1016/j.bmc.2018.09.029" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.09.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.09.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.09.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DA%252Bnovel%252B2%25252C4-diaminopyrimidine%252Bderivative%252Bas%252Bselective%252Binhibitor%252Bof%252Bprotein%252Bkinase%252BC%252Btheta%252Bprevents%252Ballograft%252Brejection%252Bin%252Ba%252Brat%252Bheart%252Btransplant%252Bmodel%26aulast%3DKunikawa%26aufirst%3DShigeki%26date%3D2018%26volume%3D26%26issue%3D20%26spage%3D5499%26epage%3D5509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Taisuke  Katoh</span>, <span class="hlFld-ContribAuthor ">Yoshihide  Tomata</span>, <span class="hlFld-ContribAuthor ">Masaki  Setoh</span>, <span class="hlFld-ContribAuthor ">Satoshi  Sasaki</span>, <span class="hlFld-ContribAuthor ">Takafumi  Takai</span>, <span class="hlFld-ContribAuthor ">Yayoi  Yoshitomi</span>, <span class="hlFld-ContribAuthor ">Tomoya  Yukawa</span>, <span class="hlFld-ContribAuthor ">Hideyuki  Nakagawa</span>, <span class="hlFld-ContribAuthor ">Shoji  Fukumoto</span>, <span class="hlFld-ContribAuthor ">Tetsuya  Tsukamoto</span>, <span class="hlFld-ContribAuthor ">Yoshihisa  Nakada</span>. </span><span class="cited-content_cbyCitation_article-title">Practical application of 3-substituted-2,6-difluoropyridines in drug discovery: Facile synthesis of novel protein kinase C theta inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (11)
                                     , 2497-2501. <a href="https://doi.org/10.1016/j.bmcl.2017.03.099" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.03.099</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.03.099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.03.099%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPractical%252Bapplication%252Bof%252B3-substituted-2%25252C6-difluoropyridines%252Bin%252Bdrug%252Bdiscovery%25253A%252BFacile%252Bsynthesis%252Bof%252Bnovel%252Bprotein%252Bkinase%252BC%252Btheta%252Binhibitors%26aulast%3DKatoh%26aufirst%3DTaisuke%26date%3D2017%26volume%3D27%26issue%3D11%26spage%3D2497%26epage%3D2501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yin  Jiang</span>, <span class="hlFld-ContribAuthor ">Ai-Chun  Chen</span>, <span class="hlFld-ContribAuthor ">Guo-Tao  Kuang</span>, <span class="hlFld-ContribAuthor ">Shi-Ke  Wang</span>, <span class="hlFld-ContribAuthor ">Tian-Miao  Ou</span>, <span class="hlFld-ContribAuthor ">Jia-Heng  Tan</span>, <span class="hlFld-ContribAuthor ">Ding  Li</span>, <span class="hlFld-ContribAuthor ">Zhi-Shu  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 4-anilinoquinazoline derivatives as new c-myc G-quadruplex ligands. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>122 </em>, 264-279. <a href="https://doi.org/10.1016/j.ejmech.2016.06.040" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.06.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.06.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.06.040%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B4-anilinoquinazoline%252Bderivatives%252Bas%252Bnew%252Bc-myc%252BG-quadruplex%252Bligands%26aulast%3DJiang%26aufirst%3DYin%26date%3D2016%26volume%3D122%26spage%3D264%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cyrille  Lescop</span>, <span class="hlFld-ContribAuthor ">Claus  Müller</span>, <span class="hlFld-ContribAuthor ">Boris  Mathys</span>, <span class="hlFld-ContribAuthor ">Magdalena  Birker</span>, <span class="hlFld-ContribAuthor ">Ruben  de Kanter</span>, <span class="hlFld-ContribAuthor ">Christopher  Kohl</span>, <span class="hlFld-ContribAuthor ">Patrick  Hess</span>, <span class="hlFld-ContribAuthor ">Oliver  Nayler</span>, <span class="hlFld-ContribAuthor ">Markus  Rey</span>, <span class="hlFld-ContribAuthor ">Patrick  Sieber</span>, <span class="hlFld-ContribAuthor ">Beat  Steiner</span>, <span class="hlFld-ContribAuthor ">Thomas  Weller</span>, <span class="hlFld-ContribAuthor ">Martin H.  Bolli</span>. </span><span class="cited-content_cbyCitation_article-title">Novel S1P 1 receptor agonists – Part 4: Alkylaminomethyl substituted aryl head groups. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>116 </em>, 222-238. <a href="https://doi.org/10.1016/j.ejmech.2016.03.048" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.03.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.03.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.03.048%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BS1P%252B1%252Breceptor%252Bagonists%252B%2525E2%252580%252593%252BPart%252B4%25253A%252BAlkylaminomethyl%252Bsubstituted%252Baryl%252Bhead%252Bgroups%26aulast%3DLescop%26aufirst%3DCyrille%26date%3D2016%26volume%3D116%26spage%3D222%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Taisuke  Katoh</span>, <span class="hlFld-ContribAuthor ">Takafumi  Takai</span>, <span class="hlFld-ContribAuthor ">Takafumi  Yukawa</span>, <span class="hlFld-ContribAuthor ">Tetsuya  Tsukamoto</span>, <span class="hlFld-ContribAuthor ">Etsurou  Watanabe</span>, <span class="hlFld-ContribAuthor ">Hideyuki  Mototani</span>, <span class="hlFld-ContribAuthor ">Takeo  Arita</span>, <span class="hlFld-ContribAuthor ">Hiroki  Hayashi</span>, <span class="hlFld-ContribAuthor ">Hideyuki  Nakagawa</span>, <span class="hlFld-ContribAuthor ">Michael G.  Klein</span>, <span class="hlFld-ContribAuthor ">Hua  Zou</span>, <span class="hlFld-ContribAuthor ">Bi-Ching  Sang</span>, <span class="hlFld-ContribAuthor ">Gyorgy  Snell</span>, <span class="hlFld-ContribAuthor ">Yoshihisa  Nakada</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and optimization of 1,7-disubstituted-2,2-dimethyl-2,3-dihydroquinazolin-4(1H)-ones as potent and selective PKCθ inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (11)
                                     , 2466-2475. <a href="https://doi.org/10.1016/j.bmc.2016.04.008" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.04.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.04.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Boptimization%252Bof%252B1%25252C7-disubstituted-2%25252C2-dimethyl-2%25252C3-dihydroquinazolin-4%2525281H%252529-ones%252Bas%252Bpotent%252Band%252Bselective%252BPKC%2525CE%2525B8%252Binhibitors%26aulast%3DKatoh%26aufirst%3DTaisuke%26date%3D2016%26volume%3D24%26issue%3D11%26spage%3D2466%26epage%3D2475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qianyu  Wang</span>, <span class="hlFld-ContribAuthor ">Chengrong  Lu</span>, <span class="hlFld-ContribAuthor ">Bei  Zhao</span>, <span class="hlFld-ContribAuthor ">Yingming  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Characterization of Amidato Divalent Lanthanide Complexes and Their Use in Forming 2,4-Quinazolidinones from CO
              2
              and 2-Aminobenzonitriles. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>2016 </em>
                                    (14)
                                     , 2555-2559. <a href="https://doi.org/10.1002/ejoc.201600291" title="DOI URL">https://doi.org/10.1002/ejoc.201600291</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201600291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201600291%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Band%252BCharacterization%252Bof%252BAmidato%252BDivalent%252BLanthanide%252BComplexes%252Band%252BTheir%252BUse%252Bin%252BForming%252B2%25252C4-Quinazolidinones%252Bfrom%252BCO%252B2%252Band%252B2-Aminobenzonitriles%26aulast%3DWang%26aufirst%3DQianyu%26date%3D2016%26date%3D2016%26volume%3D2016%26issue%3D14%26spage%3D2555%26epage%3D2559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiyi  Li</span>, <span class="hlFld-ContribAuthor ">Na  Yang</span>, <span class="hlFld-ContribAuthor ">Yajing  Lyu</span>. </span><span class="cited-content_cbyCitation_article-title">A mechanistic study on guanidine-catalyzed chemical fixation of CO
              2
              with 2-aminobenzonitrile to quinazoline-2,4(1H,3H)-dione. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2016,</strong> <em>3 </em>
                                    (7)
                                     , 823-835. <a href="https://doi.org/10.1039/C6QO00085A" title="DOI URL">https://doi.org/10.1039/C6QO00085A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6QO00085A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6QO00085A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DA%252Bmechanistic%252Bstudy%252Bon%252Bguanidine-catalyzed%252Bchemical%252Bfixation%252Bof%252BCO%252B2%252Bwith%252B2-aminobenzonitrile%252Bto%252Bquinazoline-2%25252C4%2525281H%25252C3H%252529-dione%26aulast%3DLi%26aufirst%3DWeiyi%26date%3D2016%26date%3D2016%26volume%3D3%26issue%3D7%26spage%3D823%26epage%3D835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patrick M  Lelliott</span>, <span class="hlFld-ContribAuthor ">Brendan J  McMorran</span>, <span class="hlFld-ContribAuthor ">Simon J  Foote</span>, <span class="hlFld-ContribAuthor ">Gaetan  Burgio</span>. </span><span class="cited-content_cbyCitation_article-title">The influence of host genetics on erythrocytes and malaria infection: is there therapeutic potential?. </span><span class="cited-content_cbyCitation_journal-name">Malaria Journal</span><span> <strong>2015,</strong> <em>14 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12936-015-0809-x" title="DOI URL">https://doi.org/10.1186/s12936-015-0809-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12936-015-0809-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12936-015-0809-x%26sid%3Dliteratum%253Aachs%26jtitle%3DMalaria%2520Journal%26atitle%3DThe%252Binfluence%252Bof%252Bhost%252Bgenetics%252Bon%252Berythrocytes%252Band%252Bmalaria%252Binfection%25253A%252Bis%252Bthere%252Btherapeutic%252Bpotential%25253F%26aulast%3DLelliott%26aufirst%3DPatrick%2BM%26date%3D2015%26date%3D2015%26volume%3D14%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brandon  Leonard</span>, <span class="hlFld-ContribAuthor ">Jennifer L.  McCann</span>, <span class="hlFld-ContribAuthor ">Gabriel J.  Starrett</span>, <span class="hlFld-ContribAuthor ">Leah  Kosyakovsky</span>, <span class="hlFld-ContribAuthor ">Elizabeth M.  Luengas</span>, <span class="hlFld-ContribAuthor ">Amy M.  Molan</span>, <span class="hlFld-ContribAuthor ">Michael B.  Burns</span>, <span class="hlFld-ContribAuthor ">Rebecca M.  McDougle</span>, <span class="hlFld-ContribAuthor ">Peter J.  Parker</span>, <span class="hlFld-ContribAuthor ">William L.  Brown</span>, <span class="hlFld-ContribAuthor ">Reuben S.  Harris</span>. </span><span class="cited-content_cbyCitation_article-title">The PKC/NF-κB Signaling Pathway Induces APOBEC3B Expression in Multiple Human Cancers. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2015,</strong> <em>75 </em>
                                    (21)
                                     , 4538-4547. <a href="https://doi.org/10.1158/0008-5472.CAN-15-2171-T" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-15-2171-T</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-15-2171-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-15-2171-T%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DThe%252BPKC%25252FNF-%2525CE%2525BAB%252BSignaling%252BPathway%252BInduces%252BAPOBEC3B%252BExpression%252Bin%252BMultiple%252BHuman%252BCancers%26aulast%3DLeonard%26aufirst%3DBrandon%26date%3D2015%26date%3D2015%26volume%3D75%26issue%3D21%26spage%3D4538%26epage%3D4547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shigeki  Kunikawa</span>, <span class="hlFld-ContribAuthor ">Akira  Tanaka</span>, <span class="hlFld-ContribAuthor ">Koichiro  Mukoyoshi</span>, <span class="hlFld-ContribAuthor ">Shinya  Nagashima</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Tominaga</span>, <span class="hlFld-ContribAuthor ">Noboru  Chida</span>, <span class="hlFld-ContribAuthor ">Mamoru  Tasaki</span>, <span class="hlFld-ContribAuthor ">Fumiyuki  Shirai</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of 2,4-diamino-5-fluoropyrimidine derivatives as protein kinase C theta inhibitors with mitigated time-dependent drug–drug interactions and P-gp liability. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (13)
                                     , 3269-3277. <a href="https://doi.org/10.1016/j.bmc.2015.04.050" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.04.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.04.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.04.050%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252B2%25252C4-diamino-5-fluoropyrimidine%252Bderivatives%252Bas%252Bprotein%252Bkinase%252BC%252Btheta%252Binhibitors%252Bwith%252Bmitigated%252Btime-dependent%252Bdrug%2525E2%252580%252593drug%252Binteractions%252Band%252BP-gp%252Bliability%26aulast%3DKunikawa%26aufirst%3DShigeki%26date%3D2015%26volume%3D23%26issue%3D13%26spage%3D3269%26epage%3D3277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Le Xuan Truong  Nguyen</span>, <span class="hlFld-ContribAuthor ">Yunqin  Lee</span>, <span class="hlFld-ContribAuthor ">Lenore  Urbani</span>, <span class="hlFld-ContribAuthor ">Paul J.  Utz</span>, <span class="hlFld-ContribAuthor ">Anne W.  Hamburger</span>, <span class="hlFld-ContribAuthor ">John B.  Sunwoo</span>, <span class="hlFld-ContribAuthor ">Beverly S.  Mitchell</span>. </span><span class="cited-content_cbyCitation_article-title">Regulation of ribosomal RNA synthesis in T cells: requirement for GTP and Ebp1. </span><span class="cited-content_cbyCitation_journal-name">Blood</span><span> <strong>2015,</strong> <em>125 </em>
                                    (16)
                                     , 2519-2529. <a href="https://doi.org/10.1182/blood-2014-12-616433" title="DOI URL">https://doi.org/10.1182/blood-2014-12-616433</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1182/blood-2014-12-616433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1182%2Fblood-2014-12-616433%26sid%3Dliteratum%253Aachs%26jtitle%3DBlood%26atitle%3DRegulation%252Bof%252Bribosomal%252BRNA%252Bsynthesis%252Bin%252BT%252Bcells%25253A%252Brequirement%252Bfor%252BGTP%252Band%252BEbp1%26aulast%3DNguyen%26aufirst%3DLe%2BXuan%2BTruong%26date%3D2015%26volume%3D125%26issue%3D16%26spage%3D2519%26epage%3D2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aurore  Saudemont</span>. </span><span class="cited-content_cbyCitation_article-title">TIF-IA and Ebp1 regulate RNA synthesis in T cells. </span><span class="cited-content_cbyCitation_journal-name">Blood</span><span> <strong>2015,</strong> <em>125 </em>
                                    (16)
                                     , 2456-2457. <a href="https://doi.org/10.1182/blood-2015-03-630780" title="DOI URL">https://doi.org/10.1182/blood-2015-03-630780</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1182/blood-2015-03-630780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1182%2Fblood-2015-03-630780%26sid%3Dliteratum%253Aachs%26jtitle%3DBlood%26atitle%3DTIF-IA%252Band%252BEbp1%252Bregulate%252BRNA%252Bsynthesis%252Bin%252BT%252Bcells%26aulast%3DSaudemont%26aufirst%3DAurore%26date%3D2015%26volume%3D125%26issue%3D16%26spage%3D2456%26epage%3D2457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yunqing  Xiao</span>, <span class="hlFld-ContribAuthor ">Xianqiang  Kong</span>, <span class="hlFld-ContribAuthor ">Zhicheng  Xu</span>, <span class="hlFld-ContribAuthor ">Changsheng  Cao</span>, <span class="hlFld-ContribAuthor ">Guangsheng  Pang</span>, <span class="hlFld-ContribAuthor ">Yanhui  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient synthesis of quinazoline-2,4(1H,3H)-diones from CO
              2
              catalyzed by N-heterocyclic carbene at atmospheric pressure. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (7)
                                     , 5032-5037. <a href="https://doi.org/10.1039/C4RA13752C" title="DOI URL">https://doi.org/10.1039/C4RA13752C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4RA13752C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4RA13752C%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DEfficient%252Bsynthesis%252Bof%252Bquinazoline-2%25252C4%2525281H%25252C3H%252529-diones%252Bfrom%252BCO%252B2%252Bcatalyzed%252Bby%252BN-heterocyclic%252Bcarbene%252Bat%252Batmospheric%252Bpressure%26aulast%3DXiao%26aufirst%3DYunqing%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D7%26spage%3D5032%26epage%3D5037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuehui  He</span>, <span class="hlFld-ContribAuthor ">Hans J.P.M.  Koenen</span>, <span class="hlFld-ContribAuthor ">Ruben L.  Smeets</span>, <span class="hlFld-ContribAuthor ">Romy  Keijsers</span>, <span class="hlFld-ContribAuthor ">Esther  van Rijssen</span>, <span class="hlFld-ContribAuthor ">Andreas  Koerber</span>, <span class="hlFld-ContribAuthor ">Peter C.  van de Kerkhof</span>, <span class="hlFld-ContribAuthor ">Annemieke M.H.  Boots</span>, <span class="hlFld-ContribAuthor ">Irma  Joosten</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting PKC in Human T Cells Using Sotrastaurin (AEB071) Preserves Regulatory T Cells and Prevents IL-17 Production. </span><span class="cited-content_cbyCitation_journal-name">Journal of Investigative Dermatology</span><span> <strong>2014,</strong> <em>134 </em>
                                    (4)
                                     , 975-983. <a href="https://doi.org/10.1038/jid.2013.459" title="DOI URL">https://doi.org/10.1038/jid.2013.459</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/jid.2013.459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fjid.2013.459%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Investigative%2520Dermatology%26atitle%3DTargeting%252BPKC%252Bin%252BHuman%252BT%252BCells%252BUsing%252BSotrastaurin%252B%252528AEB071%252529%252BPreserves%252BRegulatory%252BT%252BCells%252Band%252BPrevents%252BIL-17%252BProduction%26aulast%3DHe%26aufirst%3DXuehui%26date%3D2014%26volume%3D134%26issue%3D4%26spage%3D975%26epage%3D983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rami  Rahal</span>, <span class="hlFld-ContribAuthor ">Mareike  Frick</span>, <span class="hlFld-ContribAuthor ">Rodrigo  Romero</span>, <span class="hlFld-ContribAuthor ">Joshua M  Korn</span>, <span class="hlFld-ContribAuthor ">Robert  Kridel</span>, <span class="hlFld-ContribAuthor ">Fong  Chun Chan</span>, <span class="hlFld-ContribAuthor ">Barbara  Meissner</span>, <span class="hlFld-ContribAuthor ">Hyo-eun  Bhang</span>, <span class="hlFld-ContribAuthor ">Dave  Ruddy</span>, <span class="hlFld-ContribAuthor ">Audrey  Kauffmann</span>, <span class="hlFld-ContribAuthor ">Ali  Farsidjani</span>, <span class="hlFld-ContribAuthor ">Adnan  Derti</span>, <span class="hlFld-ContribAuthor ">Daniel  Rakiec</span>, <span class="hlFld-ContribAuthor ">Tara  Naylor</span>, <span class="hlFld-ContribAuthor ">Estelle  Pfister</span>, <span class="hlFld-ContribAuthor ">Steve  Kovats</span>, <span class="hlFld-ContribAuthor ">Sunkyu  Kim</span>, <span class="hlFld-ContribAuthor ">Kerstin  Dietze</span>, <span class="hlFld-ContribAuthor ">Bernd  Dörken</span>, <span class="hlFld-ContribAuthor ">Christian  Steidl</span>, <span class="hlFld-ContribAuthor ">Alexandar  Tzankov</span>, <span class="hlFld-ContribAuthor ">Michael  Hummel</span>, <span class="hlFld-ContribAuthor ">John  Monahan</span>, <span class="hlFld-ContribAuthor ">Michael P  Morrissey</span>, <span class="hlFld-ContribAuthor ">Christine  Fritsch</span>, <span class="hlFld-ContribAuthor ">William R  Sellers</span>, <span class="hlFld-ContribAuthor ">Vesselina G  Cooke</span>, <span class="hlFld-ContribAuthor ">Randy D  Gascoyne</span>, <span class="hlFld-ContribAuthor ">Georg  Lenz</span>, <span class="hlFld-ContribAuthor ">Frank  Stegmeier</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma. </span><span class="cited-content_cbyCitation_journal-name">Nature Medicine</span><span> <strong>2014,</strong> <em>20 </em>
                                    (1)
                                     , 87-92. <a href="https://doi.org/10.1038/nm.3435" title="DOI URL">https://doi.org/10.1038/nm.3435</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nm.3435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnm.3435%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Medicine%26atitle%3DPharmacological%252Band%252Bgenomic%252Bprofiling%252Bidentifies%252BNF-%2525CE%2525BAB%2525E2%252580%252593targeted%252Btreatment%252Bstrategies%252Bfor%252Bmantle%252Bcell%252Blymphoma%26aulast%3DRahal%26aufirst%3DRami%26date%3D2014%26date%3D2013%26volume%3D20%26issue%3D1%26spage%3D87%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura J.  Savage</span>, <span class="hlFld-ContribAuthor ">Dennis G.  McGonagle</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Biological and Small Molecule Therapy in the Management of Psoriatic Arthritis. </span><span class="cited-content_cbyCitation_journal-name">Biologics in Therapy</span><span> <strong>2013,</strong> <em>3 </em>
                                    (2)
                                     , 61-81. <a href="https://doi.org/10.1007/s13554-013-0010-0" title="DOI URL">https://doi.org/10.1007/s13554-013-0010-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13554-013-0010-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13554-013-0010-0%26sid%3Dliteratum%253Aachs%26jtitle%3DBiologics%2520in%2520Therapy%26atitle%3DThe%252BRole%252Bof%252BBiological%252Band%252BSmall%252BMolecule%252BTherapy%252Bin%252Bthe%252BManagement%252Bof%252BPsoriatic%252BArthritis%26aulast%3DSavage%26aufirst%3DLaura%2BJ.%26date%3D2013%26date%3D2013%26volume%3D3%26issue%3D2%26spage%3D61%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan-Miguel  Jimenez</span>, <span class="hlFld-ContribAuthor ">Christopher  Davis</span>, <span class="hlFld-ContribAuthor ">Dean  Boyall</span>, <span class="hlFld-ContribAuthor ">Damien  Fraysse</span>, <span class="hlFld-ContribAuthor ">Ronald  Knegtel</span>, <span class="hlFld-ContribAuthor ">Luca  Settimo</span>, <span class="hlFld-ContribAuthor ">Stephen  Young</span>, <span class="hlFld-ContribAuthor ">Claire  Bolton</span>, <span class="hlFld-ContribAuthor ">Peter  Chiu</span>, <span class="hlFld-ContribAuthor ">Adam  Curnock</span>, <span class="hlFld-ContribAuthor ">Richele  Rasmussen</span>, <span class="hlFld-ContribAuthor ">Adam  Tanner</span>, <span class="hlFld-ContribAuthor ">Ian  Ager</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based optimization of aminopyridines as PKCθ inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (14)
                                     , 4645-4649. <a href="https://doi.org/10.1016/j.bmcl.2012.05.114" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.05.114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.05.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.05.114%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-based%252Boptimization%252Bof%252Baminopyridines%252Bas%252BPKC%2525CE%2525B8%252Binhibitors%26aulast%3DJimenez%26aufirst%3DJuan-Miguel%26date%3D2012%26volume%3D22%26issue%3D14%26spage%3D4645%26epage%3D4649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caitriona  Ryan</span>, <span class="hlFld-ContribAuthor ">Amanda  Abramson</span>, <span class="hlFld-ContribAuthor ">Mahir  Patel</span>, <span class="hlFld-ContribAuthor ">Alan  Menter</span>. </span><span class="cited-content_cbyCitation_article-title">Current investigational drugs in psoriasis. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2012,</strong> <em>21 </em>
                                    (4)
                                     , 473-487. <a href="https://doi.org/10.1517/13543784.2012.669372" title="DOI URL">https://doi.org/10.1517/13543784.2012.669372</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2012.669372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2012.669372%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DCurrent%252Binvestigational%252Bdrugs%252Bin%252Bpsoriasis%26aulast%3DRyan%26aufirst%3DCaitriona%26date%3D2012%26date%3D2012%26volume%3D21%26issue%3D4%26spage%3D473%26epage%3D487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/medium/jm-2011-00469u_0012.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200469u&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/medium/jm-2011-00469u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Generic Synthesis of the Quinazolinyl Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200469u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: yields are given for <b>1</b> (R<sub>1</sub>, R<sub>2</sub> = H); (a) POCl<sub>3</sub>, dimethylphenylamine, 110 °C, 81%; (b) (i) 3-oxobutyric acid ethyl ester, NaH, THF, 0 °C, then toluene, 110 °C; (ii) NH<sub>4</sub>OH, room temperature; (iii) ethyl acetate, 76 °C, 54%; (c) <i>N</i>-methylpiperazine, 1-methyl-2-pyrrolidinone, 50 °C, 69%; (d) (1<i>H</i>-indol-3-yl)oxoacetic acid methyl ester, KO<i><sup>t</sup></i>Bu, THF, 0 °C to room temperature, 47%.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/medium/jm-2011-00469u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the Naphthyl Derivative <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200469u&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, BnBr, Bu<sub>4</sub>NI (cat.), DMF, room temperature, 93%; (b) tributylstannanylacetic acid ethyl ester, ZnBr<sub>2</sub>, PdCl<sub>2</sub>[P(<i>o</i>-tolyl)<sub>3</sub>]<sub>2</sub> (0.2 equiv), DMF, 80 °C, 42%; (c) Pd/C 10%, H<sub>2</sub>, MeOH, room temperature, 95%; (d) (CF<sub>3</sub>SO<sub>2</sub>)<sub>2</sub>O, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, room temperature, 89%; (e) Pd<sub>2</sub>(dba)<sub>3</sub> (0.05 equiv), 2-(di-<i>tert</i>-butylphosphino)biphenyl (0.05 equiv), <i>N</i>-methylpiperazine, K<sub>3</sub>PO<sub>4</sub>, THF, 80 °C, 84%; (f) formamide, NaOMe, DMF, 105 °C, 92%; (g) (1<i>H</i>-indol-3-yl)oxoacetic acid methyl ester, KO<i><sup>t</sup></i>Bu, THF, room temperature, 66%.</p></p></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/medium/jm-2011-00469u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the Quinolinyl Derivative <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200469u&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) POCl<sub>3</sub> (1.6 equiv), 2 h, 80 °C, 95%; (b) NH<sub>4</sub>OH (28% aqueous), 16 h, room temperature, 62%; (c) <i>N</i>-methylpiperazine (5 equiv), NMP, 60 h, room temperature, 80%; (d) (1<i>H</i>-indol-3-yl)oxoacetic acid methyl ester (1 equiv), KO<i><sup>t</sup></i>Bu (5 equiv), DMF, 19 h, 80 °C, 62%.</p></p></figure><figure data-id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/medium/jm-2011-00469u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the Isoquinolinyl Derivative <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200469u&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) malonic acid diethyl ester (3 equiv), NaH (2.8 equiv), xylene, 3 h, 140 °C, 62%; (b) NH<sub>3</sub> (4 M in MeOH), 16 h, 130 °C, 76%; (c) (1<i>H</i>-indol-3-yl)oxoacetic acid methyl ester (2.5 equiv), KO<sup><i>t</i></sup>Bu (1 M in THF, 5 equiv), 1 h, 80 °C, 54%; (d) <i>N</i>-methylpiperazine, 18 h, 130 °C, 29%.</p></p></figure><figure data-id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/medium/jm-2011-00469u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Area under concentration time curve in blood, mesenteric lymph node, spleen, thymus after peroral administration of 30 mg/kg <b>1</b> or <b>32</b> to male Wistar rats. In situ formation of metabolite <b>31</b> was measured in parallel after administration of either <b>1</b> or <b>32</b>. Formulation was PEG400/1 M HCl/5% glucose.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200469u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/medium/jm-2011-00469u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Surface activity pH profiles of <b>1</b> and <b>32</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-17/jm200469u/production/images/large/jm-2011-00469u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200469u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i52">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27851" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27851" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 27 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Dumont, F. J.</span><span> </span><span class="NLM_article-title">Immunosuppressive strategies for prevention of transplant rejection</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm200469u&amp;key=10.1517%2F13543776.11.3.377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslSisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=377-404&author=F.+J.+Dumont&title=Immunosuppressive+strategies+for+prevention+of+transplant+rejection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Immunosuppressive strategies for prevention of transplant rejection</span></div><div class="casAuthors">Dumont, Francis J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">377-404</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with 560 refs. is given.  Organ transplantation is the treatment of choice for end stage organ failure.  This procedure has greatly benefited from the introduction of potent immunosuppressive drugs that suppress anti-allograft immune response, esp. cyclosporin A (CsA) and FK506 which both inhibit calcineurin, a crit. mol. switch of T-cell activation.  However, use of these agents is limited by severe mechanism-based adverse effects, principally nephrotoxicity and neurotoxicity.  Although newer immunosuppressants, including monoclonal antibodies (mAbs) to CD3 and IL-2 receptor (IL-2R), mycophenolate mofetil and more recently rapamycin, have contributed to mitigate the toxicity of calcineurin inhibitors and decrease the rate of acute graft rejection, the long-term graft survival is still a major problem due to poorly controlled chronic rejection.  Late loss of transplant is all the more frustrating given the current penury in donated organs.  There is therefore considerable incentive to discover more effective and safer immunosuppressive agents or methodologies affecting immunoregulatory pathways in a manner distinct from existing drugs.  The patent literature of the last three years (1998-2000), reviewed here, reflects intense academic and industrial research towards this goal.  Capitalising on recent advances in the understanding of T-cell activation and immune regulation, efforts have been focused on strategies that (a) inhibit signalling mechanisms and/or proliferation of T-cells, (b) interfere with cell surface mols. involved in immune cell interactions or (c) alter the trafficking/intragraft recruitment of lymphocytes responsible for graft rejection.  Many of these patents claim for agents and modalities that may help achieve allograft tolerance, the ultimate goal of transplantation medicine.  Special efforts were also devoted to xenotransplantation with hopes that this exptl. technol. will graduate to the clinic in a not too distant future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4iUc5l-eeRrVg90H21EOLACvtfcHk0ljZrWyj2ADWig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslSisrY%253D&md5=5ba6973f9e63ceec460c69f363180b26</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1517%2F13543776.11.3.377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.11.3.377%26sid%3Dliteratum%253Aachs%26aulast%3DDumont%26aufirst%3DF.%2BJ.%26atitle%3DImmunosuppressive%2520strategies%2520for%2520prevention%2520of%2520transplant%2520rejection%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2001%26volume%3D11%26spage%3D377%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Halloran, P. F.</span><span> </span><span class="NLM_article-title">Immunosuppressive drugs for kidney transplantation</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x">, </span> <span class="NLM_fpage">2715</span><span class="NLM_x">–</span> <span class="NLM_lpage">2729</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm200469u&amp;key=10.1056%2FNEJMra033540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm200469u&amp;key=15616206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFWitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2004&pages=2715-2729&author=P.+F.+Halloran&title=Immunosuppressive+drugs+for+kidney+transplantation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Immunosuppressive drugs for kidney transplantation</span></div><div class="casAuthors">Halloran, Philip F.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2715-2729</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review on immunosuppressive agents that are either approved or in phase 2 or phase 3 trials in kidney transplantation.  Immunosuppression can be achieved by depleting lymphocytes, diverting lymphocyte traffic, or blocking lymphocyte response pathways.  Immunosuppressive drugs have three effects: the therapeutic effect (suppressing rejection), undesired consequences of immunodeficiency (infection or cancer), and nonimmune toxicity to other tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfWUKDaIyFxLVg90H21EOLACvtfcHk0lghe-YOA8Z2AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFWitw%253D%253D&md5=322c7383267f227e2ef128bac1183fa1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMra033540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra033540%26sid%3Dliteratum%253Aachs%26aulast%3DHalloran%26aufirst%3DP.%2BF.%26atitle%3DImmunosuppressive%2520drugs%2520for%2520kidney%2520transplantation%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D351%26spage%3D2715%26epage%3D2729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Liu, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harlan, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span> </span><span class="NLM_article-title">T cell-directed therapies: lessons learned and future prospects</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm200469u&amp;key=10.1038%2Fni1429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm200469u&amp;key=17179969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlaqsL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=25-30&author=E.+H.+Liuauthor=R.+M.+Siegelauthor=D.+M.+Harlanauthor=J.+J.+O%E2%80%99Shea&title=T+cell-directed+therapies%3A+lessons+learned+and+future+prospects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">T cell-directed therapies: lessons learned and future prospects</span></div><div class="casAuthors">Liu, Eric H.; Siegel, Richard M.; Harlan, David M.; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-30</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Agents interfering with T cell function are therapeutic mainstays for various autoimmune diseases and for transplant approaches to organ failure.  The understanding of T cell biol. has blossomed since the development of most agents now in use.  Here we discuss T cell-specific agents now in use, others recently added to the therapeutic armamentarium and promising agents being investigated in clin. and preclin. studies.  In addn., we reflect on the risks and benefits involved in the testing of such agents clin., with examples of agents that have successfully been used in the clinic and agents that failed to reach therapeutic use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBHcvwZuFJhrVg90H21EOLACvtfcHk0lghe-YOA8Z2AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlaqsL7L&md5=eeaddb16c63810e784f5d53c0a12d268</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fni1429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1429%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DE.%2BH.%26aulast%3DSiegel%26aufirst%3DR.%2BM.%26aulast%3DHarlan%26aufirst%3DD.%2BM.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DT%2520cell-directed%2520therapies%253A%2520lessons%2520learned%2520and%2520future%2520prospects%26jtitle%3DNat.%2520Immunol.%26date%3D2007%26volume%3D8%26spage%3D25%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Wagner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Matt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedrani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrhardt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rummel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strauss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan-Jacob, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beerli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weckbecker, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evenou, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zenke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottens, S.</span><span> </span><span class="NLM_article-title">Discovery of 3-(1<i>H</i>-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]-pyrrole-2,5-dione (AEB071), a potent and selective inhibitor of protein kinase C isotypes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6193</span><span class="NLM_x">–</span> <span class="NLM_lpage">6196</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901108b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6193-6196&author=J.+Wagnerauthor=P.+von+Mattauthor=R.+Sedraniauthor=R.+Albertauthor=N.+Cookeauthor=C.+Ehrhardtauthor=M.+Geiserauthor=G.+Rummelauthor=W.+Starkauthor=A.+Straussauthor=S.+W.+Cowan-Jacobauthor=C.+Beerliauthor=G.+Weckbeckerauthor=J.-P.+Evenouauthor=G.+Zenkeauthor=S.+Cottens&title=Discovery+of+3-%281H-indol-3-yl%29-4-%5B2-%284-methylpiperazin-1-yl%29quinazolin-4-yl%5D-pyrrole-2%2C5-dione+%28AEB071%29%2C+a+potent+and+selective+inhibitor+of+protein+kinase+C+isotypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm901108b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901108b%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3Dvon%2BMatt%26aufirst%3DP.%26aulast%3DSedrani%26aufirst%3DR.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DCooke%26aufirst%3DN.%26aulast%3DEhrhardt%26aufirst%3DC.%26aulast%3DGeiser%26aufirst%3DM.%26aulast%3DRummel%26aufirst%3DG.%26aulast%3DStark%26aufirst%3DW.%26aulast%3DStrauss%26aufirst%3DA.%26aulast%3DCowan-Jacob%26aufirst%3DS.%2BW.%26aulast%3DBeerli%26aufirst%3DC.%26aulast%3DWeckbecker%26aufirst%3DG.%26aulast%3DEvenou%26aufirst%3DJ.-P.%26aulast%3DZenke%26aufirst%3DG.%26aulast%3DCottens%26aufirst%3DS.%26atitle%3DDiscovery%2520of%25203-%25281H-indol-3-yl%2529-4-%255B2-%25284-methylpiperazin-1-yl%2529quinazolin-4-yl%255D-pyrrole-2%252C5-dione%2520%2528AEB071%2529%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520protein%2520kinase%2520C%2520isotypes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6193%26epage%3D6196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Evenou, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zenke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovarik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welzenbach, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weitz-Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guntermann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Towbin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaminski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letschka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutz-Nicoladoni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann-Kleiter, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thuille, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baier, G.</span><span> </span><span class="NLM_article-title">The potent protein kinase C selective inhibitor AEB071 (sotrastaurin) represents a new class of immunosuppressive agents affecting early T cell activation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">792</span><span class="NLM_x">–</span> <span class="NLM_lpage">801</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm200469u&amp;key=10.1124%2Fjpet.109.153205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm200469u&amp;key=19491325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVyitLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2009&pages=792-801&author=J.-P.+Evenouauthor=J.+Wagnerauthor=G.+Zenkeauthor=V.+Brinkmannauthor=K.+Wagnerauthor=J.+Kovarikauthor=K.+A.+Welzenbachauthor=G.+Weitz-Schmidtauthor=C.+Guntermannauthor=H.+Towbinauthor=S.+Cottensauthor=S.+Kaminskiauthor=T.+Letschkaauthor=C.+Lutz-Nicoladoniauthor=T.+Gruberauthor=N.+Hermann-Kleiterauthor=N.+Thuilleauthor=G.+Baier&title=The+potent+protein+kinase+C+selective+inhibitor+AEB071+%28sotrastaurin%29+represents+a+new+class+of+immunosuppressive+agents+affecting+early+T+cell+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The potent protein kinase C-selective inhibitor AEB071 (sotrastaurin) represents a new class of immunosuppressive agents affecting early T-cell activation</span></div><div class="casAuthors">Evenou, Jean-Pierre; Wagner, Jurgen; Zenke, Gerhard; Brinkmann, Volker; Wagner, Kathrin; Kovarik, Jiri; Welzenbach, Karl A.; Weitz-Schmidt, Gabriele; Guntermann, Christine; Towbin, Harry; Cottens, Sylvain; Kaminski, Sandra; Letschka, Thomas; Lutz-Nicoladoni, Christina; Gruber, Thomas; Hermann-Kleiter, Natascha; Thuille, Nikolaus; Baier, Gottfried</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">792-801</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">There is a pressing need for immunosuppressants with an improved safety profile.  The search for novel approaches to blocking T-cell activation led to the development of the selective protein kinase C (PKC) inhibitor AEB071 (sotrastaurin).  In cell-free kinase assays AEB071 inhibited PKC, with Ki values in the subnanomolar to low nanomolar range.  Upon T-cell stimulation, AEB071 markedly inhibited in situ PKCθ catalytic activity and selectively affected both the canonical nuclear factor-κB and nuclear factor of activated T cells (but not activator protein-1) transactivation pathways.  In primary human and mouse T cells, AEB071 treatment effectively abrogated at low nanomolar concn. markers of early T-cell activation, such as interleukin-2 secretion and CD25 expression.  Accordingly, the CD3/CD28 antibody- and alloantigen-induced T-cell proliferation responses were potently inhibited by AEB071 in the absence of nonspecific antiproliferative effects.  Unlike former PKC inhibitors, AEB071 did not enhance apoptosis of murine T-cell blasts in a model of activation-induced cell death.  Furthermore, AEB071 markedly inhibited lymphocyte function-assocd. antigen-1-mediated T-cell adhesion at nanomolar concns.  The mode of action of AEB071 is different from that of calcineurin inhibitors, and AEB071 and cyclosporine A seem to have complementary effects on T-cell signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLsBh_sy4icrVg90H21EOLACvtfcHk0lghe-YOA8Z2AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVyitLzN&md5=de769c096a575c867056def9491244b9</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.153205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.153205%26sid%3Dliteratum%253Aachs%26aulast%3DEvenou%26aufirst%3DJ.-P.%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DZenke%26aufirst%3DG.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DWagner%26aufirst%3DK.%26aulast%3DKovarik%26aufirst%3DJ.%26aulast%3DWelzenbach%26aufirst%3DK.%2BA.%26aulast%3DWeitz-Schmidt%26aufirst%3DG.%26aulast%3DGuntermann%26aufirst%3DC.%26aulast%3DTowbin%26aufirst%3DH.%26aulast%3DCottens%26aufirst%3DS.%26aulast%3DKaminski%26aufirst%3DS.%26aulast%3DLetschka%26aufirst%3DT.%26aulast%3DLutz-Nicoladoni%26aufirst%3DC.%26aulast%3DGruber%26aufirst%3DT.%26aulast%3DHermann-Kleiter%26aufirst%3DN.%26aulast%3DThuille%26aufirst%3DN.%26aulast%3DBaier%26aufirst%3DG.%26atitle%3DThe%2520potent%2520protein%2520kinase%2520C%2520selective%2520inhibitor%2520AEB071%2520%2528sotrastaurin%2529%2520represents%2520a%2520new%2520class%2520of%2520immunosuppressive%2520agents%2520affecting%2520early%2520T%2520cell%2520activation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D330%26spage%3D792%26epage%3D801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Skvara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawid, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleyn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meingassner, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumortier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopp, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fallahi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stary, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkhart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grenet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hijazi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGeown, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rordorf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, C. E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stingl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, T.</span><span> </span><span class="NLM_article-title">The PKC inhibitor AEB071 may be a therapeutic option for psiorasis</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">3151</span><span class="NLM_x">–</span> <span class="NLM_lpage">3159</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=3151-3159&author=H.+Skvaraauthor=M.+Dawidauthor=E.+Kleynauthor=B.+Wolffauthor=J.+G.+Meingassnerauthor=H.+Knightauthor=T.+Dumortierauthor=T.+Koppauthor=N.+Fallahiauthor=G.+Staryauthor=C.+Burkhartauthor=O.+Grenetauthor=J.+Wagnerauthor=Y.+Hijaziauthor=R.+M.+Morrisauthor=C.+McGeownauthor=C.+Rordorfauthor=C.+E.+M.+Griffithsauthor=G.+Stinglauthor=T.+Jung&title=The+PKC+inhibitor+AEB071+may+be+a+therapeutic+option+for+psiorasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkvara%26aufirst%3DH.%26aulast%3DDawid%26aufirst%3DM.%26aulast%3DKleyn%26aufirst%3DE.%26aulast%3DWolff%26aufirst%3DB.%26aulast%3DMeingassner%26aufirst%3DJ.%2BG.%26aulast%3DKnight%26aufirst%3DH.%26aulast%3DDumortier%26aufirst%3DT.%26aulast%3DKopp%26aufirst%3DT.%26aulast%3DFallahi%26aufirst%3DN.%26aulast%3DStary%26aufirst%3DG.%26aulast%3DBurkhart%26aufirst%3DC.%26aulast%3DGrenet%26aufirst%3DO.%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DHijazi%26aufirst%3DY.%26aulast%3DMorris%26aufirst%3DR.%2BM.%26aulast%3DMcGeown%26aufirst%3DC.%26aulast%3DRordorf%26aufirst%3DC.%26aulast%3DGriffiths%26aufirst%3DC.%2BE.%2BM.%26aulast%3DStingl%26aufirst%3DG.%26aulast%3DJung%26aufirst%3DT.%26atitle%3DThe%2520PKC%2520inhibitor%2520AEB071%2520may%2520be%2520a%2520therapeutic%2520option%2520for%2520psiorasis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2008%26volume%3D118%26spage%3D3151%26epage%3D3159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Budde, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommerer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asderakis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietruck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grinyo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigotti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dantal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barten, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, M.</span><span> </span><span class="NLM_article-title">Sotrastaurin, a novel small molecule inhibiting protein kinase C: first clinical results in renal-transplant recipients</span> <span class="citation_source-journal">Am. J. Transpl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">581</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm200469u&amp;key=10.1111%2Fj.1600-6143.2009.02980.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm200469u&amp;key=20121745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1ahtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=571-581&author=K.+Buddeauthor=C.+Sommererauthor=T.+Beckerauthor=A.+Asderakisauthor=F.+Pietruckauthor=J.+M.+Grinyoauthor=P.+Rigottiauthor=J.+Dantalauthor=J.+Ngauthor=M.+J.+Bartenauthor=M.+Weber&title=Sotrastaurin%2C+a+novel+small+molecule+inhibiting+protein+kinase+C%3A+first+clinical+results+in+renal-transplant+recipients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Sotrastaurin, a novel small molecule inhibiting protein kinase C: first clinical results in renal-transplant recipients</span></div><div class="casAuthors">Budde, K.; Sommerer, C.; Becker, T.; Asderakis, A.; Pietruck, F.; Grinyo, J. M.; Rigottig, P.; Dantal, J.; Ng, J.; Barten, M. J.; Weber, M.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Transplantation</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">571-581</span>CODEN:
                <span class="NLM_cas:coden">AJTMBR</span>;
        ISSN:<span class="NLM_cas:issn">1600-6135</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Sotrastaurin, a novel protein-kinase-C inhibitor, blocks early T-cell activation.  In this 12-mo, Phase II study, de novo renal-transplant patients were randomized to sotrastaurin (200 mg b.i.d.) + std.-exposure tacrolimus (SET) or reduced-exposure tacrolimus (RET) (SET: n = 76; RET: n = 66), or control (SET + mycophenolic acid [MPA, 720 mg b.i.d.]; n = 74).  In both sotrastaurin groups, patients were converted from tacrolimus to MPA after Month 3, achieving calcineurin inhibitor-free immunosuppression.  The primary endpoint was composite efficacy failure (treated biopsyproven acute rejection, graft loss, death or loss to follow-up).  The key secondary endpoint was glomerular filtration rate (GFR).  Composite efficacy failure rates were: 4.1%, 5.4% and 1.5% at Month 3 (preconversion) and 7.8%, 44.8% and 34.1% at study end in the control, sotrastaurin + SET and sotrastaurin + RET groups, resp.; these results led to premature study discontinuation.  Median GFR at Month 6 was: 57.0, 53.0 and 60.0 mL/min/1.73 m2, resp.  Study-drug discontinuations due to adverse events occurred in 16.2%, 18.4% and 12.1%, resp.  Leukopenia and neutropenia occurred more frequently preconversion in control vs. sotrastaurin groups: 13.7%, 5.6%, and 4.6%; and 11.1%, 4.3% and 3.1%, resp.  The initial sotrastaurin + tacrolimus regimen was efficacious and well tolerated but the postconversion sotrastaurin + MPA regimen showed inadequate efficacy.  Longer-term evaluation of sotrastaurin + tacrolimus is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsD4GC4kdZtrVg90H21EOLACvtfcHk0liSaP3V6lrZKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1ahtLw%253D&md5=d4399839e8fb66b9f46ea2e2aed304d5</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-6143.2009.02980.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-6143.2009.02980.x%26sid%3Dliteratum%253Aachs%26aulast%3DBudde%26aufirst%3DK.%26aulast%3DSommerer%26aufirst%3DC.%26aulast%3DBecker%26aufirst%3DT.%26aulast%3DAsderakis%26aufirst%3DA.%26aulast%3DPietruck%26aufirst%3DF.%26aulast%3DGrinyo%26aufirst%3DJ.%2BM.%26aulast%3DRigotti%26aufirst%3DP.%26aulast%3DDantal%26aufirst%3DJ.%26aulast%3DNg%26aufirst%3DJ.%26aulast%3DBarten%26aufirst%3DM.%2BJ.%26aulast%3DWeber%26aufirst%3DM.%26atitle%3DSotrastaurin%252C%2520a%2520novel%2520small%2520molecule%2520inhibiting%2520protein%2520kinase%2520C%253A%2520first%2520clinical%2520results%2520in%2520renal-transplant%2520recipients%26jtitle%3DAm.%2520J.%2520Transpl.%26date%3D2010%26volume%3D10%26spage%3D571%26epage%3D581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Newton, A. C.</span><span> </span><span class="NLM_article-title">Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">371</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2003&pages=361-371&author=A.+C.+Newton&title=Regulation+of+the+ABC+kinases+by+phosphorylation%3A+protein+kinase+C+as+a+paradigm"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNewton%26aufirst%3DA.%2BC.%26atitle%3DRegulation%2520of%2520the%2520ABC%2520kinases%2520by%2520phosphorylation%253A%2520protein%2520kinase%2520C%2520as%2520a%2520paradigm%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D370%26spage%3D361%26epage%3D371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Tan, S.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, P. J.</span><span> </span><span class="NLM_article-title">Emerging and diverse roles of protein kinase C in immune cell signalling</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">552</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=2003&pages=545-552&author=S.-L.+Tanauthor=P.+J.+Parker&title=Emerging+and+diverse+roles+of+protein+kinase+C+in+immune+cell+signalling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DS.-L.%26aulast%3DParker%26aufirst%3DP.%2BJ.%26atitle%3DEmerging%2520and%2520diverse%2520roles%2520of%2520protein%2520kinase%2520C%2520in%2520immune%2520cell%2520signalling%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D376%26spage%3D545%26epage%3D552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Baier, G.</span><span> </span><span class="NLM_article-title">The PKC gene module: molecular biosystematics to resolve its T cell function</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">192</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm200469u&amp;key=10.1034%2Fj.1600-065X.2003.00018.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm200469u&amp;key=12670396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsVOnt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2003&pages=64-79&author=G.+Baier&title=The+PKC+gene+module%3A+molecular+biosystematics+to+resolve+its+T+cell+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The PKC gene module: molecular biosystematics to resolve its T cell functions</span></div><div class="casAuthors">Baier, Gottfried</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">64-79</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">A review.  The distinct protein kinase C (PKC) multigene family (PKC gene module) is known to be the 'classic' intracellular receptor for mitogenic phorbol esters, and it is widely accepted in the scientific community that the 'PKC effect' is essential in activation, differentiation, adhesion and motility, as well as in cellular survival, of T cells.  Nevertheless, the first concepts about PKC isotype heterogeneity of cellular localization and function emerged only recently, when the PKC-.vtheta. pathways were mapped to crit. signaling networks that control T cell receptor (TCR)/CD3-dependent interleukin (IL)-2 prodn. and proliferation in T lymphocytes.  This review summarizes the current knowledge about T cell expressed PKC gene products, their known and/or suspected regulation and cellular effector pathways, as well as physiol. functions in T lymphocytes (as detd. by mol. cell biol. and ongoing mouse genetic studies).  Given PKCs integral role in T cell function but today's very fragmentary mol. understanding of directly PKC-mediated effector functions in transmembrane signaling, a 'mol. biosystematics' approach is suggested to resolve the isotype-selective functions of this PKC gene family.  Such an approach has to be based not only on genomic/cytogenetic anal. to establish its genetic relationships but also on biochem./cell biol. and genetic studies to resolve its functional diversity and, ultimately, nonredundant roles in real T cell physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcRXXh24tHqrVg90H21EOLACvtfcHk0liSaP3V6lrZKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsVOnt70%253D&md5=981fe5f84b4da5cae591d65a234d8d00</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1034%2Fj.1600-065X.2003.00018.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1600-065X.2003.00018.x%26sid%3Dliteratum%253Aachs%26aulast%3DBaier%26aufirst%3DG.%26atitle%3DThe%2520PKC%2520gene%2520module%253A%2520molecular%2520biosystematics%2520to%2520resolve%2520its%2520T%2520cell%2520function%26jtitle%3DImmunol.%2520Rev.%26date%3D2003%26volume%3D192%26spage%3D64%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Guo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlings, D. J.</span><span> </span><span class="NLM_article-title">Protein kinase C family functions in B-cell activation</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm200469u&amp;key=10.1016%2Fj.coi.2004.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm200469u&amp;key=15134787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVamtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2004&pages=367-373&author=B.+Guoauthor=T.+T.+Suauthor=D.+J.+Rawlings&title=Protein+kinase+C+family+functions+in+B-cell+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase C family functions in B-cell activation</span></div><div class="casAuthors">Guo, Beichu; Su, Thomas T.; Rawlings, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">367-373</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Members of the protein kinase C (PKC) family play important but distinct roles in B-cell activation, as demonstrated by emerging genetic and biochem. studies.  PKCβ is indispensable for B-cell antigen receptor (BCR)-induced NF-κB activation and B-cell survival.  Recent evidence indicates that PKCβ might regulate inhibitor of κB kinase (IKK) and NF-κB activation through interaction with the CARMA1/Bcl10/MALT signaling complex in BCR microdomains.  By contrast, the novel PKC isoform PKCδ is specifically required to maintain the tolerance of self-reactive B cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMGBS557krDLVg90H21EOLACvtfcHk0liIuMmyQiqeCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVamtrk%253D&md5=6642a6eb30c04cb0ac2ea3ee9909c92b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.coi.2004.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coi.2004.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DB.%26aulast%3DSu%26aufirst%3DT.%2BT.%26aulast%3DRawlings%26aufirst%3DD.%2BJ.%26atitle%3DProtein%2520kinase%2520C%2520family%2520functions%2520in%2520B-cell%2520activation%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2004%26volume%3D16%26spage%3D367%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Ife, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blurton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keeling, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meeson, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theobald, C. J.</span><span> </span><span class="NLM_article-title">Reversible inhibitors of the gastric (H<sup>+</sup>/K<sup>+</sup>)-ATPase. 5. Substituted 2,4-diaminoquinazolines and thienopyrimidines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">2763</span><span class="NLM_x">–</span> <span class="NLM_lpage">2773</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00014a027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=2763-2773&author=R.+J.+Ifeauthor=T.+H.+Brownauthor=P.+Blurtonauthor=D.+J.+Keelingauthor=C.+A.+Leachauthor=M.+L.+Meesonauthor=M.+E.+Parsonsauthor=C.+J.+Theobald&title=Reversible+inhibitors+of+the+gastric+%28H%2B%2FK%2B%29-ATPase.+5.+Substituted+2%2C4-diaminoquinazolines+and+thienopyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm00014a027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00014a027%26sid%3Dliteratum%253Aachs%26aulast%3DIfe%26aufirst%3DR.%2BJ.%26aulast%3DBrown%26aufirst%3DT.%2BH.%26aulast%3DBlurton%26aufirst%3DP.%26aulast%3DKeeling%26aufirst%3DD.%2BJ.%26aulast%3DLeach%26aufirst%3DC.%2BA.%26aulast%3DMeeson%26aufirst%3DM.%2BL.%26aulast%3DParsons%26aufirst%3DM.%2BE.%26aulast%3DTheobald%26aufirst%3DC.%2BJ.%26atitle%3DReversible%2520inhibitors%2520of%2520the%2520gastric%2520%2528H%252B%252FK%252B%2529-ATPase.%25205.%2520Substituted%25202%252C4-diaminoquinazolines%2520and%2520thienopyrimidines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D2763%26epage%3D2773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Faul, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winneroski, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumrich, C. A.</span><span> </span><span class="NLM_article-title">A new, efficient method for the synthesis of bisindolylmaleimides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">6053</span><span class="NLM_x">–</span> <span class="NLM_lpage">6058</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo980513c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADyaK1cXkvFKmtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=6053-6058&author=M.+M.+Faulauthor=L.+L.+Winneroskiauthor=C.+A.+Krumrich&title=A+new%2C+efficient+method+for+the+synthesis+of+bisindolylmaleimides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A New, Efficient Method for the Synthesis of Bisindolylmaleimides</span></div><div class="casAuthors">Faul, Margaret M.; Winneroski, Leonard L.; Krumrich, Christine A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6053-6058</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Both sym. and unsym. bisindolylmaleimides were prepd. by reaction of indole-3-acetamides with Me indolyl-3-glyoxylates using a soln. of KOBu-t in THF.  The reaction is successful in the presence of a variety of functional groups (H, alkyl, Oh, NMe2, OTr).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6p6e4vJJuurVg90H21EOLACvtfcHk0liIuMmyQiqeCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvFKmtL8%253D&md5=3d2975997fde454c6d7ed53c8b8ede22</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjo980513c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo980513c%26sid%3Dliteratum%253Aachs%26aulast%3DFaul%26aufirst%3DM.%2BM.%26aulast%3DWinneroski%26aufirst%3DL.%2BL.%26aulast%3DKrumrich%26aufirst%3DC.%2BA.%26atitle%3DA%2520new%252C%2520efficient%2520method%2520for%2520the%2520synthesis%2520of%2520bisindolylmaleimides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D6053%26epage%3D6058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Kosugi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kameyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migita, T.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed displacement of aryl halide by tin analogue of Reformatsky reagent</span> <span class="citation_source-journal">Bull. Chem. Soc. Jpn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3383</span><span class="NLM_x">–</span> <span class="NLM_lpage">3384</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1985&pages=3383-3384&author=M.+Kosugiauthor=Y.+Negishiauthor=M.+Kameyamaauthor=T.+Migita&title=Palladium-catalyzed+displacement+of+aryl+halide+by+tin+analogue+of+Reformatsky+reagent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKosugi%26aufirst%3DM.%26aulast%3DNegishi%26aufirst%3DY.%26aulast%3DKameyama%26aufirst%3DM.%26aulast%3DMigita%26aufirst%3DT.%26atitle%3DPalladium-catalyzed%2520displacement%2520of%2520aryl%2520halide%2520by%2520tin%2520analogue%2520of%2520Reformatsky%2520reagent%26jtitle%3DBull.%2520Chem.%2520Soc.%2520Jpn.%26date%3D1985%26volume%3D58%26spage%3D3383%26epage%3D3384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Wolfe, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed amination of aryl triflates</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1264</span><span class="NLM_x">–</span> <span class="NLM_lpage">1267</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo961915s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADyaK2sXhs1Cqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=1264-1267&author=J.+P.+Wolfeauthor=S.+L.+Buchwald&title=Palladium-catalyzed+amination+of+aryl+triflates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Amination of Aryl Triflates</span></div><div class="casAuthors">Wolfe, John P.; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1264-1267</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The conversion of aryl triflates to the corresponding aniline derivs. was accomplished in moderate to good yield using a catalyst consisting of the combination of palladium acetate (2 mol %) and either BINAP or Tol-BINAP.  In contrast to the corresponding palladium-catalyzed amination of aryl bromides and iodides, electronically neutral aryl triflates gave higher yields of arylamines than did electron deficient aryl triflates, presumably due to the increased rate of base-promoted triflate cleavage in electron deficient substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDMTN7WXJXArVg90H21EOLACvtfcHk0liIuMmyQiqeCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhs1Cqs74%253D&md5=d5a541960bab033e95cc5e6b9816a1de</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjo961915s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo961915s%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DJ.%2BP.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DPalladium-catalyzed%2520amination%2520of%2520aryl%2520triflates%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D1264%26epage%3D1267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Jagdmann, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munson, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gero, T. W.</span><span> </span><span class="NLM_article-title">A mild efficient procedure for the conversion of carboxylic acid esters to primary amides using formamide/methanolic sodium methoxide</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1203</span><span class="NLM_x">–</span> <span class="NLM_lpage">1208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm200469u&amp;key=10.1080%2F00397919008052828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADyaK3cXmtFSqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1990&pages=1203-1208&author=G.+E.+Jagdmannauthor=H.+R.+Munsonauthor=T.+W.+Gero&title=A+mild+efficient+procedure+for+the+conversion+of+carboxylic+acid+esters+to+primary+amides+using+formamide%2Fmethanolic+sodium+methoxide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A mild efficient procedure for the conversion of carboxylic acid esters to primary amides using formamide/methanolic sodium methoxide</span></div><div class="casAuthors">Jagdmann, G. Erik, Jr.; Munson, H. Randall, Jr.; Gero, Thomas W.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1203-8</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">A variety of primary amides were prepd. from esters by using 3 mol equiv formamide and 0.33-0.69 mol equiv 25% methanolic NaOH in DMF or THF.  The reactions were carried out at 60-100° and were usually complete in less than one hour.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8PjBCLiG_ErVg90H21EOLACvtfcHk0lh1sM0f9YLA0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmtFSqtrY%253D&md5=3333a65c7a4bef6b5073bf4884698d5d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1080%2F00397919008052828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919008052828%26sid%3Dliteratum%253Aachs%26aulast%3DJagdmann%26aufirst%3DG.%2BE.%26aulast%3DMunson%26aufirst%3DH.%2BR.%26aulast%3DGero%26aufirst%3DT.%2BW.%26atitle%3DA%2520mild%2520efficient%2520procedure%2520for%2520the%2520conversion%2520of%2520carboxylic%2520acid%2520esters%2520to%2520primary%2520amides%2520using%2520formamide%252Fmethanolic%2520sodium%2520methoxide%26jtitle%3DSynth.%2520Commun.%26date%3D1990%26volume%3D20%26spage%3D1203%26epage%3D1208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">McCort, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoornaert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aletru, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denys, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duclos, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadilhac, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guilpain, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dellac, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galzin, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delahaye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guilbert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, S.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of 3- and 4-substituted quinolin-2-ones: discovery of mixed 5-HT<sub>1B</sub>/5-HT<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2129</span><span class="NLM_x">–</span> <span class="NLM_lpage">2137</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=2129-2137&author=G.+McCortauthor=C.+Hoornaertauthor=M.+Aletruauthor=C.+Denysauthor=O.+Duclosauthor=C.+Cadilhacauthor=E.+Guilpainauthor=G.+Dellacauthor=P.+Janiakauthor=A.-M.+Galzinauthor=M.+Delahayeauthor=F.+Guilbertauthor=S.+O%E2%80%99Connor&title=Synthesis+and+SAR+of+3-+and+4-substituted+quinolin-2-ones%3A+discovery+of+mixed+5-HT1B%2F5-HT2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCort%26aufirst%3DG.%26aulast%3DHoornaert%26aufirst%3DC.%26aulast%3DAletru%26aufirst%3DM.%26aulast%3DDenys%26aufirst%3DC.%26aulast%3DDuclos%26aufirst%3DO.%26aulast%3DCadilhac%26aufirst%3DC.%26aulast%3DGuilpain%26aufirst%3DE.%26aulast%3DDellac%26aufirst%3DG.%26aulast%3DJaniak%26aufirst%3DP.%26aulast%3DGalzin%26aufirst%3DA.-M.%26aulast%3DDelahaye%26aufirst%3DM.%26aulast%3DGuilbert%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520SAR%2520of%25203-%2520and%25204-substituted%2520quinolin-2-ones%253A%2520discovery%2520of%2520mixed%25205-HT1B%252F5-HT2A%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2001%26volume%3D9%26spage%3D2129%26epage%3D2137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Kovarik, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sfikas, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandler, P. A.</span><span> </span><span class="NLM_article-title">The effect on sotrastaurin pharmacokinetics of strong CYP3A inhibition by ketoconazole</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">385</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm200469u&amp;key=10.1111%2Fj.1365-2125.2009.03457.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm200469u&amp;key=19740395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ylsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2009&pages=381-385&author=J.+M.+Kovarikauthor=H.-L.+A.+Huangauthor=A.+Sladeauthor=N.+Sfikasauthor=P.+A.+Chandler&title=The+effect+on+sotrastaurin+pharmacokinetics+of+strong+CYP3A+inhibition+by+ketoconazole"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The effect on sotrastaurin pharmacokinetics of strong CYP3A inhibition by ketoconazole</span></div><div class="casAuthors">Kovarik, John M.; Huang, Hsun-Lun A.; Slade, Alan; Sfikas, Nikos; Chandler, Patricia A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">381-385</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims: Sotrastaurin is an immunosuppressant that reduces T-lymphocyte activation via protein kinase C inhibition.  The effect of CYP3A4 inhibition by ketoconazole on the pharmacokinetics of sotrastaurin, a CYP3A4 substrate, was investigated.  Methods: This was a two-period, single-sequence crossover study in 18 healthy subjects.  They received a single 50 mg oral dose of sotrastaurin in period 1 followed by a 14-day inter-treatment phase.  In period 2 they received ketoconazole 200 mg twice daily for 6 days and a single 50 mg dose of sotrastaurin on the fourth day of ketoconazole administration.  Results: Co-administration of single-dose sotrastaurin during steady-state ketoconazole increased sotrastaurin Cmax by 2.5-fold (90% confidence interval 2.2, 2.9) from 285 ± 128 to 678 ± 189 ng ml-1 and increased AUC by 4.6-fold (4.1, 5.2) from 1666 ± 808 to 7378 ± 3011 ng ml-1 h.  Sotrastaurin half-life was nearly doubled from 5.9 ± 1.7 to 10.6 ± 2.5 h.  The AUC of the active metabolite N-desmethyl-sotrastaurin was increased by 6.8-fold.  Sotrastaurin did not alter ketoconazole steady-state predose plasma concns.  Conclusions: The strong CYP3A4 inhibitor ketoconazole increased sotrastaurin AUC by 4.6-fold.  A compensatory redn. in the dose of sotrastaurin is warranted when strong CYP3A4 inhibitors are co-administered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0RW-0VPBjErVg90H21EOLACvtfcHk0lh1sM0f9YLA0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ylsLzE&md5=2c193041610ebc6d3136016be7a295b8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2009.03457.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2009.03457.x%26sid%3Dliteratum%253Aachs%26aulast%3DKovarik%26aufirst%3DJ.%2BM.%26aulast%3DHuang%26aufirst%3DH.-L.%2BA.%26aulast%3DSlade%26aufirst%3DA.%26aulast%3DSfikas%26aufirst%3DN.%26aulast%3DChandler%26aufirst%3DP.%2BA.%26atitle%3DThe%2520effect%2520on%2520sotrastaurin%2520pharmacokinetics%2520of%2520strong%2520CYP3A%2520inhibition%2520by%2520ketoconazole%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2009%26volume%3D68%26spage%3D381%26epage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Choc, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhmle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charnick, S. B.</span><span> </span><span class="NLM_article-title">Relative bioavailability of Neoral versus Sandimmun in the presence of a P450IIIA and P-glycoprotein inhibitor</span> <span class="citation_source-journal">Transplant Proc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1664</span><span class="NLM_x">–</span> <span class="NLM_lpage">1665</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm200469u&amp;key=10.1016%2FS0041-1345%2898%2900383-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm200469u&amp;key=9723234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADyaK1cXlvV2jtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1998&pages=1664-1665&author=M.+G.+Chocauthor=E.+A.+Muellerauthor=W.+T.+Robinsonauthor=A.+Kuhmleauthor=H.+T.+Smithauthor=S.+B.+Charnick&title=Relative+bioavailability+of+Neoral+versus+Sandimmun+in+the+presence+of+a+P450IIIA+and+P-glycoprotein+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Relative bioavailability of Neoral versus Sandimmune in the presence of a P450IIIA and P-glycoprotein inhibitor</span></div><div class="casAuthors">Choc, M. G.; Mueller, E. A.; Robinson, W. T.; Kumle, A.; Smith, H. T.; Charnick, S. B.</div><div class="citationInfo"><span class="NLM_cas:title">Transplantation Proceedings</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1664-1665</span>CODEN:
                <span class="NLM_cas:coden">TRPPA8</span>;
        ISSN:<span class="NLM_cas:issn">0041-1345</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">In order to test the possibility that a formulation-specific inhibition of metab. or counter transport provide the mechanism for Neoral's increased bioavailability vs. Sandimmune, this study compared cyclosporine A bioavailability for both Neoral and Sandimmune in the presence and absence of a well-characterized inhibitor of P450IIIA/P-glycoprotein.  Cyclosporine AUC , Cmax, and bioavailability ratios in the presence and absence of the P450IIIA/P-gp inhibitor were not statistically different between the two cyclosporine formulations.  These results suggest that the enhanced bioavailability of Neoral compared to Sandimmune is simply explained by improved drug absorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTNX65pnWVg7Vg90H21EOLACvtfcHk0lh1sM0f9YLA0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlvV2jtbk%253D&md5=94850a1f38a26999a33ce287db0f0fce</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0041-1345%2898%2900383-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0041-1345%252898%252900383-2%26sid%3Dliteratum%253Aachs%26aulast%3DChoc%26aufirst%3DM.%2BG.%26aulast%3DMueller%26aufirst%3DE.%2BA.%26aulast%3DRobinson%26aufirst%3DW.%2BT.%26aulast%3DKuhmle%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DH.%2BT.%26aulast%3DCharnick%26aufirst%3DS.%2BB.%26atitle%3DRelative%2520bioavailability%2520of%2520Neoral%2520versus%2520Sandimmun%2520in%2520the%2520presence%2520of%2520a%2520P450IIIA%2520and%2520P-glycoprotein%2520inhibitor%26jtitle%3DTransplant%2520Proc.%26date%3D1998%26volume%3D30%26spage%3D1664%26epage%3D1665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Weckbecker, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pally, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beerli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkhart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieczorek, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metzler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span> </span><span class="NLM_article-title">Effects of the novel protein kinase C inhibitor AEB071 (sotrastaurin) on rat cardiac allograft survival using single agent treatment or combination therapy with cyclosporine, everolimus or FTY720</span> <span class="citation_source-journal">Transpl. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">552</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm200469u&amp;key=10.1111%2Fj.1432-2277.2009.01015.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm200469u&amp;key=20003043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFCksr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=543-552&author=G.+Weckbeckerauthor=C.+Pallyauthor=C.+Beerliauthor=C.+Burkhartauthor=G.+Wieczorekauthor=B.+Metzlerauthor=R.+E.+Morrisauthor=J.+Wagnerauthor=C.+Bruns&title=Effects+of+the+novel+protein+kinase+C+inhibitor+AEB071+%28sotrastaurin%29+on+rat+cardiac+allograft+survival+using+single+agent+treatment+or+combination+therapy+with+cyclosporine%2C+everolimus+or+FTY720"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the novel protein kinase C inhibitor AEB071 (Sotrastaurin) on rat cardiac allograft survival using single agent treatment or combination therapy with cyclosporine, everolimus or FTY720</span></div><div class="casAuthors">Weckbecker, Gisbert; Pally, Charles; Beerli, Christian; Burkhart, Christoph; Wieczorek, Grazyna; Metsler, Barbara; Morris, Randall E.; Wagner, Juergen; Bruns, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Transplant International</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">543-552</span>CODEN:
                <span class="NLM_cas:coden">TRINE5</span>;
        ISSN:<span class="NLM_cas:issn">0934-0874</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">NVP-AEB071 (AEB, sotrastaurin), an oral inhibitor of protein kinase C (PKC), effectively blocks T-cell activation.  The immunosuppressive effects of oral AEB were demonstrated in a rat local graft vs. host (GvH) reaction and rat cardiac transplantation models.  T-cell activation was suppressed by 95% in blood from AEB-treated rats, with a pos. correlation between T-cell inhibition and AEB blood concn.  In GvH studies, AEB inhibited lymph node swelling dose-dependently (3-30 mg/kg).  BN and DA cardiac allografts were acutely rejected within 6-10 days post-transplantation in untreated LEW rats.  AEB at 10 and 30 mg/kg b.i.d. prolonged BN graft survival to a mean survival time of 15 and >28 days, and DA grafts to 6.5 and 17.5 days, resp.  In the DA to LEW model, combining a nonefficacious dose of AEB (10 mg/kg b.i.d.) with a nonefficacious dose of cyclosporine, everolimus or FTY720 led to prolonged median survival times (26 days, >68 days and >68 days, resp.).  Pharmacokinetic monitoring excluded drug-drug interactions, suggesting synergy.  In conclusion, these studies are the first to demonstrate that AEB prolongs rat heart allograft survival safely as monotherapy and in combination with nonefficacious doses of cyclosporine, everolimus or FTY720.  Thus, AEB may have the potential to offer an alternative to calcineurin inhibitor-based therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB6Ge3QcvIKbVg90H21EOLACvtfcHk0liAiUJee47lxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFCksr0%253D&md5=64942e83bfffc98d94bdfdc2c01d9d88</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-2277.2009.01015.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-2277.2009.01015.x%26sid%3Dliteratum%253Aachs%26aulast%3DWeckbecker%26aufirst%3DG.%26aulast%3DPally%26aufirst%3DC.%26aulast%3DBeerli%26aufirst%3DC.%26aulast%3DBurkhart%26aufirst%3DC.%26aulast%3DWieczorek%26aufirst%3DG.%26aulast%3DMetzler%26aufirst%3DB.%26aulast%3DMorris%26aufirst%3DR.%2BE.%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DBruns%26aufirst%3DC.%26atitle%3DEffects%2520of%2520the%2520novel%2520protein%2520kinase%2520C%2520inhibitor%2520AEB071%2520%2528sotrastaurin%2529%2520on%2520rat%2520cardiac%2520allograft%2520survival%2520using%2520single%2520agent%2520treatment%2520or%2520combination%2520therapy%2520with%2520cyclosporine%252C%2520everolimus%2520or%2520FTY720%26jtitle%3DTranspl.%2520Int.%26date%3D2010%26volume%3D23%26spage%3D543%26epage%3D552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><div class="note"><p class="first last">For experimental details, see the following: </p></div><span class="NLM_contrib-group">Suomalainen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johans, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soederlund, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinnunen, P. K. J.</span><span> </span><span class="NLM_article-title">Surface activity profiling of drugs applied to the prediction of blood–brain barrier permeability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1783</span><span class="NLM_x">–</span> <span class="NLM_lpage">1788</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0309001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1783-1788&author=P.+Suomalainenauthor=C.+Johansauthor=T.+Soederlundauthor=P.+K.+J.+Kinnunen&title=Surface+activity+profiling+of+drugs+applied+to+the+prediction+of+blood%E2%80%93brain+barrier+permeability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm0309001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0309001%26sid%3Dliteratum%253Aachs%26aulast%3DSuomalainen%26aufirst%3DP.%26aulast%3DJohans%26aufirst%3DC.%26aulast%3DSoederlund%26aufirst%3DT.%26aulast%3DKinnunen%26aufirst%3DP.%2BK.%2BJ.%26atitle%3DSurface%2520activity%2520profiling%2520of%2520drugs%2520applied%2520to%2520the%2520prediction%2520of%2520blood%25E2%2580%2593brain%2520barrier%2520permeability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1783%26epage%3D1788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Frenkel, Y. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewi, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, P. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1974</span><span class="NLM_x">–</span> <span class="NLM_lpage">1983</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049439i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm200469u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhs1CqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1974-1983&author=Y.+V.+Frenkelauthor=A.+D.+Clarkauthor=K.+Dasauthor=Y.-H.+Wangauthor=P.+J.+Lewiauthor=P.+A.+J.+Janssenauthor=E.+Arnold&title=Concentration+and+pH+dependent+aggregation+of+hydrophobic+drug+molecules+and+relevance+to+oral+bioavailability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability</span></div><div class="casAuthors">Frenkel, Yulia Volovik; Clark, Arthur D., Jr.; Das, Kalyan; Wang, Yuh-Hwa; Lewi, Paul J.; Janssen, Paul A. J.; Arnold, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1974-1983</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have examd. selected physicochem. properties of compds. from the diaryltriazine/diarylpyrimidine (DATA/DAPY) classes of non-nucleoside reverse transcriptase inhibitors (NNRTIs) and explored possible correlations with their bioavailability.  In simple aq. solns. designed to mimic the gastrointestinal (GI) environment of a fasting individual, all NNRTIs demonstrated formation of aggregates as detected by dynamic light scattering and electron microscopy.  Under various conditions mimicking physiol. transitions in the GI environment, aggregate size distributions were shown to depend on compd. concn. and pH.  NNRTIs with good absorption were capable of forming aggregates with hydrodynamic radii of ≤100 nm at higher concns. and over wide ranges of pH, while poorly absorbed inhibitors form aggregates with radii of ≥250 nm at concns. above 0.01 mM, probably representing ppt.  We propose a model in which the uptake rate into systemic circulation depends on having hydrophobic drug aggregates of appropriate size available for absorption at different locations within the GI tract.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNGjTCVuba-7Vg90H21EOLACvtfcHk0liAiUJee47lxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhs1CqtLY%253D&md5=a80f14252dbef3b4152447d5b350b495</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm049439i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049439i%26sid%3Dliteratum%253Aachs%26aulast%3DFrenkel%26aufirst%3DY.%2BV.%26aulast%3DClark%26aufirst%3DA.%2BD.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.-H.%26aulast%3DLewi%26aufirst%3DP.%2BJ.%26aulast%3DJanssen%26aufirst%3DP.%2BA.%2BJ.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DConcentration%2520and%2520pH%2520dependent%2520aggregation%2520of%2520hydrophobic%2520drug%2520molecules%2520and%2520relevance%2520to%2520oral%2520bioavailability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1974%26epage%3D1983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Porter, C. J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">William, N.</span><span> </span><span class="NLM_article-title">Transport and absorption of drugs via the lymphatic system</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">2</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2001&pages=1-2&author=C.+J.+H.+Porterauthor=N.+William&title=Transport+and+absorption+of+drugs+via+the+lymphatic+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DC.%2BJ.%2BH.%26aulast%3DWilliam%26aufirst%3DN.%26atitle%3DTransport%2520and%2520absorption%2520of%2520drugs%2520via%2520the%2520lymphatic%2520system%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D50%26spage%3D1%26epage%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Wasan, K. M.</span><span> </span><span class="NLM_article-title">The role of lymphatic transport in enhancing oral protein and peptide drug delivery</span> <span class="citation_source-journal">Drug Dev. Ind. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1047</span><span class="NLM_x">–</span> <span class="NLM_lpage">1058</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2002&pages=1047-1058&author=K.+M.+Wasan&title=The+role+of+lymphatic+transport+in+enhancing+oral+protein+and+peptide+drug+delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWasan%26aufirst%3DK.%2BM.%26atitle%3DThe%2520role%2520of%2520lymphatic%2520transport%2520in%2520enhancing%2520oral%2520protein%2520and%2520peptide%2520drug%2520delivery%26jtitle%3DDrug%2520Dev.%2520Ind.%2520Pharm.%26date%3D2002%26volume%3D28%26spage%3D1047%26epage%3D1058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Smits, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuiderveld, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broeker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sansuk, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guaita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coruzzi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haaksma, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span> </span><span class="NLM_article-title">Discovery of quinazolines as histamine H<sub>4</sub> receptor inverse agonists using a scaffold hopping approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7855</span><span class="NLM_x">–</span> <span class="NLM_lpage">7865</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800876b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7855-7865&author=R.+A.+Smitsauthor=I.+J.+P.+de+Eschauthor=O.+P.+Zuiderveldauthor=J.+Broekerauthor=K.+Sansukauthor=E.+Guaitaauthor=G.+Coruzziauthor=M.+Adamiauthor=E.+Haaksmaauthor=R.+Leurs&title=Discovery+of+quinazolines+as+histamine+H4+receptor+inverse+agonists+using+a+scaffold+hopping+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm800876b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800876b%26sid%3Dliteratum%253Aachs%26aulast%3DSmits%26aufirst%3DR.%2BA.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DZuiderveld%26aufirst%3DO.%2BP.%26aulast%3DBroeker%26aufirst%3DJ.%26aulast%3DSansuk%26aufirst%3DK.%26aulast%3DGuaita%26aufirst%3DE.%26aulast%3DCoruzzi%26aufirst%3DG.%26aulast%3DAdami%26aufirst%3DM.%26aulast%3DHaaksma%26aufirst%3DE.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520quinazolines%2520as%2520histamine%2520H4%2520receptor%2520inverse%2520agonists%2520using%2520a%2520scaffold%2520hopping%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7855%26epage%3D7865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Dawson, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farhana, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiselyuk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correa, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itkin-Ansar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontana, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.-K.</span><span> </span><span class="NLM_article-title">Derivation of a retinoid X receptor scaffold from peroxisome proliferator-activated receptor γ ligand 1-di(1<i>H</i>-indol-3-yl)methyl-4-trifluoromethylbenzene</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1106</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1106-1119&author=M.+I.+Dawsonauthor=M.+Yeauthor=X.+Caoauthor=L.+Farhanaauthor=Q.-Y.+Huauthor=Y.+Zhaoauthor=L.+P.+Xuauthor=A.+Kiselyukauthor=R.+G.+Correaauthor=L.+Yangauthor=T.+Houauthor=J.+C.+Reedauthor=P.+Itkin-Ansarauthor=F.+Levineauthor=M.+F.+Sannerauthor=J.+A.+Fontanaauthor=X.-K.+Zhang&title=Derivation+of+a+retinoid+X+receptor+scaffold+from+peroxisome+proliferator-activated+receptor+%CE%B3+ligand+1-di%281H-indol-3-yl%29methyl-4-trifluoromethylbenzene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DM.%2BI.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DFarhana%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DQ.-Y.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DL.%2BP.%26aulast%3DKiselyuk%26aufirst%3DA.%26aulast%3DCorrea%26aufirst%3DR.%2BG.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DHou%26aufirst%3DT.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DItkin-Ansar%26aufirst%3DP.%26aulast%3DLevine%26aufirst%3DF.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DFontana%26aufirst%3DJ.%2BA.%26aulast%3DZhang%26aufirst%3DX.-K.%26atitle%3DDerivation%2520of%2520a%2520retinoid%2520X%2520receptor%2520scaffold%2520from%2520peroxisome%2520proliferator-activated%2520receptor%2520%25CE%25B3%2520ligand%25201-di%25281H-indol-3-yl%2529methyl-4-trifluoromethylbenzene%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1106%26epage%3D1119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Ilovich, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billauer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishani, E.</span><span> </span><span class="NLM_article-title">Labeled 3-aryl-4-indolylmaleimide derivatives and their potential as angiogenic PET biomarkers</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">612</span><span class="NLM_x">–</span> <span class="NLM_lpage">620</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=612-620&author=O.+Ilovichauthor=H.+Billauerauthor=S.+Dotanauthor=E.+Mishani&title=Labeled+3-aryl-4-indolylmaleimide+derivatives+and+their+potential+as+angiogenic+PET+biomarkers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIlovich%26aufirst%3DO.%26aulast%3DBillauer%26aufirst%3DH.%26aulast%3DDotan%26aufirst%3DS.%26aulast%3DMishani%26aufirst%3DE.%26atitle%3DLabeled%25203-aryl-4-indolylmaleimide%2520derivatives%2520and%2520their%2520potential%2520as%2520angiogenic%2520PET%2520biomarkers%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D612%26epage%3D620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm200469u&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Fjm200469u%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-17" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm200469u" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679971e348d33d00","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
